STABILIZATION OF CONCENTRATES IN SUSPENSION BY MEANS OF HYDROPHOBIC SMOKY SILICA.

Abstract

The invention relates to an aqueous agrochemical composition comprising (a) suspended particles of an active ingredient; and (b) hydrophobically modified fumed silica. It also relates to the use of the hydrophobically modified fumed silica to stabilize an aqueous agrochemical composition comprising suspended particles of an active ingredient; to a method for stabilizing an agrochemical composition comprising the suspended particles of an active ingredient; to a method for treating, controlling, preventing, or protecting animals from parasitic infestation or infection by applying the agrochemical composition; to a method for preparing the agrochemical composition; and to plant propagation material containing the agrochemical composition.

Description

STABILIZATION OF CONCENTRATE IN SUSPENSION USING HYDROPHOBIC FUMED SILICA The invention relates to an aqueous agrochemical composition comprising suspended particles of an active ingredient having a water solubility of at least 1 g / L at 25°C and hydrophobically modified fumed silica. The invention also relates to a process for the preparation of the agrochemical composition; to a method to control phytopathogenic fungi and / or unwanted plant growth and / or unwanted attack by insects or mites and / or to regulate plant growth, wherein the agrochemical composition is allowed to act on the respective pests, in their environment or in the crop plants that are to be protected from the respective pests, in the soil and / or in the unwanted plants and / or in the crop plants and / or in their environment. It also refers to a non-therapeutic method of treating animals infested or infected with parasites or preventing animals from becoming infested or infected with parasites or protecting animals against parasite infestation or infection comprising administering or applying orally, topically or parenterally to animals a parasitically effective amount of the agrochemical composition; a method of treating, controlling, preventing or protecting animals from parasite infestation or infection by administering or applying orally, topically or parenterally to animals the agrochemical composition; to the use of the agrochemical composition to protect growing plants or plant propagating material from attack or infestation by invertebrate pests; the use of the agrochemical composition to combat parasites or insects in animals; and to the agrochemical composition for use in a method for controlling or preventing infestation of an animal with insects or parasites. Another objective is the use of hydrophobically modified fumed silica to stabilize an aqueous agrochemical composition comprising suspended particles of the active ingredient; and a method for stabilizing an aqueous agrochemical composition comprising the suspended particles of the active ingredient comprising contacting the hydrophobically modified fumed silica with particles of the active ingredient and water. Combinations of embodiments with other embodiments, regardless of their respective level of preference, are within the scope of the invention. Aqueous suspension concentrates are one of the most commonly used formulation types in the agrochemical industry. They are generally limited to active ingredients that have very low water solubility. Active ingredients with high water solubility are difficult to form into concentrates in aqueous suspension, as the particles dissolve during storage or undergo Ostwald ripening, which therefore results in a larger particle size. particle and eventual sedimentation. Other stability problems of such formulations are gelation, that is, the formation of structureless conglomerates of the active ingredient negatively influences the desired rheological profiles, for example, by increasing viscosity or by clogging spray nozzles. On the other hand, concentrates in aqueous suspension have the advantage of a low content of organic solvents and relatively safe handling and application for those who apply them. Therefore, it was desirable to provide an aqueous agrochemical composition containing an active ingredient with a high water solubility in the form of suspended particles, which is stable upon storage, is not subject to particle growth, aggregation or conglomeration of the particles. particles and is therefore not prone to particle gelation or sedimentation. The objective was achieved by means of an aqueous agrochemical composition comprising a) suspended particles of an active ingredient; and b) hydrophobically fumed silica; wherein the active ingredient has a water solubility of at least 1 g / L at 25°C. Surprisingly, it was discovered that the hydrophobic modification of fumed silica is essential to generate the advantageous composition of the present invention. The agrochemical composition is an aqueous agrochemical composition. The water content of the agrochemical composition is generally at least 1% by weight, preferably at least 5% by weight, more preferably at least 10% by weight, more preferably at least 15% by weight, most preferably at least 20% by weight, most preferably at least 25% by weight, particularly preferably at least 30% by weight, and in particular at least 35% by weight, each time based on the total weight of the agrochemical compositions. The water content of the agrochemical composition is generally up to 95% by weight, preferably up to 90% by weight, more preferably up to 80% by weight, most preferably up to 70% by weight, especially preferably up to 60% by weight. and, in particular, up to 50% by weight based on the total weight of the agrochemical composition. The water content of the agrochemical composition is generally 10 to 85% by weight, preferably 10 to 65% by weight, more preferably 15 to 60% by weight based on the total weight of the agrochemical composition. The agrochemical composition comprises hydrophobically modified fumed silica, which is generally present in the form of suspended particles. Hydrophobically modified silica is commercially available under the Aerosil tradenames, eg, Aerosil R805, among others. As used herein, the term fumed silica is a synonym for the term fumed silica. It refers to amorphous silica, which can be produced, for example, from a precursor, eg SiCU, by flame pyrolysis, or from quartz sand vaporized in an electric arc. As used herein, the term "hydrophobically modified" refers to modification of the fumed silica, typically on the surface of the fumed silica particles. The modification generally results in the covalent attachment of at least one hydrocarbon chain to the fumed silica, preferably to the surface of the fumed silica particles. In general, the term "hydrophobically modified fumed silica" refers to fumed silica having at least one covalently attached hydrocarbon chain containing 1 to 20 carbon atoms, preferably 1 to 16, more preferably 1 to 10, carbon atoms. Hydrophobically modified fumed silica is generally not covalently attached to a hydrocarbon chain that is substituted with a hydroxyl group, carboxylate group, sulfonate group, or phosphonate group. The hydrophobically modified fumed silica is generally present as suspended particles in the aqueous agrochemical composition. Particles can be characterized by their size distribution, which can be determined using dynamic light scattering techniques. Suitable dynamic light scattering measurement units are produced, inter alia, under the trade name Malvern Mastersizer 3000. Particles can be characterized by their median diameter, which is usually abbreviated x50 value. The x50 value refers to a particular particle diameter, where half of the population of particles by volume is less than this diameter. The x50 value is usually determined in accordance with ISO 13320:2009. The particles may have a x50 value of 0.5 nm to 1 pm, preferably 1 nm to 500 nm, more preferably 5 to 100 pm, most preferably 10 pm to 50 pm. The particles generally have a x50 value of at least 0.75 nm, preferably at least 2 nm. Hydrophobically modified fumed silica is non-porous. It may have a BET surface area of ​​at least 50 m2 / g, preferably at least 60 m2 / g, more preferably at least 80 m2 / g. The hydrophobically modified fumed silica may have a BET surface area of ​​up to 400 m2 / g, preferably up to 350 m2 / g, more preferably up to 300 m2 / g. The hydrophobically modified fumed silica may have a BET surface area of ​​10 to 500 m2 / g, preferably 50 to 400 m2 / g. The BET surface can be determined according to DIN ISO 9277:2014-01. The concentration of the hydrophobically modified fumed silica may be at least 0.01% by weight, preferably at least 0.1% by weight, more preferably at least 0.2% by weight, most preferably at least 0.3% by weight and in particular at least 0.4% by weight, such as at least 0.5% by weight based on the total weight of the agrochemical composition. The concentration of the hydrophobically modified fumed silica can be up to 15% by weight, preferably up to 10% by weight, more preferably up to 5% by weight, most preferably up to 1.8% by weight based on the total weight of the agrochemical composition. The concentration of the hydrophobically modified fumed silica is generally 0.1 to 10% by weight, preferably 0.1 to 5% by weight, more preferably 0.3 to 2% by weight, most preferably 0.4 to 1.7% by weight based on the total weight of the agrochemical composition. The weight ratio of the active ingredient to the hydrophobically modified fumed silica is generally 1000:1 to 1:1, preferably 500:1 to 5:1, more preferably 200:1 to 20:1: 1, with maximum preference from 100:1 to 25:1. Generally, the weight ratio of the active ingredient to the hydrophobically modified fumed silica is at least 15:1, preferably 18:1, more preferably 22:1. The hydrophobically modified fumed silica generally has a carbon content of at least 0.1% by weight, preferably at least 0.5% by weight based on the total weight of the hydrophobically modified silica. The hydrophobically modified fumed silica may have a carbon content of up to 10% by weight, preferably up to 8% by weight based on the total weight of the hydrophobically modified silica. The agrochemical composition contains an active ingredient. The active ingredient can be selected from the group of fungicides, insecticides, nematicides, herbicides, protectants, micronutrients, biopesticides, nitrification inhibitors, urease inhibitors and / or growth regulators. In one embodiment, the pesticide is an insecticide. In another embodiment, the pesticide is a fungicide. In yet another embodiment, the pesticide is a herbicide. The mid-level trade person is familiar with these pesticides, which can be found, for example, in Pesticide Manual, 16.aed. (2013), The British Crop Protection Council, London. Suitable insecticides are insecticides of the carbamate class, organophosphates, organochlorine insecticides, phenylpyrazoles, pyrethroids, neonicotinoids, spinosins, avermectins, milbemycin, juvenile hormone analogues, alkyl halides, organotin compounds, nereistoxin analogues, benzoylureas, diacylhydrazines, METI acaricides and insecticides, such as chloropicrin, pymetrozine, flonicamid, clofentezine, hexithiazox, etoxazole, diafenthiuron, propargite, tetradifon, chlorfenapyr, DNOC, buprofezin, cyromazine, amitraz, hydramethylnon, acequinocyl, fluacripyrim, rotenone or derivatives thereof. Suitable fungicides are fungicides from the classes of dinitroanilines, allylamines, anilinopyrimidines, antibiotics, aromatic hydrocarbons, benzenesulfonamides, benzimidazoles, benzisothiazoles, benzophenones, benzothiadiazoles, benzotriazines, benzylcarbamates, carbamates, carboxamides, carboxylic acid diamides, chloronitriles, oximes of cyanoacetamide, cyanoimidazoles , cyclopropanecarboxamides, dicarboximides, dihydrodioxazines, dinitrophenylcrotonates, dithiocarbamates, dithiolanes, ethylphosphonates, ethylaminothiazolcarboxamides, guanidines, hydrox¡-(2-amino)pyrimidnes, hydroxyanilides, imidazoles, imidazolinones, inorganic substances, isobenzofuranones, methoxyacrylates, methoxy arbamates, morpholines, N-phenylcarbamates, oxazolidinediones, oxyminoacetates, oxyminoacetamides, peptidylpyrimidinenucleosides, phenylacetamides, phenylamides, phenylpyrroles, phenylureas, phosphonates, phosphorothiolates, phthalamic acids, phthalimides, piperazines, piperidines, propionamides, pyridazinones, pyridines, pyridine ylmethylbenzamides, pyrimidinamines, pyrimidines, pyrimidinonehydrazones, pyrroloquinolinones , quinazolinones, quinolines, quinones, sulfonamides, sulfamoyltriazoles, thiazolcarboxamides, thiocarbamates, thiophanates, thiophencarboxamides, toluamides, triphenyltin compounds, triazines, triazoles. Suitable herbicides are herbicides from the classes of acetamides, amides, aryloxyphenoxypropionates, benzamides, benzofuran, benzoic acids, benzothiadiazinones, bipyridylium, carbamates, chloroacetamides, chlorocarboxylic acids, cyclohexanediones, dinitroanilines, dinitrophenol, diphenyl ethers, glycines, imidazolinones, isoxazoles, isoxazolidinones, nitrites, Nphenylphthalimides, oxadiazoles, oxazolidinediones, oxyacetamides, phenoxycarboxylic acids, phenylcarbamates, phenylpyrazoles, phenylpyrazolines, phenylpyridazines, phosphinic acids, phosphoroamidates, phosphorodithioates, phthalates, pyrazoles, pyridazinones, pyridines, pyridinecarboxylic acids s, pyridinecarboxamides, pyrimidinediones, pyrimidinyl(thio)benzoates , quinolinecarboxylic acids, semicarbazones, sulfonylaminocarbonyltriazolinones, sulfonylureas, tetrazolinones, thiadiazoles, thiocarbamates, triazines, triazinones, triazoles, triazolinones, triazolocarboxamides, triazolopyrimidines, triketones, uracils, ureas. Suitable plant growth regulators are antiauxins, auxins, cytokinins, defoliants, ethylene modulators, ethylene releasers, gibberellins, growth inhibitors, morphactins, growth retardants, growth stimulators and other unclassified plant growth regulators. Suitable micronutrients are compounds comprising boron, zinc, iron, copper, manganese, chlorine and molybdenum. The agrochemical composition comprises a pesticide effective amount of the active ingredient. The term effective amount indicates an amount of the active ingredient that is sufficient to control harmful fungi in cultivated plants or in the protection of materials and that does not generate substantial damage to the treated plants. Such amount can vary over a wide range and depends on various factors, such as the pest species to be controlled, the material or cultivated plants treated, climatic conditions and the specific active ingredient used. The concentration of the active ingredient in the agrochemical composition is generally at least 5% by weight, more preferably at least 10% by weight, most preferably at least 15% by weight, with particular preference at least 20% by weight, with Preference is given to at least 25% by weight and, in particular, at least 30% by weight based on the total weight of the agrochemical composition. The concentration of the active ingredient in the agrochemical composition is generally up to 95% by weight, preferably up to 85% by weight, more preferably up to 75% by weight, especially preferably up to 75% by weight and, in particular, up to 65%. by weight based on the total weight of the agrochemical composition. The agrochemical composition generally contains the active ingredient in a concentration of 10 to 90% by weight, preferably 15 to 60% by weight, more preferably 20 to 50% by weight based on the total weight of the agrochemical composition. The active ingredient is present in the agrochemical composition in the form of suspended particles. Particles can be characterized by their size distribution, which can be determined using dynamic light scattering techniques. Suitable dynamic light scattering measurement units are produced, among others, under the trade name Malvern Mastersizer 3000. Particles can be characterized by their median diameter, which is usually abbreviated as x50 value. The x50 value refers to a particular particle diameter, where half of the particle population by volume is smaller than this diameter. The x50 value is usually determined in accordance with ISO 13320:2009. The particles may have a x50 value of 0.05 pm to 30 pm, preferably 0.1 pm to 20 pm, more preferably 0.5 to 20 pm, most preferably 0.5 pm to 15 pm, most preferably 0.5 pm to 10 pm. . The particle generally has a x50 value of at least 0.75 pm, preferably at least 1 pm. The active ingredient has a water solubility of at least 1 g / L at 20°C. Preferably, the active ingredient has a water solubility of at least 5 g / L, preferably at least 10 g / L, more preferably at least 20 g / L, most preferably at least 30 g / L and, in particular, at least 40 g / L. The active ingredient may have a solubility in water at 25°C of up to 200 g / L, preferably up to 100 g / L, more preferably up to 80 g / L, most preferably up to 60 g / L, most preferably up to 50 g / L. The active ingredient may have a solubility in water at 25°C of 15 g / L to 70 g / L, preferably 25 g / L to 40 g / L. The agrochemical composition may contain an additional active ingredient, which may be selected from fungicides, insecticides, nematicides, herbicides, protectants, micronutrients, biopesticides, nitrification inhibitors, urease inhibitors and / or growth regulators. The additional active ingredient may be present in dissolved form or as suspended particles in the agrochemical composition. In one embodiment, the additional active ingredient is present as an emulsified liquid. The concentration of the additional active ingredient is generally 1 to 50% by weight, preferably 10 to 25% by weight based on the total weight of the agrochemical composition. The active ingredient may be a compound of Formula I wherein RP1, RP2 and RP3 are independently of each other H, CN, halogen, Ci-C4-alkyl, Ci-Cs-haloalkyl, Ci-C4-alkoxy, Ci-Cs-haloalkoxy, Ci-C4-alkylthio, Ci-Cs- haloalkylthio, Ci-C4-alkylsulfinyl, CiCs-haloalkylsulfinyl, C-ι-C4-alkylsulfonyl, Ci-Cs-haloalkylsulfonyl, Cs-Ce-cycloalkyl, C3Ce-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl or Ci-C4-alkoxy¡Ci-C4-alkyl; Z1esNoCH; Z2es N or GR4; Z3es N or GR5; T is S, O or NR1b, where R1bes H, Ci-Cio-alkyl, Ci-C4-haloalkyl, Cs-Cio-cycloalkyl, Cs-Cio-cycloalkylmethyl, C3Cio-halocycloalkyl, C2-Cio-alkenyl, C2-Cio-haloalkenyl, C2-Cio-alkynyl, C1 -C10alkoxy-Ci-C4-alkyl, ORa, 3- to 10-membered heterocyclyl, 3- to 10-membered heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci -C4-alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different Raa substituents; R1is H, CN, Ci-Cw-alkyl, Ci-Cio-haloalkyl, Cs-Cio-cycloalkyl, Cs-Cio-halocycloalkyl, Ci-C4-alkoxy-Ci-C4-alkyl, C2-Cio-alkenyl, C2-Cio -haloalkenyl, C2-Cio-alkylene, Cs-Cio-haloalkynyl, Ci-Cs-alkylene-CN, ORa, Ci-Cs-alkylene-OR3, C(Y)Rb, Ci-Cs-alkylene C(Y)Rb, C(Y)ORC, Ci-C5-alkylene-C(Y)ORc, S(O)2Rd, NReRf, Ci-C5-alkylene-NReRf, C(Y)NR9Rh, Ci- C5-alkylene-C(Y)NR9Rh, S(O)mNReRf, C(Y)NR'NReRf, Ci-C5-alkyleneS(O)2Rd, Ci-C5-alkylene-S(O)mNReRf, Ci- C5-alkylene-C(Y)NR'NReRf, aryl, 3- to 10-membered heterocyclyl, hetaryl, aryl-Ci-Cs-alkyl, Cs-Cio-cycloalkyl-Ci-Cs-alkyl, 3-membered heterocyclylCi-Cs-alkyl 10-membered or hetaryl-Ci-Cs-alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different Rr and / or Rxí substituents; R2is H, CN, NO2, Ci-Cio-alkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, L1-C3-Cio-cycloalkyl, L1-(3- to 6-membered heterocyclyl), L1-aryl or L1- heteroaryl, whose heterocyclyl groups contain one or more equal or different O, N, S(O)m or NR3A heteroatoms, whose cyclic groups may contain one or more CO groups, and wherein the groups are unsubstituted or substituted with one or more Rxequal or different substituents; where L1 is a direct bond, Ci-Cs-alkylene, C2-C8-alkenylene, C2-C8-alkynylene or C3-C6cycloalkylene, wherein the C atoms are unsubstituted or substituted with one or more equal or different substituents; R3 is H, halogen, CN, C-i-Cio-alkyl, Ci-Cio-haloalkyl, Ci-Cw-alkoxy or Ci-Cio-haloalkoxy; R4, R5 are independently (i) H, CN, NO2, halogen, Ci-Cio-alkyl, C2-Cio-alkenyl or Ca-Cw-alkynyl, wherein the C atoms are unsubstituted or substituted with one or more substituents Rxequal or different; or OR% SRd, C(Y)Rb, C(Y)ORC, S(O)Rd, S(O)2Rd, NReRf, C(Y)NR9Rh, S(O)mNReRf, C(Y)NR'NReRf, Ci-C5-alkylene-ORa, Ci-C5-alkylene-CN, Ci-C5-alkylene-C(Y)Rb, C1-C5-alkylene-C(Y)ORc, Ci-C5-alkylene-NReRf, Ci-C5- alkylene-C(Y)NR9Rh, Ci-Cs-alkyleneS(O)mRd, Ci-C5-alkylene-S(O)mNReRf, Ci-C5-alkylene-NRNReRf; or 3- to 10-membered heterocyclyl, hetaryl, Cs-Cio-cycloalkyl, Cs-Cio-cycloalkenyl, aryl, 3- to 10-membered heterocyclyl-Ci-Cs-alkyl, hetaryl-Ci-Cs-alkyl, Cs-Cio-cycloalkyl -CiCs-alkyl, Cs-Cio-cycloalkenyl-Ci-Cs-alkyl or aryl-Ci-Cs-alkyl, wherein the cyclic moieties are unsubstituted or are substituted with one or more equal or different Rv substituents; or R4 is (i) L2-C3-Cio-cycloalkenyl, L2-C3-Cio-cycloalkenyloxy¡ or L2-C3-Cio-cycloalkenylth¡o, wherein the cycloalkenyl rings are unsubstituted or substituted with one or more Ry substituents same or different; where L2 is Ci-Ce-alkylene, C2-C8-alkenylene, C2-C8-alkynylene or Cs-Ce-cycloalkylene, wherein the C atoms are unsubstituted or substituted with one or more equal or different substituents; or R4es (iii) any of the following groups where R4a, R4b and R4c are independently of each other H, halogen, CN, NO2, Ci-Cio-alkyl, C2-C10alkenyl or C2-Cio-alkynyl, wherein the C atoms are unsubstituted or substituted with one or more substituents Rx¡ same or different; Ci-Cio-haloalkyl, Ci-Cio-alkoxy or Ci-C4-alkoxy-Ci-Cio-alkyl, wherein the C atoms are unsubstituted or substituted with one or more Rigial or different substituents; ORa, SRa, C(Y)Rb, C(Y)ORC, C(Y)NR9Rh, C(Y)NR'NReRf, S(O)mRd, S(O)mNReRf, C1-C5alkylene-ORa, Ci- Cs-alkylene-CN, Ci-C5-alkylene-C(Y)Rb, Ci-C5-alkylene-C(Y)ORc, C1-C5alkylene-NReRf, Ci-C5-alkylene-C(Y)NR9Rh, Ci- C5-alkylene-S(O)mRd, Ci-Cs-alkyleneS(O)mNReRfo Ci-C5-alkylene-NR'NReRf; 3- to 10-membered heterocyclyl, Cs-Cw-cycloalkyl, Cs-Cio-cycloalkenyl, hetaryl, aryl, 3- to 10-membered heterocyclyl-Ci-Cs-alkyl, Cs-Cio-cycloalkyl-Ci-Cs-alkyl, C3- C10cycloalkenyl-Ci-C5-alkyl, hetaryl-Ci-C5-alkyl or aryl-Ci-Cs-alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more Ryequal or different substituents; A is a 3- to 12-membered non-aromatic carbocycle or heterocycle, whose heterocycle contains one or more identical or different N, O or S heteroatoms, where S may be oxidized, and whose carbocycles or heterocycles are unsubstituted or substituted with one or more substituents R¡ and / or R1 the same or different; D is a direct bond, Ci-Ce-alkylene, C2-C6-alkenylene or C2-C6-alkynylene, whose carbon chains are unsubstituted or substituted with one or more equal or different substituents; E is a 3- to 12-membered non-aromatic carbocycle or heterocycle, whose heterocycle contains one or more identical or different N, O or S heteroatoms, where S may be oxidized, and whose carbocycles or heterocycles are unsubstituted or substituted with one or more of the same or different Rn and / or R1 substituents; R4 des Ci-C4-haloalkyl or Cs-Cs-cycloalkyl, which may be halogenated; G is Ci-Ce-alkylene, C2-C6-alkenylene, C2-C6-alkynylene, Ca-Ce-cycloalkylene or Cs-Cecycloalkenylene, wherein the C atoms are unsubstituted or substituted with one or more equal or different Rp substituents ; or R4es (iv) any of the following groups Μ l-W-V R4fN={R4e(iva), R49(ivb); where R4ees H, Ci-Ce-alkyl, C2-C8-alkenyl, Cz-Cs-alkynyl, Ca-Ce-cycloalkyl, Ca-Cecycloalkenyl or a 3- to 6-membered heterocycle, which heterocycle contains one or more N, O or heteroatoms S equal or different, where S may be oxidized, whose groups are unsubstituted or substituted with one or more equal or different Rry / or R1 substituents; Q is a direct bond, Ci-Cs-alkylene, Cz-Cs-alkenylene or Cz-Cs-alkynylene, whose carbon chains are unsubstituted or substituted with one or more equal or different substituents; Q and R4 together form a 3- to 6-membered carbocyclic ring or a 4- to 6-membered heterocycle with a direct bond to the imidazole, which heterocycle contains one or more of the same or different N, O or S heteroatoms, where S may be oxidized, and whose rings are unsubstituted or substituted with one or more identical or different Rry / or R1¡ substituents; M is O, S, NRM, NORMo NSRM; where RM is a group mentioned for R4eo where RM and Q together form a 4- to 6-membered non-aromatic unsaturated N-containing heterocycle, which heterocycle may contain an additional O or S heteroatom, where S may be oxidized, and whose ring is unsubstituted or substituted with one or more substituents. Same or different; R4ges H, Ci-Cs-alkyl, Ci-Ce-alkyl-X, Ca-Ce-cycloalkyl or Ca-Ce-cycloalkyl-X; and R4fes Ci-Ce-alkyl, O-Ce-alkyl-X, Ca-Ce-cycloalkyl or Ca-Ce-cycloalkyl-X, wherein the Ci-Ce-alkyl or Ca-Ce-cycloalkyl groups are unsubstituted or substituted with one or more equal or different substituents; where X is O, S, NH or NR1; either R4s and R4f together with the carbon atom to which they are attached form a saturated or unsaturated carbocycle or heterocycle of 3 to 8 members, whose heterocycle contains one or more N, O or S heteroatoms, the same or different, where S can be oxidized, and wherein the carbocycles or heterocycles are unsubstituted or substituted with one or more identical or different R' and / or R1 substituents; W is Ci-Cs-alkylene, Ca-Cs-cycloalkylene, Ca-Cs-heterocycloalkylene, Cs-Cs-alkenylene, Cs-Cs-cycloalkenylene, Ca-Cs-heterocycloalkenylene or Ca-Ce-alkynylene, where W is unsubstituted or is substituted with one or more identical or different R' and / or R1 substituents; V is O, S or NR1a, where R1aes H, Ci-Cio-alkyl, Ci-C4-haloalkyl, Cs-Cio-cycloalkyl, Ca-Cio-cycloalkylmethyl, Ca10 Cio-halocycloalkyl, C2-Cio-alkenyl, C2-Cio-haloalkenyl, C2-Cio-alkynyl, C1-C10alkoxy-Ci-C4-alkyl, ORa, 3- to 10-membered heterocyclyl, 3-membered heterocyclyl-Ci-C4-alkyl 10-membered, aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different substituents; or where R1a and R4a together with the carbon atom to which R4a is attached and the nitrogen atom to which R1a is attached, as well as the nitrogen atom between said carbon atom and said nitrogen atom, form a 4 to 8 membered heterocycle , which contains the two nitrogen atoms as heteroatoms and may further contain one or more N, O or S heteroatoms, the same or different, where S may be oxidized, and where the heterocycle is unsubstituted or substituted with one or more equal or different R* and / or R1 substituents; or R4 is (v) any of the groups (va) S(O)m-R4h, (vb) O-R4' or (ve) NR4¡R4k; where R4h, R4'are independently of each other CN; Ci-Cs-alkyl, C2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA1 substituents; Cs-Cs-cycloalkyl, Cs-Cs-cycloalkenyl or 3- to 8-membered heterocyclyl, the heterocyclyl group of which contains one or more O, N, S(O)m or NR3A heteroatoms, the same or different of which cyclic groups may contain one or more equal or different C(GA)R2A groups, and whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; C3-C8-cycloalkyl-Ci-C4-alkyl, C5-C8-cycloalkenyl-Ci-C4-alkyl or 3- to 8-membered heterocyclyl-Ci-C4alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O )m or NR3A¡equal or different, whose cyclic groups may contain one or more C(GA)R2A groups equal or different, and where the C atoms of these groups are unsubstituted or are substituted with one or more substituents RA4¡same or different; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more identical or different RA5 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; where GAes O, N-CN or N-OR2A; R2Ais H; C1-Ce-alkyl, O2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, Cs-Cs-cycloalkenyl or 3- to 8-membered heterocyclyl, whose heterocyclyl group contains one or more equal or different O or S(O)heteroatoms, and whose cyclic groups are unsubstituted or substituted with one or more identical or different RA4 substituents; Cs-Cs-cycloalkyl-Ci-Ci-alkyl, Cs-Cs-cycloalkenyl-Ci-CA-alkyl or 3- to 8-membered heterocyclyl-Ci-C4alkyl, the heterocyclyl group of which contains one or more O or S(O)m heteroatoms same or different, and wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more equal or different RA6 substituents; R3Aes H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Ce-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; or CONR2AR4Aor COR2A; R4Ais H; Ci-Ce-alkyl, Cs-Ce-alkenyl or Cs-Ce-alkynyl, whose aliphatic groups are unsubstituted or substituted with one or more identical or different RA3 substituents; and where R4)is H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cz-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more identical or different RA4 substituents; or C(O)R2B, C(O)NR3BR4B, C(O)OR5B, SO2R6B; R4kes H; NR3aBR4aB; Ci-Cs-alkyl, Cs-Cs-alkenyl, C2-C8-alkynyl or Ci-C4-alkoxy, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, Cs-Cs-cycloalkyl-Ci-Ci-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more O heteroatoms, N, S(O)mo NR4aBigual or different, whose cyclic groups may contain one or more CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; aryl, aryl-Ci-C4-alkyl, hetaryl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; or r4j and R4k together with the nitrogen atom to which they are attached form a 3 to 7-membered heterocycle, which heterocycle contains the nitrogen atom as a heteroatom and may also contain one or more O, N, S(O)mo N heteroatoms the same or different, and whose rings are unsubstituted or substituted with one or more RA8 equal or different substituents; where R2B, R3B, R4B are independently of each other H; Ci-Ca-alkyl, C2-C8-alkenyl or Cz-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more identical or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; R3aBes H; Ci-Ce-alkyl, whose aliphatic groups are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; R4aBes H; Ci-C4-alkyl, the aliphatic groups of which are unsubstituted or substituted with one or more substituents selected from the same or different halogen or Ci-C4-alkoxy; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; either C(O)R2B, C(O)OR5Bo SO2R6B R5Bes Ci-Cs-alkyl, Cz-Cs-alkenyl or Cz-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more substituents selected from the same or different halogen or Ci-C4-alkoxy; either Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; R6Bes Ci-Cs-alkyl, Cz-Cs-alkenyl or Cz-Cs-alkynyl, whose aliphatic groups are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more identical or different RA4 substituents; or aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; or R4es (vi) any of the groups (via) C(T1)R41, (vib) C(O)OR4m, (vic) C(Y)NR4nR4° or (vid) C(Y)NR4PNR4c<R4r; where R41 is H; Ci-Ce-alkyl, Gs-Cs-alkenyl or Cz-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl or 3- to 8-membered heterocyclyl, whose heterocyclyl group contains one or more equal or different O or S(O) heteroatoms, and whose cyclic groups are unsubstituted or substituted with one or more RA4 substituents equal to or different; C3-C8-cycloalkyl-Ci-C4-alkyl or heterocyclyl-Ci-C4-alkyl of 3 to 8 members, the heterocyclyl group of which contains one or more identical or different O or S(O)m heteroatoms and where the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; and where T1is O, N-OR1C, N-NR2CR3Co & & , where # are the bonds to the carbon atom of the C(T1) portion of the C(T1)R41 group; and where LAand LBare independently of each other O or S(O)m; and A1 is C2-C4-alkylene, wherein the C atoms are unsubstituted or substituted with one or more equal or different R4 substituents; and where R1Ces H; Ci-Cs-alkyl, Cs-Ce-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; C3-C8-cycloalkyl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA4 substituents; aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; R2Ces H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, Ci-Cs-alkylcarbonyl, Ci-Cs-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-CiC4-alkoxy, the groups of which are unsubstituted or substituted with one or more RA4 substituents equal to or different; R3Ces H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, Cs-Cs-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl groups of which contain one or more O heteroatoms, N, S(O)mo NR3A¡equal or different, whose cyclic groups may contain one or more CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more RA4 equal or different substituents; aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; R4Ces halogen; Ci-Ce-alkyl, C2-Cs-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; aryl, wherein these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; or two R4C attached to the same carbon atom form a C2-C4-alkylene chain, the chain of which is unsubstituted or substituted with one or more equal or different RA4 substituents; or two R4C attached to the same carbon atom form a Ci-C4-alkenylene chain with the double bond of the chain that is attached to said carbon atom, whose chain is unsubstituted or is substituted with one or more equal RA4 substituents or different; R4month H; Ci-Ce-alkyl, C2-C8-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Ce-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more identical or different RA4 substituents; C3-C8-cycloalkyl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; R4nes H; Ci-Ce-alkyl, Cs-Cs-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, Ci-C4-alkylsulfonyl, Cs-Ce-cycloalkylsulfonyl, Ci-C4-alkylcarbonyl or Ci-C4-alkoxycarbonyl, the groups of which are unsubstituted or substituted with one or more identical or different RA4 substituents; or phenyl-Ci-C2-alkoxycarbonyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; R4° is H; Ci-Cs-alkyl, Cs-Cs-alkenyl, C2-C8-alkynyl, Ci-C4-alkoxy, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA2 substituents; Cs-Cs-cycloalkyl or 3- to 8-membered heterocyclyl, whose heterocyclyl group contains one or more heteroatoms O, N, S(O)m or NR3Aequal or different, whose cyclic groups may contain one or more CO groups, and whose cyclic groups do not are substituted or are substituted with one or more identical or different RA4 substituents; Cs-Cs-cycloalkyl-Ci-Ci-alkyl or heterocyclyl-Ci-C4-alkyl of 3 to 8 members, whose heterocyclyl group contains one or more heteroatoms O, N, S(O)mo NR4A¡equal or different, whose groups cyclic may contain one or more CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more identical or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more identical or different RA7 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA7 substituents; either R4n and R4o together with θ| nitrogen atom to which they are attached form a 3 to 8 membered heterocycle, which heterocycle contains one or more same or different N, O or S heteroatoms, where S may be oxidized, and where the heterocycle is unsubstituted or substituted with one or more identical or different RA4 substituents; R4pes H; Ci-Cs-alkyl, C2-Cs-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, Ci-Cs-alkylcarbonyl, Ci-Cs-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-CiC4-alkoxy, the groups of which are unsubstituted or substituted with one or more identical or different RA4 substituents; R4ci is H; Ci-Cs-alkyl, C2-C8-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted by one or more of the same or different RA3 substituents; Cs-Cs-cycloalkyl, Ci-Cs-alkylcarbonyl, Ci-Cs-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-CiC4-alkoxy, whose groups are unsubstituted or substituted by one or more of the same or different RA4 substituents; R4res H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted by one or more of the same or different RA3 substituents; Cs-Cs-cycloalkyl, Cs-Cs-cycloalkyl-Ci-C4-alkyl, 3 to 8-membered heterocyclyl or heterocyclyl-Ci-C4-3 to 8-membered alkyl, the heterocyclyl group of which contains one or more O, N, heteroatoms S(O)mo NR3A, the same or different, whose cyclic groups may contain one or more of the same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted by one or more of the same RA4 substituents or different; aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, whose groups are unsubstituted or are substituted by one or more of the same or different RA6 substituents; or R4es (vii) R4sin where R4ses aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more R1D¡equal or different substituents; where R1Des CN, NO2, halogen, NR2DR3D; Ci-C4-alkyl, Ci-C4-alkoxy-Ci-C4-alkyl, C1-C4halogenalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkyl-S(O)m-, Ci-C4 -haloalkylS(O)m-, carboxy; or aryl or hetaryl, the groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; or two adjacent R1D groups together with the neighboring atoms to which they are attached form a fused 3 to 8-membered heterocycle, which heterocycle contains one or more of the same or different N, O or S heteroatoms, wherein S may be oxidized, and whose heterocycle is unsubstituted or substituted with one or more identical or different RA6 substituents; R2Des H; Ci-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl or Cs-Ce-cycloalkyl, whose groups are unsubstituted or are substituted by one or more of the same or different RA3 or RA4 substituents; R3Des H; Ci-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl or Cs-Ce-cycloalkyl, whose groups are unsubstituted or are substituted by one or more of the same or different RA3 or RA4 substituents; either R2Dy rsd together with the nitrogen atom to which they are attached form a 3- to 8-membered heterocycle, which heterocycle contains one or more of the same or different N, O or S heteroatoms, where S may be oxidized, and which heterocycle is not substituted or is substituted with one or more identical or different RA6 substituents; or R4es (viii) CR4tR4uR4ven where R4tes H; CN; Ci-Cs-alkyl, C2-C8-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted by one or more of the same or different RA3 substituents; Cs-Cs-cycloalkyl, Ca-Ce-cycloalkyl-Ci-Cz-alkyl, 3 to 8-membered heterocyclyl or heterocyclyl-Ci-C4-3 to 8-membered alkyl, the heterocyclyl group of which contains one or more O, N, heteroatoms Same or different S(O)mo NR1F, whose cyclic groups may contain one or more of the same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted by one or more of the same or different RA4 substituents ; Cb-Cs-cycloalkenyl or 3- to 8-membered heterocyclyl, whose heterocyclyl group contains one or more O, N, S(O)m or NR1Fi heteroatoms, the same or different, whose cyclic groups may contain one or more of the same or different CO groups, and in where the C atoms of these groups are unsubstituted or substituted with one or more equal or different RA4 substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, whose groups are unsubstituted or are substituted by one or more of the same or different RA6 substituents; R4ues H; Ci-C4-alkyl, whose aliphatic groups are unsubstituted or substituted with one or more equal or different RA3 substituents; either R4t and R4Utogether with the carbon atom to which they are attached form a 3- to 8-membered carbocyclic or heterocyclic ring, which heterocyclic ring contains one or more O, N, S(O)m or NR1F heteroatoms, the cyclic groups of which may contain one or more more of the same or different CO groups, and wherein the carbocyclic or heterocyclic ring is unsubstituted or is substituted by one or more of the same or different RA3 substituents; either R4t and R4u together are Cz-Ce-alkenyl, the aliphatic groups of which are unsubstituted or substituted by one or more of the same or different RA3 substituents; R4ves H; S(O)mR1E, OR2E or N(R3E)(R4E), where if R4ty / or R4 is H or Ci-Cs-alkyl, whose aliphatic groups are unsubstituted or are substituted by one or more of the same or different RA3 substituents, R4ves S (O)mR1E, OR2Eo N(R3E)(R4E); R1E is Ci-Cs-alkyl, Ca-Cs-alkenyl or Cg-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted by one or more of the same or different RA9 substituents; Cs-Cs-cycloalkyl, Cs-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more O heteroatoms, N, S(O)m or NR1Equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; Cs-Cs-cycloalkenyl, C5-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1Equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; R2Ees H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA9 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1F¡equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; Cs-Cs-cycloalkenyl, C5-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more O heteroatoms, N, S(O)mo NR1F¡equal or different, whose cyclic groups may contain one or more CO groups the same or different, and where the C atoms of these groups are unsubstituted or are substituted with one or more substituents RA4 same or different; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; R3Ees H; Ci-Ce-alkyl, Ca-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1F¡equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; Cs-Cs-cycloalkenyl, Cs-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more O heteroatoms, N, S(O)m or NR1F¡equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents or different; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; R4Ees H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; or C(O)N(R5E)(R6E), C(O)R7E, C(O)OR8Eor SO2R9E; either R3E and R4E together with the nitrogen atom to which they are attached form a heterocycle of 3 to 9 members, whose heterocyclyl group contains one or more heteroatoms O, N, S(O) or NR1F, the same or different, whose cyclic groups may contain one or more more same or different CO groups, and wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA8 substituents; either R5E and R6E are independently of each other H; Ci-Cs-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more O heteroatoms, N, S(O)m or NR1 Same or different, whose cyclic groups may contain one or more same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more substituents RA4 same or different; Cs-Cs-cycloalkenyl or 3- to 8-membered heterocyclyl, whose heterocyclyl group contains one or more O, N, S(O)mo NR1 Same or different heteroatoms, whose cyclic groups may contain one or more same or different CO groups, and in where the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA4 substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; either R5E and R6E together with e| nitrogen atom to which they are attached form a 3- to 8-membered heterocyclic ring, which heterocyclic ring contains one or more of the same or different O or S(O)m heteroatoms, and whose heterocycle is unsubstituted or substituted with one or more same or different RA1° substituents; R7Ees H; Ci-Cs-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1Equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; Cs-Cs-cycloalkenyl, C5-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1Equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more substituents RA4 equal or different ; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; R8Ees H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1F¡equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; Cs-Cs-cycloalkenyl, C5-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more O heteroatoms, N, S(O)mo NR1 Same or different, whose cyclic groups may contain one or more same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more substituents RA4 same or different; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; R9E is Ci-Cs-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1Físame or different, whose cyclic groups may contain one or more CO groups the same or different, and where the C atoms of these groups are unsubstituted or are substituted with one or more identical or different RA4 substituents; Cs-Cs-cycloalkenyl, Cs-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1Equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; R1FesH; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, where the C atoms of these groups are unsubstituted or substituted with one or more equal or different RA4 substituents; or aryl, hetaryl, aryl-Ci-Ci-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RAS substituents; and where Ra, Rb, Rc are independently of each other H, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, Cs-Cs-cycloalkylmethyl, Cs-Ce-halocycloalkyl, Cs-Ce-cycloalkenyl, Cs-Cecycloalkenylmethyl, Cs-Ce-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, 3-6 membered heterocyclyl, 3-6 membered heterocyclyl-Ci-C4alkyl members, aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different Raa substituents, Rdes H, Ci-C4-alkoxy, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, C3-C6cycloalkylmethyl, Cs-Cs-halocycloalkyl, Cs-Cs-cycloalkenyl, Cs-Cs-cycloalkenylmethyl, Cs-Ce-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4alkoxy-Ci-C4-alkyl, 3- to 6-membered heterocyclyl, 3-membered heterocyclyl-Ci-C4-alkyl 6-membered, aryl, hetaryl, ahl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different Raa substituents; Re, Rf are independently of each other H, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, Cs-Ce-cycloalkylmethyl, Cs-Ce-halocycloalkyl, Cs-Ce-cycloalkenyl, Cs-Cecycloalkenylmethyl, Ce-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, C1C4-alkylsulfonyl, Ci- C4-haloalkylsulfonyl, 3- to 6-membered heterocyclyl, 3- to 6-membered heterocyclylCi-C4-alkyl, 3- to 6-membered heterocylcarbonyl, 3- to 6-membered heterocyclyl-CiC4-alkylcarbonyl, heterocyclyl-Ci-C4-alkyl- 3- to 6-membered sulfonyl, aryl, arylcarbonyl, aryl-Ci-C4-alkylcarbonyl, arylsulfonyl, hetaryl, hetaryl-CiC4-alkylcarbonyl, hetarylcarbonyl, hetarylsulfonyl, aryl-Ci-C4-alkyl or hetaryl-Ci -C4alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different substituents; either King Rf together with the nitrogen atom to which they are attached form a saturated or unsaturated 5- or 6-membered heterocycle, which may contain an additional O, S, or N heteroatom, where S may be oxidized, and where the heterocycles are unsubstituted. or are substituted with one or more identical or different Raa substituents; R9, Rhson independently of each other H, Ci-C4-alkyl, Ci-C4-haloalkyl, L-Cs-Ce-cycloalkyl, L-Cs-Ce-halocycloalkyl, L-Cs-Ce-cycloalkenyl, L-Cs-Ce-halocycloalkenyl, C2-C4alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, Ci-C4-alkoxy-Ci-C4- alkyl, 3- to 6-membered heterocyclyl, 3- to 6-membered heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4alkyl or hetaryl-Ci-C4-alkyl, wherein the cyclic moieties are unsubstituted or are substituted with one or more similar or different substituents; Ries H, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, L-Cs-Ce-cycloalkyl, L-Cs-Ce-halocycloalkyl, L-Cs-Ce-cycloalkenyl, L-Cs-Ce-halocycloalkenyl , C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, aryl or aryl-Ci-C4-alkyl, wherein the aryl rings are unsubstituted or are substituted with one or more equal or different substituents; R¡ attached to C is halogen, OH, CN, NO2, Ci-Cw-alkyl, Ci-Cw-haloalkyl, Ci-Cw-alkoxy, C1Cio-haloalkoxy, S(O)mRk, Cs-Ce-cycloalkyl or heterocycle 3 to 6 members, whose heterocycle contains one or more equal or different N, O or S heteroatoms, where S may be oxidized, whose Rjno groups are substituted or are substituted with one or more identical or different Rmy / or R1 substituents, and in where two R groups connected to the same ring atoms or to adjacent ring atoms can together form a 3- to 6-membered carbocycle or heterocycle, which heterocycle contains one or more identical or different N, O, or S heteroatoms, where S it may be oxidized, the cycles of which are unsubstituted or substituted with one or more Rmy / or R1¡equal or different substituents; Rkes H, Ci-C4-alkyl, Ci-C4-haloalkyl or Cs-Ce-cycloalkyl, the cycle of which is unsubstituted or substituted with one or more R1 identical or different substituents; R1 attached to N is Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkylcarbonyl, C1-C4haloalkylcarbonyl or Ci-C4-alkoxycarbonyl; Runited to C is halogen, OH, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy or S(O)mRk; Attached to C is halogen, CN, NO2, Ci-C2-alkyl, Ci-C4-haloalkyl, C2-C6-alkenyl, C2-C6alkynyl, Cs-Ce-cycloalkyl, Cs-Ce-cycloalkenyl, Ci-C4-alkoxy , Ci-C4-haloalkoxy, C1-C4alkylidene, =0, =S, =NR1°, =NOR1°, =NSR1° or S(O)mR1°, or two Rnadjacent groups form together with the atoms to which they are attached a 3- to 8-membered carbocycle or heterocycle, which heterocycle contains one or more same or different N, O or S heteroatoms, where S may be oxidized, whose Rncyclic portions are unsubstituted or substituted with one or more halogen substituents, R ° and / or R1¡equal or different; R1° is H, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl or Ci-C4-alkoxy; R° attached to C is Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, Ci-C4-alkoxy, C1-C4alkylcarbonyl, Ci-C4-haloalkylcarbonyl or Ci-C4-alkoxycarbonyl; Rp is halogen, CN, NO2, Ci-C2-alkyl, Ci-C2-haloalkyl, Cs-Ce-cycloalkyl, Ci-C4-alkoxy or Ci-C2-haloalkoxy, or two Rp groups may together form a 3- to 6-membered carbocycle or heterocycle, which heterocycle contains one or more N, O, or S heteroatoms, the same or different, where S may be oxidized, which carbocycle or heterocycle is unsubstituted or substituted with one or more equal or different substituents; Rqes halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, Ci-C4-alkoxy¡ or Ci-C4-haloalkoxy¡; Rrund to C is halogen, CN, NO2, Ci-C2-alkyl, Ci-C2-haloalkyl, Ci-C4-alkoxy, C1-C2haloalkoxy or S(O)mRk; or two Rr groups together form a 3- to 6-membered carbocycle or heterocycle, which heterocycle contains one or more N, O, or S heteroatoms, where S may be oxidized, and whose carbocycles or heterocycles are unsubstituted or substituted with Rs; Halogen Rses, CN, NO2, Ci-C2-alkyl, Ci-C2-haloalkyl, Cs-Ce-cycloalkyl, Ci-C4-alkoxy or Ci-C2-haloalkoxy; R* attached to C is halogen, NO2, CN, Ci-Ce-alkyl, Ci-Ce-alkoxy, Ci-Ce-haloalkyl, Ci-Cehaloalkoxy, Cs-Ce-cycloalkyl, Cs-Ce-cycloalkoxy, Cs-Ce- halocycloalkyl, Cs-Cehalocycloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, S(O)mRw, =0, =S, =NRV, =NORVor =NSRV; or two R' attached to the same carbon atom or to adjacent carbon atoms together with the carbon atoms to which they are attached form a saturated or unsaturated 3- to 6-membered carbocycle or heterocycle, which heterocycle contains one or more N, O heteroatoms or Same or different, where S may be oxidized, where N is unsubstituted or substituted with one or more R1 same or different substituents; Rves Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl or Cs-Ce-halocycloalkyl; Rwes H, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, Cs-Ce-halocycloalkyl, C1-C4alkoxy or Ci-C4-haloalkoxy; Halogen Rxes, CN, NOs, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkox¡, S(O)mRd, S(O)mNReRf, NReRf, C(O) NRaRh, Ci-Ci0-alkylcarbonyl, C1-C4haloalkylcarbonyl, Ci-C4-alkoxycarbonyl, Ci-C4-haloalkoxycarbonyl, Cs-Ce-cycloalkyl, 5- to 7-membered heterocyclyl, 5- or 6-membered hetaryl, aryl, Cs-Ce- cycloalkoxy, 3- to 6-membered heterocyclyloxy or phenoxy, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different substituents; Ryes halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy¡, Ci-C4-haloalkoxy¡, S(O)mRd, S(O)mNReRf, Ci-C4-alkylcarbonyl , Ci-C4-haloalkylcarbonyl, C1-C4alkoxycarbonyl, Ci-C4-haloalkoxycarbonyl, Cs-Ce-cycloalkyl, Cs-Ce-halocycloalkyl, C2C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl or Ci-C4-alkoxy -Ci-C4-alkyl; Raaes halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy or Ci-C4-haloalkoxy; RA1is CN, halogen, Ci-C4-alkoxy, C1 -C4-alkyl-S(O)m-, C(O)R2A, C(O)NR2AR3Aor C(GA)R2A; RA2 is CN, halogen, OH, Ci-C4-alkoxy, Ci-C4-alkoxycarbonyl or Ci-C4-alkyl-S(O)m-; RA3 is CN, halogen, Ci-C4-alkoxy or Ci-C4-alkyl-S(O)m-; RA4 is CN, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl or Ci-C4-alkoxy; RA5es CN, NO2, halogen, oxime ether, acylamido, Ci-C4-alkyl, Ci-C4-haloalkyl, C1-C4alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkyl-S(O)m-, Ci- C4-haloalkyl-S(O)m-; or aryl, aryloxy, hetaryl or hetaryloxy, the aromatic groups of which are unsubstituted or substituted with one or more identical or different RZ1 substituents; where RZ1es CN, NO2, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkyl-S(O)m-, Ci-C4-haloalkyl -S(O)m-, hetaryloxy or aryloxy; RA6is CN, NO2, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkyl-S(O)m- or Ci-C4- haloalkyl-S(0)m-; RA7is CN, NO2, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, OH, Ci-C4-alkoxy, C1-C4haloalkoxy, Ci-C4-alkyl-S(O)m- or Ci-C4-haloalkyl -S(O)m-; RA8es H, CN, NO2, Ci-C4-alkyl, Cs-Ce-cycloalkyl, Ci-Cs-haloalkyl, Ci-C4-alkoxy, C1-C4haloalkoxy, Cs-Ce-halogencycloalkyl, Ci-C4-alkoxy-Ci- C4-alkyl, cyano-Ci-C4-alkyl, C3Cs-cycloalkyl-Ci-C4-alkyl, C2-C6-alkenyl, Cs-Ce-alkynyl, Ci-C4-alkyl-S(O)m-, C1-C4alkylcarbonyl , Ci-Cs-haloalkylcarbonyl, Ci-Ce-alkoxycarbonyl, Ci-Cealkylaminocarbonyl, di-(Ci-C6)-alkylaminocarbonyl, Ci-Ce-alkylcarbonylamino, aryl or hetaryl, wherein the aryl or hetaryl groups are unsubstituted or substituted with one or more identical or different RZ2 substituents; where RZ2is CN, NO2, halogen, Ci-Ce-alkyl, Cz-Ce-alkenyl, Cs-Ce-alkynyl, Ci-C4-alkoxy, C1-C4haloalkyl, Ci-Ce-haloalkoxy or Ci-C4-alkylthio; RA9 is CN, halogen, Ci-C4-alkoxy, C1 -C4-alkyl-S(O)m-, C(O)OR2A, C(O)NR2AR3Aor C(GA)R2A; RA1° is Ci-C2-alkyl, Ci-C2-haloalkyl, Ci-C2-alkoxy; And thatOoS; m is 0, 1 or 2; and the salts, stereoisomers, tautomers and N-oxides thereof. The compounds of Formula I and the methods for their preparation are known and are described, among others, in WO2018 / 029102, WO2016 / 128298, WO2018 / 210625, WO2011 / 009804, WO2010 / 034737, WO2016 / 180833, PCT / EP2019 / 050537, and .EP sol. No. 16,197,196.5. If any of the compounds that are within the definition of Formula I cannot be accessed by conventional methods or by the methods provided in the prior art documents cited in this paragraph, they can be accessed by other methods. compounds of Formula I by methods and techniques known to the person of the intermediate level trade as well as by common general knowledge. The term active ingredients or compounds of Formula I comprises the compounds as defined herein as well as a stereoisomer, salt, tautomer or N-oxide thereof. Radicals attached to the backbone of Formula I may contain one or more chirality centers. In this case, the compounds of Formula I are present in the form of different enantiomers or diastereomers, depending on the substituents. The present invention relates to each possible stereoisomer of Formula I, ie to single enantiomers or diastereomers, as well as mixtures thereof. As already indicated above, the compounds of the formula I can also be present in the form of different tautomers depending, for example, on the selection of the radical R4. The present invention relates to each possible tautomer of Formula I. As already indicated above, the compounds of the formula I can also be present in the form of different geometric isomers depending, for example, on the selection of the radical R4. If geometric isomers are possible, the present invention relates to the E and Z isomers of the compounds of Formula I. Compounds of Formula I may be amorphous or may exist in one or more different crystalline states (polymorphs) which may have different macroscopic properties, such as stability, or display different biological properties, such as activities. The present invention relates to amorphous and crystalline compounds of the Formula I, mixtures of different crystalline states of the respective Compound I, as well as amorphous or crystalline salts thereof. The salts of the compounds of Formula I are preferably veterinary and / or agriculturally acceptable salts, preferably agriculturally acceptable salts. They can be formed in the usual way, for example by reacting the compound with an acid of the anion in question if the compound of Formula I has basic functionality. The salts useful from the veterinary and / or agricultural point of view of the compounds of Formula I include especially the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the pesticidal action of the compounds of Formula I. Formula I. Useful acid addition salt anions are mainly chloride, bromide, fluoride, hydrogen sulfate, sulfate, dihydrogen phosphate, hydrogen phosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate and the Ci-C4-alkanoic acid anions, preferably formate, acetate, propionate and butyrate. They can be formed by reacting the compounds of Formula I with an acid of the corresponding anion, preferably hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid. The term N-oxide includes any compound of Formula I having at least one tertiary nitrogen atom that is oxidized to an N-oxide moiety. The organic moieties mentioned in the above definitions of the variables are, like the term halogen, collective terms for individual listings of the individual members of the groups. The prefix Cn-Cm indicates in each case the possible number of carbon atoms in the group. The term halogen in each case indicates fluorine, bromine, chlorine or iodine, in particular fluorine, chlorine and bromine. The term alkyl as used herein and in the alkyl portions of alkylamino, alkylcarbonyl, alkylthio, alkylsulfinyl, alkylsulfonyl, and alkoxyalkyl indicates in each occurrence an alkyl group. Μλ / a / zuzi / ui ów / straight or branched chain generally having 1 to 10 carbon atoms, often 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms, more preferably 1 to 3 carbon atoms. Examples of an alkyl group are methyl, ethyl, n-propyl, isopropyl, n-butyl, 2-butyl, isobutyl, tert-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2- dimethylpropyl, 1-ethylpropyl, n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3- dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1 -ethyl2-methylpropyl. The term haloalkyl as used herein and in the haloalkyl portions of haloalkylcarbonyl, haloalkoxycarbonyl, haloalkylthio, haloalkylsulfonyl, haloalkylsulfinyl, haloalkoxy, and haloalkoxyalkyl each indicates a straight or branched chain alkyl group generally having from 1 to 10 carbon atoms, often from 1 to 6 carbon atoms, preferably from 1 to 4 carbon atoms, wherein the hydrogen atoms of this group are partly or wholly replaced by halogen atoms. Preferred haloalkyl moieties are selected from C1-C4haloalkyl, more preferably Ci-Cs-haloalkyl or Ci-Cs-haloalkyl, in particular C1-C2fluoroalkyl, such as fluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl and the like. The term "alkoxy" as used herein indicates in each instance a straight or branched chain alkyl group, which is attached via an oxygen atom and generally having 1 to 10 carbon atoms, often 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms. Examples of an alkoxy group are methoxy, ethoxy, n-propoxy, iso-propoxy, n-butyloxy, 2-butyloxy, isobutyloxy, tert-butyloxy and the like. The term "alkoxyalkyl" as used herein refers to an alkyl generally comprising 1 to 10, often 1 to 4, preferably 1 or 2 carbon atoms, wherein 1 carbon atom has an alkoxy radical containing It generally comprises 1 to 4, preferably 1 or 2 carbon atoms as defined above. Examples are CH2OCH3, CH2-OC2H5, 2(methoxy)ethyl and 2-(ethoxy)ethyl. The term haloalkoxy as used herein indicates in each occurrence a straight or branched chain alkoxy group having 1 to 10 carbon atoms, often 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms, wherein the hydrogen atoms of this group are partially or totally replaced by halogen atoms, in particular fluorine atoms. Preferred haloalkoxy moieties include Ci-C4-haloalkoxy, in particular Ci-C2-fluoroalkoxy, such as fluoromethoxy, difluoromethoxy, trifluoromethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-fluoroethoxy. -chloro-2-fluoroethoxy, 2-chloro-2,2-difluoro-ethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy and the like. The term alkylthio (alkylsulfanyl: alkyl-S) as used herein refers to a straight-chain or branched saturated alkyl group, having 1 to 10 carbon atoms, preferably 1 to 4 carbon atoms (= Ci -C4-alkythio), more preferably 1 to 3 carbon atoms, which is linked by a sulfur atom. The term haloalkythio as used herein refers to an alkythio group as mentioned above wherein the hydrogen atoms are partially or completely substituted with fluorine, chlorine, bromine and / or iodine. The term alkylsulfinyl (alkylsulfoxyl: Ci-C6-alkyl-S(=O)-) as used herein refers to a straight-chain or branched saturated alkyl group (as mentioned above), having from 1 to 10 carbon atoms, preferably 1 to 4 carbon atoms (=Ci-C4-alkylsulfinyl), more preferably 1 to 3 carbon atoms, which is attached via the sulfur atom of the sulfinyl group at any position in the alkyl group . The term haloalkylsulfinyl as used herein refers to an alkylsulfinyl group as mentioned above wherein the hydrogen atoms are partially or completely substituted with fluorine, chlorine, bromine and / or iodine. The term alkylsulfonyl (alkyl-S(=O)2-) as used herein refers to a straight-chain or branched saturated alkyl group, having 1 to 10 carbon atoms, preferably 1 to 4 carbon atoms. carbon (=Ci-C4-alkylsulfonyl), preferably 1 to 3 carbon atoms, which is linked by the sulfur atom of the sulfonyl group at any position in the alkyl group. The term haloalkylsulfonyl as used herein refers to an alkylsulfinyl group as mentioned above in which the hydrogen atoms are partially or fully substituted with fluorine, chlorine, bromine and / or iodine. The term "alkylcarbonyl" refers to an alkyl group as defined above, which is attached via the carbon atom of a carbonyl (C=O) group to the remainder of the molecule. The term "haloalkylcarbonyl" refers to an alkylcarbonyl group as mentioned above, wherein the hydrogen atoms are partially or completely substituted with fluorine, chlorine, bromine and / or iodine. The term "alkoxycarbonyl" refers to an alkylcarbonyl group as defined above, which is attached via an oxygen atom to the remainder of the molecule. The term "haloalkoxycarbonyl" refers to an alkoxycarbonyl group as mentioned above, wherein the hydrogen atoms are partially or completely substituted with fluorine, chlorine, bromine and / or iodine. The term alkenyl as used herein indicates in each case a single unsaturated hydrocarbon radical having generally 2 to 10, often 2 to 6, preferably 2 to 4 carbon atoms, for example vinyl, allyl (2-propen-1-yl), 1-propen-1-yl, 2-propen-2-yl, methallyl (2-methylprop-2-en-1-yl), 2-buten-1-yl, 3-buten-1-yl, 2-penten-1-yl, 3-penten-1-yl, 4-penten-1-yl, 1methylbut-2-en-1-yl, 2-ethylprop-2-en- 1-yl and the like. The term "haloalkenyl" as used herein refers to an alkenyl group as defined above, wherein the hydrogen atoms are partially or fully substituted with halogen atoms. The term alkynyl as used herein indicates in each case a single unsaturated hydrocarbon radical having generally 2 to 10, often 2 to 6, preferably 2 to 4 carbon atoms, for example ethynyl, propargyl (2-propyn-1-yl), 1 -propyn-1 -lyo, 1 -methylprop-2-¡n-1 ¡lo), 2-butyn-1-yl, 3-butyn-1 -yl , 1-pentin-1-yl, 3-pentin-1-yl, 4-pentin-1-yl, 1-methylbut-2-yn-1-yl, 1-ethylprop2-ín-1-yl and the like. The term haloalkynyl as used herein refers to an alkynyl group as defined above, wherein the hydrogen atoms are partially or fully substituted with halogen atoms. The term cycloalkyl as used herein and in the cycloalkyl portions of cycloalkylalkyl, cycloalkoxy, and cycloalkylthio in each instance indicates a cycloaliphatic monocyclic radical generally having 3 to 10 or 3 to 6 carbon atoms, such as cyclopropyl , cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, and cyclodecyl or cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The term halocycloalkyl as used herein and in the halocycloalkyl portions of halocycloalkoxy and halocycloalkylthio indicates in each occurrence a cycloaliphatic monocyclic radical generally having 3 to 10 carbon atoms or 3 to 6 carbon atoms, wherein at least one, for example, 1, 2, 3, 4 or 5 of the hydrogen atoms is replaced with halogen, in particular with fluorine or chlorine. Examples are 1 and 2-fluorocyclopropyl, 1,2-, 2,2- and 2,3-difluorocyclopropyl, 1,2,2-trifluorocyclopropyl, 2,2,3,3-tetrafluorocyclopropyl, 1- and 2-chlorocyclopropyl, 1, 2-, 2,2- and 2,3-dichlorocyclopropyl, 1,2,2-trichlorocyclopropyl, 2,2,3,3-tetrachlorocyclopropyl, 1-, 2-and 3-fluorocyclopentyl, 1,2-, 2,2 -, 2,3-, 3,3-, 3,4-, 2,5-difluorocyclopentyl, 1-, 2- and 3-chlorocyclopentyl, 1,2-, 2,2-, 2,3-, 3, 3-, 3,4-, 2,5-dichlorocyclopentyl and the like. The term cycloalkoxy refers to a cycloalkyl group as defined above, which is attached via an oxygen atom to the rest of the molecule. The term halocycloalkoxy refers to a halocycloalkyl group as defined above, which is attached via an oxygen atom to the rest of the molecule. The term cycloalkythio refers to a cycloalkyl group as defined above, which is attached via a sulfur atom to the rest of the molecule. The term halocycloalkythio refers to a halocycloalkyl group as defined above, which is attached via a sulfur atom to the rest of the molecule. The term cycloalkylalkyl refers to a cycloalkyl group as defined above that is linked through an alkyl group, such as a Ci-Cs-alkyl group or a Ci-C4-alkyl group, in particular a methyl group (=cycloalkylmethyl), to the rest of the molecule. The term cycloalkylsulfonyl refers to a cycloalkyl group, which is linked via the sulfur atom of the sulfonyl group to the rest of the molecule. The term cycloalkenyl as used herein and in the cycloalkenyl portions of cycloalkenylalkyl, cycloalkenyloxy and cycloalkenylthio indicates in each case a single monocyclic unsaturated non-aromatic radical having generally from 3 to 10, for example, 3o4ode5a10 carbon atoms, preferably 3 to 8 carbon atoms, more preferably 3 to 6 carbon atoms. The cycloalkenyl group can be linked to the rest of the molecule through a carbon atom, which forms the double bond, or through a carbon atom, which forms a single bond, preferably through a carbon atom, which forms a double bond. Exemplary cycloalkenyl groups include cyclopropen-1-yl, cyclohexen-1-yl, cyclohepten-1-yl or cycloocten-1-yl. The term halocycloalkenyl as used herein and in the halocycloalkenyl portions of halocycloalkenyloxy and halocycloalkenylthio indicates in each case a single monocyclic unsaturated non-aromatic radical having generally from 3 to 10, for example, 3o4ode5a10 carbon atoms, preferably of 3 to 8 carbon atoms, more preferably 3 to 6 carbon atoms, where at least one, for example, 1, 2, 3, 4 or 5 of the hydrogen atoms is replaced with halogen, in particular with fluorine or chlorine. The halocycloalkenyl group can be linked to the rest of the molecule through a carbon atom, which forms the double bond, or through a carbon atom, which forms a single bond, preferably through a carbon atom, which forms a double bond. Examples are 3,3,-difluorocyclopropen-1-yl and 3,3-dichlorocyclopropen-1-yl. The term cycloalkenyloxy refers to a cycloalkenyl group as defined above, which is attached via an oxygen atom to the rest of the molecule. The term halocycloalkenyloxy refers to a halocycloalkenyl group as defined above, which is attached via an oxygen atom to the rest of the molecule. The term cycloalkenylthio refers to a cycloalkenyl group as defined above, which is attached via a sulfur atom to the rest of the molecule. The term halocycloalkenylthio refers to a halocycloalkenyl group as defined above, which is attached via a sulfur atom to the rest of the molecule. The term cycloalkenylalkyl refers to a cycloalkenyl group as defined above that is linked through an alkyl group, such as a Ci-Cs-alkyl group or a Ci-C4-alkyl group, in particular a methyl group (= cycloalkenylmethyl), to rest of the molecule. The term carbocycle or carbocyclyl generally includes a 3- to 12-membered, preferably 3- to 8-membered, or 5- to 8-membered, more preferably 5- or 6-membered, non-aromatic monocyclic ring comprising 3 to 12, preferably 3 to 8 or 5 to 8, more preferably 5 or 6 carbon atoms. Preferably the term carbocycle covers cycloalkyl and cycloalkenyl groups as defined above. The term heterocycloalkyl generally includes 3- to 8-membered, particularly 6-membered, saturated monocyclic heterocyclic nonaromatic radicals. Heterocyclic non-aromatic radicals generally comprise 1, 2 or 3 heteroatoms selected from N, O and S as ring members, where the S atoms as ring members may be present as S, SO or SO2. The term heterocycloalkenyl generally includes 3- to 8-membered, particularly 6-membered, monocyclic individually unsaturated heterocyclic nonaromatic radicals. Heterocyclic non-aromatic radicals generally comprise 1,2 or 3 heteroatoms selected from N, O and S as ring members, where the S atoms as ring members may be present as S, SO or SO2. The term heterocycle or heterocyclyl generally includes non-aromatic monocyclic heterocyclic radicals of 3 to 12 members, preferably 3 to 8 members or 5 to 8 members, more preferably 5 or 6 members, in particular 6 members. Heterocyclic non-aromatic radicals generally comprise 1,2, 3, 4 or 5, preferably 1,2 or 3 heteroatoms selected from N, O and S as ring members, where S atoms as ring members may be present as S , SO or SO2. Examples of 5- or 6-membered heterocyclic radicals comprise non-aromatic, saturated or unsaturated heterocyclic rings, such as oxiranyl, oxetanyl, thietanyl, thietanyl-Soxide (S-oxothietanyl), thietanyl-S-dioxide (S-dioxothietanyl), pyrrolidinyl, pyrrolinyl, pyrazoli nil, tetrahydrofuranyl, dihydrofuranyl, 1,3-dioxolanyl, thiolanyl, S-oxothiolanyl, S-dioxothiolanyl, dihydrothienyl, Soxodihydrothienyl, S-dioxodihydro-thienyl, oxazolidinyl, oxazolinyl, thiazolinyl, oxathiolanyl, piperidinyl, piperazinyl, pyranyl, dihi dropyranil , tetrahydropyranyl, 1,3- and 1,4-dioxanyl, thiopyranyl, S-oxothiopyranyl, Sdioxothiopyranyl, dihydrothiopyranyl, S-oxodihydrothiopyranyl, S-dioxodihydrothiopyranyl, tetrahydrothiopyranyl, Soxotetrahydrothiopyranyl, S-dioxotetrahydrothiopyranyl, morpholinyl, thiomorpholinyl , S-oxothiomorpholinyl, Sdioxothiomorpholinyl, thiazinyl and the like. Examples of heterocyclic ring that also comprise 1 or 2 carbonyl groups as ring members include pyrrolidin-2-onyl, pyrrolidin-2,5-dionyl, imidazolidin-2-onyl, oxazolidin-2-onyl, thiazolidin-2-onyl, 2-onyl and the like. The term aryl includes monocyclic, bicyclic or tricyclic aromatic radicals having generally 6 to 14, preferably 6, 10 or 14 carbon atoms. Exemplary aryl groups include phenyl, naphthyl, and anthracenyl. Phenyl is preferred as the aryl group. The term hetaryl includes monocyclic 5- or 6-membered heteroaromatic radicals comprising as ring members 1,2, 3, or 4 heteroatoms selected from N, O, and S. Examples of 5- or 6-membered heteroaromatic radicals include pyridyl, ie, 2-, 3- or 4-pyridyl, pyrimidinyl, i.e. 2-, 4- or 5-pyrimidinyl, pyrazinyl, pyridazinyl, i.e. 3- or 4-pyridazinyl, thienyl, i.e. 2- or 3-thienyl, furyl , i.e. 2- or 3-furyl, pyrrolyl, i.e. 2- or 3-pyrrolyl, oxazolyl, i.e. 2-, 3- or 5-oxazolyl, isoxazolyl, i.e. 3-, 4- or 5-isoxazolyl , thiazolyl, i.e. 2-, 3- or 5-thiazolyl, isothiazolyl, i.e. 3-, 4- or 5-isothiazolyl, pyrazolyl, i.e. 1-, 3-, 4- or 5-pyrazolyl, is i.e., 1-, 2-, 4- or 5-imidazolyl, oxadiazolyl, for example, 2- or 5-[1,3,4]oxadiazolyl, 4- or 5-(1,2,3-oxadiazolyl)yl, 3 - or 5-(1,2,4-oxadiazol)yl, 2- or 5-(1,3,4-thiadiazol)yl, thiadiazolyl, for example, 2- or 5-(1,3,4-thiadiazol)yl , 4- or 5-(1,2,3-thiadiazol)yl, 3- or 5-(1,2,4-thiadiazol)yl, triazolyl, e.g. 1H-, 2H- or 3H-1 ,2,3-triazol-4-yl, 2H-triazol-3-yl, 1H-, 2H- or 4H-1,2,4-triazolyl and tetrazolyl, that is, 1H- or 2H-tetrazolyl. The term hetaryl also includes bicyclic 8- to 10-membered heteroaromatic radicals comprising as ring members 1,2, or 3 heteroatoms selected from N, O, and S, wherein a 5- or 6-membered heteroaromatic ring is fused to a phenyl or with a 5- or 6-membered heteroaromatic radical. Examples of a 5- or 6-membered heteroaromatic ring fused to a phenyl ring or a 5- or 6-membered heteroaromatic radical include benzofuranyl, benzothienyl, indolyl, indazolyl, benzimidazolyl, benzoxathiazolyl, benzoxadiazolyl, benzothiadiazolyl, benzoxazinyl, quinolinyl, isoquinolinyl , purinyl, 1,8naphthyridyl, pteridyl, pyrido[3,2-d]pyrimidyl or pyridoimidazolyl and the like. These fused hetaryl radicals may be attached to the remainder of the molecule via any ring atom of the 5- or 6-membered heteroaromatic ring or via a carbon atom of the fused phenyl portion. The terms heterocyclyloxy, hetaryloxy, aryloxy and phenoxy refer to heterocyclyl, hetaryl and aryl as defined above and phenyl, which are attached via an oxygen atom to the remainder of the molecule. The terms heterocyclylsulfonyl, hetarylsulfonyl, arylsulfonyl, and phenylsulfonyl refer to heterocyclyl, hetaryl, and aryl as defined above and phenyl, respectively, which are attached via the sulfur atom of a sulfonyl group to the remainder of the molecule. The terms heterocyclylcarbonyl, hetarylcarbonyl, arylcarbonyl, and phenylcarbonyl refer to heterocyclyl, hetaryl, and aryl as defined above and phenyl, respectively, which are attached via the carbon atom of a carbonyl (C=O) group to the remainder of the molecule. The terms "heterocyclylalkyl" and "hetarylalkyl" refer to heterocyclyl or hetaryl, respectively, as defined above, which are linked via a Ci-Cs-alkyl group or a Ci-C4-alkyl group, in particular a methyl group (=heterocyclylmethyl or hetarylmethyl, respectively), to the rest of the molecule. The terms arylalkyl and phenylalkyl refer to aryl as defined above and phenyl, respectively, which are linked via a Ci-Cs-alkyl group or a Ci-C4-alkyl group, in particular a methyl group (= arylmethyl or phenylmethyl), to the rest of the molecule, where examples include benzyl, 1-phenylethyl, 2-phenylethyl, 2-phenoxyethyl, etc. The terms arylalkoxy and phenylalkoxy refer to arylalkyl as defined above and phenylalkoxy, respectively, which are linked via an oxygen atom to the rest of the molecule. The term phenylalkoxycarbonyl refers to phenylalkoxy as defined above that is attached via a carbonyl group (C=O) to the rest of the molecule. The terms alkylene, cycloalkylene, heterocycloalkylene, alkenylene, cycloalkenylene, heterocycloalkenylene and alkynylene refer to alkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl and alkynyl as defined above, respectively, which are linked to the rest of the molecule, by two atoms , preferably through two carbon atoms, of the respective group, so that they represent a linker between two portions of the molecule. The term "cyclic moiety" may refer to any cyclic group, which is present in the compounds of Formula I and which is defined above, for example, cycloalkyl, cycloalkenyl, carbocycle, heterocycloalkyl, heterocycloalkenyl, heterocycle, aryl, hetaryl and the like. The term aliphatic can refer to any non-aromatic hydrocarbon group, where the constituent carbon atoms can be straight chain, branched chain or cyclic and / or where the heteroatoms can be attached to the carbon chain. Furthermore, these aliphatic groups may be substituted with one or more identical or different substituents. The term carboxy refers to any carboxyl group, which is linked through the carbon atom of the carboxyl group (-COOH) to the rest of the molecule. With respect to the variables, particularly preferred embodiments of the intermediates correspond to those of the compounds of Formula I. The variables of the compounds of Formula I have the following meanings, which, both by themselves and in combination with each other, are preferred embodiments of the compounds of Formula I: In one embodiment, the active ingredient is a compound of Formula I, wherein T is O, S or NR1b. These compounds correspond to Formula 1.1, Formula I.2 and Formula I.3, respectively. In one embodiment, the active ingredient is a compound of Formula 1.1. In one embodiment, the present invention relates to compounds of Formula I, wherein the 5-membered ring is linked to the 6-membered ring via an amide group adjacent to the NR2 group of the 5-membered ring. Such compounds correspond to compounds of the Formula LA. In another embodiment, the present invention relates to compounds of Formula I, wherein the 5-membered ring is linked to the 6-membered ring via an amide group at the position adjacent to the Z3 group of the 5-membered ring. Such compounds correspond to compounds of Formula I.B. Agrochemical compositions, wherein the active ingredient is a compound of Formula I.B, are particularly preferred according to the present invention. The compounds of Formula I may be present in three tautomeric forms T.A, T.B or T.C, if R1 is H. For reasons of clarity, reference is made to T-A tautomers only throughout the specification, but their description also encompasses the disclosure of the other tautomers. In a preferred embodiment of the compounds of Formula I, T is O and the 5-membered ring is attached to the rest of the molecule in the position adjacent to the NR2 group, corresponding to the Formula 1.1.A, or adjacent to group Z3, corresponding to Formula 1.1.B, wherein compounds of Formula 1.1.B are preferred. In a further embodiment of the compounds of Formula I, RP1, RP2 and RP3 are H. These compounds correspond to Formula Γ. In a preferred embodiment, the active ingredient is a compound of Formula I.A, and RP1, rp2 and rp3sonh, corresponding to Formula Γ.Α, or a compound of Formula I.B, corresponding to Formula Γ.Β, in where the compounds of Formula l*.B are preferred. In another preferred embodiment of the compounds of Formula I, RP1, RP2 and RP3 are H and T is O. Such compounds correspond to compounds of the Formula Γ.1. In a more preferred embodiment, the active ingredient is a compound of Formula I.A or I.B, RP1, RP2 and RP3 are H and T is O. These compounds correspond to Formula Γ.1.Α or Γ.1.B, where the compounds of Formula Γ.1.B are preferred. In one embodiment, the active ingredient is a compound of Formula I, preferably a compound of Formula I.A or I.B, more preferably of Formula l*.1.A or l*.1.B, most preferably of the Formula Γ. 1 .B, where Z1 is N, Z2 is N and Z3 is CR5. In another embodiment, the active ingredient is a compound of Formula I, preferably a compound of Formula I.A or I.B, more preferably of Formula Γ.1.Α or Γ.1.B, more preferably of Formula Formula Γ.1 .B, where Z1 is CH, Z2 is CR4 and Z3 is N. In one embodiment, the active ingredient is a compound of Formula Γ.1.Α, where Z1 is N and where R1 is H, Ci-C2-alkyl or Ci-C2-alkoxy-Ci-C2-alkyl. In another embodiment, the active ingredient is a compound of Formula Γ.1.Α, where Z1 and Z2 are N, Z3 is CR5 and where R1 is H, Ci-C2-alkyl or Ci-C2-alkoxy-Ci-C2- alkyl and R5 is H or Ci-C2-alkyl. In another embodiment, the active ingredient is a compound of Formula Γ.1.Α, where Z1 and Z2 are N, Z3 is CR5 and where R1 is H, Ci-C2-alkyl or Ci-C2-alkoxy-Ci-C2- I rent; R3 is CiC4-alkyl, which is unsubstituted or halogenated; and R5 is H or Ci-C2-alkyl. In another embodiment, the active ingredient is a compound of Formula Γ.1.Α, where Z1 and Z3 are N and where R1 is H, Ci-C2-alkyl or Ci-C2-alkoxy-Ci-C2-alkyl; R3 is Ci-C4-alkyl, which is unsubstituted or halogenated; R5 is H or Ci-C2-alkyl; and R2 is CHR21R22; and where a) R21 is CH3, R22 is CH3; b) R21 is CF3, R22 is CH3; c) R21 is CH(CH3)2, R22 is CH3; d) R21 is CHFCH3, R22 is CH3; e) R21 is 1-CN-CC3H4, R22 is CH3; f) R21is 1 -C(O)NH2-cC3H4, R22is CH3; either g) R21 and R22 together are CH2CH2CF2CH2CH2. In one embodiment, the active ingredient is a compound of the Formula Γ.1.Α, where Z1 and Z2 are N and where R1 is CH2CH3; R3 is CH3; R5 is H; R2 is CHR21R22; where a) R21 is CH3, R22 is CH3; b) R21 is CF3, R22 is CH3; c) R21 is CH(CH3)2, R22 is CH3; d) R21 is CHFCH3, R22 is CH3; e) R21 is 1-CN-CC3H4, R22 is CH3; f) R21is 1 -C(O)NH2-cC3H4, R22is CH3; either g) R21 and R22 together are CH2CH2CF2CH2CH2. In one embodiment, the active ingredient is a compound of Formula Γ.1.Β, where Z1 is N and where R1 is H, Ci-C2-alkyl or Ci-C2-alkoxy-Ci-C2-alkyl. In another embodiment, the active ingredient is a compound of Formula Γ.1.Β, where Z1 and Z2 are N, Z3 is CR5 and where R1 is H, Ci-C2-alkyl or Ci-C2-alkoxy-Ci-C2- alkyl and R5 is H or Ci-C2-alkyl. Μλ / a / zuzi / uiów / In another embodiment, the active ingredient is a compound of Formula l*.1.B, where Z1 and Z2 are N, Z3 is CR5 and where R1 is H, Ci-Cs-alkyl or Ci-C2-alkoxy-Ci-C2 -I rent; R3 is CiC4-alkyl, which is unsubstituted or halogenated; and R5 is H or Ci-C2-alkyl. In another embodiment, the active ingredient is a compound of Formula Γ.1.Β, where Z1 and Z3 are N and where R1 is H, Ci-C2-alkyl or Ci-C2-alkoxy-Ci-C2-alkyl; R3 is Ci-C4-alkyl, which is unsubstituted or halogenated; R5 is H or Ci-C2-alkyl; and R2 is CHR21R22; and where a) R21 is CH3, R22 is CH3; b) R21 is CF3, R22 is CH3; c) R21 is CH(CH3)2, R22 is CH3; d) R21 is CHFCHs, R22 is CH3; e) R21 is 1-CN-CC3H4, R22 is CH3; f) R21is 1 -C(O)NH2-cC3H4, R22is CH3; either g) R21 and R22 together are CH2CH2CF2CH2CH2. In one embodiment, the active ingredient is a compound of Formula 1*.1.B, where Z1 and Z2 are N and where R1 is CH2CH3; R3 is CH3; R5 is H; R2 is CHR21R22; where a) R21 is CH3, R22 is CH3; b) R21 is CF3, R22 is CH3; c) R21 is CH(CH3)2, R22 is CH3; d) R21 is CHFCH3, R22 is CH3; e) R21es 1 -CN-cC3H4, R22es CH3; f) R21is 1 -C(O)NH2-cC3H4, R22is CH3; either g) R21 and R22 together are CH2CH2CF2CH2CH2. In one embodiment, the active ingredient is a compound of Formula Γ.1.Β, where Z1 and Z2 are N, Z3 is CH, R1 is CH2CH3; R3 is CH3; and R2 is CH(CH3)CH(CH3)2. Accordingly, such particularly preferred compound I is 1 -(1,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin- 4-yl-pyrazole-4carboxamide, which is also known as dimpropyridaz. In a further embodiment, the active ingredient is a compound of Formula I, Z2 is N and Z3 is CR4 and R4 is any of the groups (i), (i), (iiia), (iiib), (iiic), ( iiid), (iva), (ivb), (va), (vb), (ve), (via), (vib), (vic), (vid), (vii) or (viii). These compounds correspond to compounds of the Formulas l(i), l(¡), l(iiia), l(ii¡b), l(iiic), l(iiid), l(iva), l(ivb) , l(va), l(vb), l(vc), l(via), l(vib), l(vic), l(vid), l(vii) or l(viii). In a further embodiment, the active ingredient is a compound of Formula I, wherein Z2 is N, RP1, RP2 and RP3 are Η, Z3 is CR4 and R4 is any of the groups (i), (i), (iiia), ( iiib), (iiic), (iiid), (va), (ivb), (va), (vb), (ve), (via), (vib), (vic), (vid), (vii ) or (viii). These compounds correspond to compounds of the Formulas l*(¡), Γ(ϋ), l*(iiia), r(ii¡b), l*(iiic), l*(iiid), l*(iva), l*(ivb), l*(va), l*(vb), l*(vc), l*(via), l*(vib), l*(vic), l*(vid), Γ( νϋ) or Γ(νίϋ). In a further embodiment, the active ingredient is a compound of Formula I.A, wherein RP1, RP2and RP3are Η, Z2is N, Z3is CR4and R4is any of the groups (i), (i), (lia), (iiib), (iiic), (iiid), (va), (ivb), (va), (vb), (ve), (via), (vib), (vic), (vid), ( vii) or (viii). These compounds correspond MÁ / a / ¿U41 / U1 ÓW / a compounds of the Formulas l*.A(i), l*.A(¡), l*.A(iiia), l*.A(iiib), l* .A(iiic), l*.A(iiid), l*.A(iva), l*.A(ivb), l*.A(va), l*.A(vb), l*.A (vc), l*.A(via), l*.A(vib), l*.A(vic), r.A(vid), Γ.Α(νϋ) or l*.A(viii). In a further embodiment, the active ingredient is a compound of Formula I.B, wherein RP1, RP2and RP3are Η, Z2is N, Z3is CR4and R4is any of the groups (i), (i), (lia), (iüb), (He), (iiid), (va), (ivb), (va), (vb), (ve), (via), (vib), (vic), (vid), (vii) or (viii), corresponding to the compounds of the formulas l'.B(i), r.B(ü), r.B(iiia), r.B(iüb), r.B(iiic), r.B(liid), r.B( iva), r.B(ivb), l*.B(va), r.B(vb), F.B(vc), r.B(via), F.B(vib), r.B(vic), r.B(vid), r.B(vii) or l*.B(viii). Preferred are the compounds of l*.A(i), P.A(ii), l*.A(iiia), l*.A(ii¡b), l*.A(iiic), l*.A(üid ), l*.A(iva), l*.A(ivb), l*.A(va), l*.A(vb), l*.A(vc), l*.A(via), l*.A(vib), r.A(vic), l*.A(vid), l*.A(vii) or l*.A(v!!!). In a further embodiment, the active ingredient is a compound of Formula I, wherein RP1, RP2and RP3are Η, Z2is N, Z3is CR4and R4is any of the groups (i), (i), (iiia), ( iüb), (iiic), (iiid), (iva), (ivb), (va), (vb), (ve), (via), (vib), (vic), (vid), (vii) o (viii) and T is O, corresponding to compounds of the Formulas Γ.1(ί), Γ.1(ϋ), Γ.1 (iiia), IM(üib), l*.1(iiic), l *.1(¡üd), Γ.1 (iva), l*.1(ivb), r.1(va), l*.1(vb), l*.1(vc), l*.1 (via), l*.1 (vib), l*.1 (vic), l*.1 (vid), l*.1(vii) or l*.1 (viii). In a further embodiment, the active ingredient is a compound of Formula I.A, wherein RP1, RP2and RP3are Η, Z2is N, Z3is CR4and R4is any of the groups (i), (i), (iiia), ( iüb), (iiic), (iiid), (iva), (vb), (va), (vb), (ve), (via), (vib), (vic), (vid), (vii ) or (viii), and T is O. In a further embodiment, the active ingredient is a compound of Formula IA, wherein RP1, RP2 and RP3 are Η, Z2 is N, Z3 is CR4, T is O and R4 is any of groups (i), (ii), ( iiia), (iüb), (iiic), (iiid), (va), (ivb), (va), (vb), (ve), (via), (vib), (vic), (vid ), (vii) or (viii), corresponding to compounds of Formulas l*.A.1(i), l*.A.1(ii), l*.A. 1 (iiia), Γ.Α. 1 (iüb), l*.A. 1 (iiic), r.A.I(iiid), l*.A.1(iva), l*.A.1(ivb), l*.A.1(va), l*.A.1(vb), l*.A.1(vc), F.A.I(via), l*.A.1(vib), l*.A.1(vic), l*.A.1(vid), Γ.Α.1 (vii) or Γ.Α.1 (viii). In a further embodiment, the active ingredient is a compound of Formula I.B, wherein RP1, RP2and RP3are Η, Z2is N, Z3is CR4and R4is any of the groups (i), (ii), (iiia), (iüb ), (iiic), (iiid), (iva), (ivb), (va), (vb), (ve), (via), (vib), (vic), (vid), (vii) or (viii), corresponding to the compounds of the formulas l*.B(i), l*.B(ii), l*.B(üia), l*.B(iüb), l*.B(iüc) , l*.B(iiid), F.B(iva), l*.B(ivb), F.B(va), l*.B(vb), l*.B(vc), l*.B(via) , F.B(vib), F.B(vic), l*.B(vid), l*.B(v¡) or l*.B(viii). In a further embodiment, the active ingredient is a compound of Formula I.B, where RP1, RP2 and RP3 are Η, Z2 is N, Z3 is CR4, Z2 is CR4, T is O and R4 is any of the groups (i), (ii ), (iiia), (iüb), (iiic), (iiid), (iva), (ivb), (va), (vb), (ve), (via), (vib), (vic), (vid), (vii) or (viii), corresponding to compounds of Formulas l*.B.1(i), Γ.Β.1 (ii), Γ.Β.1 (iiia), Γ.Β. 1 (iüb), l*.B. 1 (iiic), l*.B. 1 (iiid), l*.B.1(iva), l*.B.1(ivb), l*.B.1(va), F.B.1(vb), l*.B.1(vc) , r.B.I(via), l*.B.1(vib), l*.B.1(vic), l*.B.1(vid), l*.B.1(v¡) or Γ. Β.1 (viii). In a preferred embodiment, the active ingredient is a compound of Formula 1.1.A(iiia). R P2 1.1 .A(iiia) In a further preferred embodiment, the active ingredient is a compound of Formula 1.1.A(iiib), 1.1.A(ii¡c) or 1.1.A(iiid). In a further preferred embodiment, the active ingredient is a compound of the Formula 1.1 .A(iva) or 1.1 .A(ivb). P2 R In a further preferred embodiment, the active ingredient is a compound of the Formula l.1.A(va), L1.A(vb) or l.1.A(vc). In a further preferred embodiment, the active ingredient is a compound of the Formula 1.1 .A(via), 1.1 .A(vib), 1.1 .A(vic) or 1.1 .A(vid), In a further preferred embodiment, the active ingredient is a compound of the Formula 1.1 .A(vii) or 1.1 .A(vi¡i). A preferred group of compounds 1.1.A are those of Formula 1.1.A(iiia), where RP1, RP2 and RP3 are H. Such compounds are compounds of Formula Γ.1.A(iiia). Another preferred group of compounds 1.1.A are those of Formula 1.1.A(iiib), where RP1, RP2 and RP3 are H. Such compounds are compounds of Formula l*.1.A(iiib). Another preferred group of compounds 1.1.A are those of Formula I.I.A(iiic), where RP1, RP2 and RP3 are H. Such compounds are compounds of Formula Γ.1.A(iiic). Another preferred group of compounds 1.1.A are those of Formula 1.1.A(iiid), where RP1, RP2y RP3son H. Such compounds are compounds of the Formula Γ.1.A(iiid). Another preferred group of compounds 1.1.A are those of Formula 1.1.A(iva), where RP1, RP2y RP3son H. Such compounds are compounds of the Formula Γ.1 .A(iva). Another preferred group of compounds 1.1.A are those of Formula l.1.A(ivb), where RP1, RP2y RP3son H. Such compounds are compounds of the Formula Γ.1 .A(ivb). Another preferred group of compounds 1.1.A are those of Formula L1.A(va), where RP1, RP2 and RP3 are H. Such compounds are compounds of Formula Γ.1.A(va). Another preferred group of compounds 1.1.A are those of Formula L1.A(vb), where RP1, RP2 and RP3 are H. Such compounds are compounds of Formula Γ.1.A(vb). l*.1.A(vb) Another preferred group of compounds 1.1.A are those of Formula 1.1.A(vc), where RP1, RP2 and RP3 are H. Such compounds are compounds of Formula 1.1.A(vc). l.1.A(vc) Another preferred group of compounds 1.1.A are those of Formula 1.1.A(via), where RP1, RP2y RP3son H. Such compounds are compounds of the Formula Γ.1 .A(via). Another preferred group of compounds 1.1.A are those of Formula l.1.A(vib), where RP1, RP2y RP3son H. Such compounds are compounds of Formula l*.1 .A(vib). Another preferred group of compounds 1.1.A are those of Formula 1.1.A(vic), where RP1, RP2y RP3 are H. Such compounds are compounds of Formula 1*.1 .A(vic). Another preferred group of compounds 1.1.A are those of Formula 1.1.A(vid), wherein RP1, RP2y RP3 are H. Such compounds are compounds of Formula Γ.1 .A(vid). Another preferred group of compounds 1.1.A are those of Formula 1.1.A(vii), where RP1, RP2 and RP3 are H. Such compounds are compounds of Formula Γ.1.A(v¡). Another preferred group of compounds 1.1.A are those of Formula I.I.A(viii), where RP1, RP2 and RP3 are H. Such compounds are compounds of Formula Γ.1.A(viii). Γ.1 .A(vii¡) Generally, in the structures of this application, Z1 is OH. In another embodiment, Z1 is N. In a further embodiment, the active ingredient is a compound of Formula I, wherein R1 is H, Ci-C2-alkyl, Cs-Cs-cycloalkyl or Ci-C2-alkoxy-Ci-C2-alkyl. Preferably, R1 is H or Ci-C2-alkyl. In a further embodiment, the active ingredient is a compound of Formula I, wherein R2 and R3 are independently of each other H, halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C4cycloalkyl or benzyl. Preferably, R2 is Ci-C2-alkyl, Ci-C2-haloalkyl, Cs-cycloalkyl or benzyl, more preferably, R2 is Ci-C2-alkyl or Ci-C2-haloalkyl. Preferably R3 is H, halogen, C1C2-alkyl or Ci-C2-haloalkyl, more preferably R3 is H. In a preferred embodiment, R1 is H, CH3 or C2H5, preferably H or CH3; R2 is CH3, CH2CH3, benzyl or halomethyl; R3is H, Br or Cl. In another preferred embodiment, R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3is H. In a particularly preferred embodiment, the active ingredient is a compound of Formula I, wherein R1 is H, CH3 or CH2CH3. In a particularly preferred embodiment, the active ingredient is a compound of Formula I, wherein R2 is CH3 or halomethyl, more preferably CH3 or fluoromethyl. In another particularly preferred embodiment, the active ingredient is a compound of Formula I, where R3 is H. It should be understood that the preferences with respect to R1, R2 and R3 are also preferred in relation to the preferred compounds described above, in particular compounds I*, compounds 1.1, compounds Γ.1, compounds I.A, compounds Γ.Α, the compounds 1.1.A, the compounds Γ.1.Α, where R4 is preferably any of the options (i), (i), (iiia), (iiib), (lile), (iiid), (iva) , (ivb), (va), (vb), (ve), (via), (vib), (vic), (vid), (vil) or (viii). In a further embodiment, the active ingredient is a compound of Formula I, in particular for compounds I*, compounds 1.1, compounds Γ.1, compounds I.A, compounds l*.A, compounds 1.1 .A, the compounds l*.1.A as defined above, where R4 is any of the options (iiia), (iiib), (iiic), (iiid), (va), (ivb), (va ), (vb), (ve), (via), (vib), (vic), (vid), (vii) or (viii) as shown below, R4a(»e), H-SW.-R·'(iM). r\ (ivb), R4¡ / N\ (ve),R4k ^-C(Y)NR4nR4o(v¡c)i C(Y)NR4PNR4^R4r(v¡d) R4a“R4bR4c (a), MR4e (va), i-s(O)m-R,h(va). (¡ib),R4fN={ R4gi4¡ ' (vb), C(T1)R41. . . 1—C(O)OR4m, ,uv5' ' (vía),5 v’ (vib), (v¡¡), CR4tR4uR4v(viii) where R4a, R4b, R4c, R4d, R4e, R4f, R4a, R4h, R4i, R4Ú R4k, R41, R4m, R4n, R4°, R4p, R4% R4r, R4s, R4t, R4u, R4v, A, D, E, G, M, Q, T1, V, W, Y, and m are as defined above. It is particularly preferred that in group (iiia) R4asea CN, C2-C6-alkyl, Ci-C2-haloalkyl, Ci-C2-alkoxy-Ci-C2-alkyl or Cs-Ce-cycloalkyl, wherein the C atoms may be substituted as indicated above; R4b is Ci-C4-alkyl, Ci-C4-haloalkyl or Cs-Ce-cycloalkyl, wherein the C atoms may be substituted as indicated above; and R4c is H or CH3. Furthermore, it is preferred that in group (iiib) R4asea H, F, CN, Ci-C2-alkyl or halomethyl; and Either a cycloalkyl ring, preferably a cyclohexyl, cyclopentyl or cyclobutyl ring or a tetrahydropyran or tetrahydropyrane ring, wherein the rings may be substituted as indicated above. Furthermore, it is preferred that in the group (iilc) R4asea CN, Ci-C2-alkyl, Ci-C2-haloalkyl or cyclopropyl, wherein the C atoms may be substituted as indicated above; R4b is H, CN, Ci-C2-alkyl or Ci-C2-haloalkyl, wherein the C atoms may be substituted as indicated above; D be a direct bond or Ci-C4-alkylene; and E is a non-aromatic heterocyclic group, wherein the heterocycle may be substituted as indicated above and wherein a phenyl group may be optionally hybridized to the heterocycle. Furthermore, it is preferred that in the group (lid) G is a C2-C3-α-branched alkylene, preferably CH(CH3) or CH(CH3)CH2; m be 0 or 1; and R4d is Ci-C2-haloalkyl or C-C3H5, where the C atoms may be halogenated. Furthermore, it is preferred that in the group (va) Q is a direct bond or a straight-chain or α-branched Ci-Cs-alkylene, C2-C8-alkenylene or C2-C8-alkynylene, where the carbon chains may be substituted or unsubstituted as indicated above; and R4 is H or CH3; either Q and R4 together form a 4- to 6-membered carbocyclic ring or a 4- to 6-membered heterocyclic ring, containing O or S as a heteroatom, and wherein the groups may be substituted as indicated above; and M is O, S, NOCH3 or NSCH3; RM is a group mentioned for R4eo where RM and Q together form a 4- to 6-membered non-aromatic unsaturated N-containing heterocycle, where the heterocycle may contain an additional heteroatom O or S, where S may be oxidized, and where the ring is unsubstituted or substituted as indicated above. Furthermore, it is preferred that in group (ivb) W is a straight-chain or α-branched Ci-Cs-alkylene, Cs-Cs-cycloalkylene or Cs-Cs-heterocycloalkylene, where W is substituted as indicated above; V be O or S; R49 is H, Ci-C4-alkyl or Cs-Cs-cycloalkyl; and R4fis H, Ci-C4-alkyl or Cs-Ce-cycloalkyl; either R49 and R4f together with the carbon atom to which they are attached form a saturated or unsaturated carbocycle or heterocycle of 3 to 8 members, where the heterocycle contains one or more equal or different N, O or S heteroatoms, where S can be oxidized , and wherein the carbocycles or heterocycles are unsubstituted or substituted as indicated above. Furthermore, it is preferred that in the group (va) R4h is methyl, ethyl, n-butyl, n-pentyl, n-propyl, iso-propyl, allyl, 3,3-dimethylallyl, propargyl, cyclohexyl, tetrahydropyranyl, tetrahydrothiopyranyl, 3-oxetanyl, 5- oxa-[3.3.0]bicycloheptanyl, methoxyethyl, methoxypropyl, ethoxyethyl, ethylthioethyl, methylthioethyl, difluoromethyl, trifluoromethyl, 2,2,2-trifluoroethyl, 3,3,3-trifluoropropyl, 3-chloro-2,2,3,3 -tetrafluoropropyl, 3-fluoropropyl, 3,3-difluoropropyl, 2,2,2-trifluoroethylthioethyl, methylcarbonylmethyl, c-propylcarbonylmethyl, tert-butylcarbonylmethyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, hydroxycarbonylmethyl, carbamoylmethyl , N-methylcarbamoyl-methyl, N-cpropylcarbamoyl-methyl, Ν,Ν-dimethylcarbamoyl-methyl, 2-methoxymino-propyl, cyclopropylmethyl, phenyl, 4-methylphenyl, 2-nitrophenyl, 3-methylthiophenyl, 4-chloro-phenyl, 4 -fluorophenyl, 4-tert-butyl-phenyl, 4-methoxy-phenyl, 4-nitrophenyl, 4-dimethylamino-phenyl, 2-fluoro-phenyl, 2-methoxy-phenyl, 2-dimethylaminosulfonyl-phenyl, 2-dimethylaminocarbamoyl-phenyl , 3-nitrophenyl, 3-trifluoromethyl-phenyl, 3-chloro-phenyl, 2,5-dichloro-phenyl, 3,5-dichloro-phenyl, 4-chloro-3trifluoromethyl-phenyl, 2,4,5-trichloro-phenyl , 2-pyridyl, 5-(2-chloro)pyridyl, 2-(5-methyl)-pyridyl, 2(6-methyl)-pyridyl, 2-(3-trifluoromethyl)-pyridyl, 2 -pyrimidyl, 2-(4-methyl)-pyrimidyl, 2-(5-methyl)pyrimidyl, 2-(4-methoxy)-pyrimidyl, 2-(5-fluoro)-pyrimidyl midyl, 2-(4-trifluoromethyl)-pyrimidyl, 2-(5trifluoromethyl)-pyrimidyl, 2-(4,6-dimethyl)-pyrimidyl, 2-(4,5-dimethyl)- pyrimidyl, 2-(4,6dimethoxy)-pyrimidyl, -CH2-2-pyrimidyl, -CH2-2-pyrazinyl, -CH2-5-(1-methyl)-imidazolyl, -CH23- (1-methyl)-pyrazolyl, -CH2-4-pyridyl, -CH2-2-pyridyl, -CH2-2-(1 -methyl)-imidazolyl, -CH2-3pyridyl, CH2-2-furanyl, -CH2 -5-(2-chloro)-pyridyl, benzyl, 3,4-dichloro-benzyl, 2,6-difluorobenzyl, 2-fluoro-6-methoxy-benzyl, 2,6-dichloro-benzyl, 2-chloro-6 -trifluoromethyl-benzyl, 2chloro-6-fluoro-benzyl, -CH2-2-(4,6-dimethoxy)-pyrimidyl, 2,6-dimethyl-benzyl, -CH2-I-(3- nitro5-methyl)-pyrazolyl, 2-(1-methyl)-benzimidazolyl, 2-(5-methyl)-oxdiazolyl, 2-[3-methyl-6(tnfluoromethyl)-imidazo[4.5]-pyridinyl, 3-[4 -ethyl-5-(trifluoromethyl)-]-1,2,4-triazolyl, 3-[4-methyl5-(trifluoromethyl)]-1,2,4-triazolyl-3-[4-methyl-5-(difluoromethyl )]-1,2,4-triazolyl, 2-(5-phenyl)-1,3,4thiadiazolyl, 2-(1-methyl-5-phenyl)-imidazolyl, 2-(4,5-dimethyl)-oxazolyl , 2-(1-methyl-5methoxycarbonyl)-imidazolyl, 2-(1-methyl)-imidazolyl or 1,2-ethanediyl; and m is 0, 1 or 2, preferably 0 or 2, particularly preferably 0. Furthermore, it is preferred that in the group (vb) R4isea methyl, ethyl, propyl, iso-propyl, cyclopentyl, sec-butyl, allyl, 3-methoxypropyl, 3-cyanopropyl, cyclohexyl, 3,3,3-trifluoro-propyl, 3-fluoro-propyl, 2-methylsulfanylethyl, 2[ (2,2,2-trifluoroethyl)sulfanyl]ethyl, 3,4,4,4-tetrafluoro-3-trifluoromethyl, tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl, tetrahydro-2H-thiopyran -4-yl, phenyl, 3-methylsulfanylphenyl, 4-chlorophenyl, 4-fluorophenyl, 2,5-difluorophenyl, 2,4-difluorophenyl, 3,5-difluorophenyl, 2-chlorophenyl, 3,4-dichlorophenyl, 3-chlorophenyl, 3-trifluoromethyl -phenyl, 3-trifluoromethoxy-phenyl, 4-fluorobenzyl, pyridin-2-yl, pyrimidin-2-yl-methyl, 5-chloropyridin-3-yl, 6-chloropyridin-3-yl, 5fluoropyridin- 3-yl, 6-methoxypyridin-3-yl, 5-trifluoromethyl-pyridin-3-yl, pyridin-3-yl-methyl, 6fluoropyridin-3-yl, 6-methylpyridin-3-yl, 6-[6-chloropyridin -3-yloxy]pyridin-3-yl, 6-[6-fluoropyridin3-¡loxy]pyridín-3-yl, 6-{6-[6-fluoroprydin-3-yloxy¡] pyridin-3-l}oxypyridin-3-yl, 4-methylpyridin-3-yl, 5-methylpyridin-3-yl, pyridin- 3-yl, 6-trifluoromethylpyridin-3-yl, 6-chloro-5-methylpyridin-3-yl, 6cyanopyridin-3-yl, 6-chloro-4-methylpyridin -3-yl, 5-methoxypyridin-3-yl, 6-bromopyridin-3-yl, 5cyanopyridin-3-yl, quinolin-3-yl, 5,6-dimethoxypyridin -3-yl, 4-chloropyridin-3-yl, 2-chloropyridin3-yl, 5-bromopyridin-3-yl, 5-chloro-2-methoxypyridin-3-yl, 2-fluoro-6-methylpyridin n-3-yl, 3cyanophenyl, 3-ethoxyphenyl, 3-acetamidophenyl, 3-ethylphenyl, 3-methoxyphenyl, 3-propylphenyl, 2fluoro-3-trifluoromethylphenyl, 3-methylphenyl, 3-methylsulfonylphenyl, 3-phenoxyphenyl, 3butylsulfanylphenyl, 4 -fluoro-3-trifluoromethylphenyl, 3-methoxycarbonimidoylphenyl, 3-chloro-4methylphenyl, 3-fluoro-5-trifluoromethylphenyl, 3-chloro-5-trifluoromethylphenyl, 3-chloro-5methoxyphenyl or 3-chloro-4-fluorophenyl, 3-trifluoromethylphenyl ; In addition, it is preferred that in the group (ve) R4¡ and R4k together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocycle, where the heterocycle contains the nitrogen atom as a heteroatom and may also contain one or two identical or different N or O heteroatoms, and wherein the rings are substituted as indicated above; Furthermore, it is preferred that in the group (via) R41is H, methyl, ethyl, iso-propyl, 1-cyane-1-methylethyl or cyclopropyl; T1 is O, N-OR1C, N-NR2CR3Co a cycle of Formula T11 as indicated above and wherein the substituents are defined as indicated above; Furthermore, it is preferred that in the group (vib) R4m is methyl or ethyl; Furthermore, it is preferred that in the group (vic) R4nsea H, methyl, ethyl, methylsulfonyl or cyclopropylsulfonyl; R4° is H, methyl, ethyl, iso-propyl, iso-butyl, tert-butyl, 2,2,2-trifluoroethyl, 2-hydroxyethyl, 2-methoxyethyl, cyanomethyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, cyclopropyl, 1-cyanocyclopropyl, cyclopentyl, cyclopropylmethyl, methoxy , ethoxy, phenyl, pyridin-3-yl, phenylmethyl or 1-phenyl-2-hydroxyethyl; either R4n and R4° together are (CH2)5, (CH2)4, (CH2)3or (CH2)2O(CH2)2; And be O or S; Furthermore, it is preferred that in the group (vid) R4p is H, Ci-Ce-alkyl, Cs-Ce-alkenyl or Cs-Ce-alkynyl, which are unsubstituted or substituted as indicated above, or Cs-Ce-cycloalkyl, Ci-Ce-alkylcarbonyl, CiCe-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-Ci-C4-alkoxy, which are unsubstituted or substituted as indicated above; and R4ci is H, Ci-Ce-alkyl, Cs-Ce-alkenyl or Cs-Ce-alkynyl, which are unsubstituted or substituted as indicated above, or Cs-Ce-cycloalkyl, Ci-Ce-alkylcarbonyl, CiCe-alkoxycarbonyl , aryl-Ci-C4-alkyl or aryl-Ci-C4-alkoxy, which are unsubstituted or substituted as indicated above; and R4rsea H, Ci-C4-alkyl, Cs-Ce-alkenyl or Cs-Ce-alkynyl, which are unsubstituted or substituted as indicated above, or Cs-Ce-cycloalkyl or Cs-C8-cycloalkyl-Ci- C4alkyl, which are unsubstituted or substituted as indicated above, or aryl, hetaryl, arylalkyl or hetarylalkyl, which are unsubstituted or substituted as indicated above. Furthermore, it is preferred that in the (vile) group R4ssea 3-[(2,2,2-trifluoroethyl)sulfanyl]phenyl, 2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfanyl]phenyl, 3-(methylsulfanyl)phenyl, pyrimidin-2-yl, 3-[(2,2,2-trifluoroethyl)sulfinyl]phenyl, phenyl, pyridin-3-yl, 3,5-dimethylphenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2, 4-dichlorophenyl, 3,4dichlorophenyl, 1 -methyl-1 H-pyrrol-2-yl, 3-furyl, 2,5-dimethyl-3-thienyl, 3[(trifluoromethyl)sulfan¡l]phenyl, 3-[( cyclopropylmethyl)sulfanyl]phenyl, 3-(methoxymethyl)phenyl, 3[(tetrahydro-2H-pyran-4-yloxy¡)methyl]phenyl, 3-(dimethylsulfamoyl)phenyl, 3-(methylsulfonyl)phenyl, 4methyl-3-( methylsulfanyl)phenyl, 1 -(2-cyanophenyl)-1 H-pyrazol-4-yl, 1 -(4-fluorophenyl)-1 H-pyrazol-4-yl, 1-phenyl-1 H-pyrazol-4-yl, 1 -naphthyl, 5-(methoxycarbonyl)-1-naphthyl, 4-fluoro-2(methoxycarbonyl)phenyl, 4-fluoro-1-naphthyl, 4-chloro-3-(ethoxycarbonyl)phenyl, 2(methoxycarbonyl)phenyl, pyridin-4-yl, 6-(ethoxycarbonyl)pyridin-2-yl, 3-(ethoxycarbonyl)phenyl, 2-naphthyl, 4-methoxycarbonyl-3-(methoxycarbonyl)phenyl, 4-chloro-2-(methoxycarbonyl)phenyl, 3-thienyl, 3-(2-ethoxy-2-oxoethoxy)-4-methylphenyl, 3-(2-ethoxy-2-oxoethoxy)phenyl, 3-(2-ethoxy -2-oxoethoxy¡)-4,5difluorophenyl, 3-(2-ethoxy-2-oxoethoxy)-4-fluorophenyl, 3-(ethoxycarbonyl)-4-fluorophenyl, (3{[(cyclopropylcarbonyl)oxy]methyl}phen¡ lo, 3-{[(cyclopropylcarbonyl)oxy]methyl}-4-fluorophenyl, pyridin-2-yl, 3-(difluoromethyl)phenyl, 3-[(trifluoromethyl)sulfanyl ]phenyl, 4-fluoro-3(trifluoromethyl)phenyl, 3-chloro-5-(trifluoromethyl)phenyl, 3-(trifluoromethyl)phenyl, 3,5-bis(trifluoromethyl)phenyl, 3-fluoro-5-(trifluoromethyl) phenyl, 4-cyano-3-(trifluoromethyl)phenyl, 3(2,2,2-trifluoroethyl)phenyl, 3-(pentafluoroethyl)phenyl, 3-cyanophenyl, 4-chloro-3-cyanophenyl, 3-cyano-5-fluorophenyl, 3-cyano-5-(trifluoromethyl)phenyl, 5-cyano-2-methoxyphenyl, 3-cyano-4fluorophenyl, 5-cyanopyridin-3-yl, 5-cyano-6-(dimethylamin)pyridin- 3-yl, 5-cyano-6-(moroflin-4yl)pyridin-3-yl, 5-cyano-6-ethoxypyridin-3-yl, 5-cyano-6-methoxypyridin-3-yl, 3 -chloro-5cyanophenyl, 1-benzofuran-2-yl, 3-phenyl-1,2-oxazol-5-yl, 3-(ethoxycarbonyl)-1,2-oxazol-5-yl, 1 -isopropyl-1 H- 1,2,3-triazol-4-yl, 1 -methyl-1 H-1,2,3-triazol-4-yl, 5-cyano-6-methoxypyridin-3yl, 6-methoxypyridin-2-yl, 2 ,3-dihydro-1-benzofuran-7-yl, 1-benzofuran-7-yl, 2,6 Μλ / a / zuzi / ui dimethoxypyridin-3-yl, 2-methoxyphenyl, 1,3-benzodioxol-4-yl, 2,4-dimethoxyphenyl, 2,5dimethoxyphenyl, 6-(trifluoromethyl)pyridin- 2-ilo, 5-chloro-2-methoxypyridin-3-yl, 2-methoxypyridin-3yl, 6-ethoxypyridin-3-yl, 5-chloro-6-methoxypyridin-3 -yl, 2-(methylsulfanyl)pyridin-3-yl, 2ethoxypyridin-3-yl, 5,6-dimethoxypyridin-3-yl, 2-methoxypyridin-4-yl, 6-methoxy 5(trifluoromethyl)pyridin-3-yl, 6-methoxy-5-nitropyridin-3-yl, 2,6-dimethoxypyridin-4-yl, 2(methylsulfanyl)phenyl, 2-methoxy-6-(trifluoromethyl)-p¡ rhidin-4-yl, 3-cyano-5-methoxyphenyl, 5-fluoro2-methoxypyridin-3-yl, 6-isopropoxypyridin-3-yl, 6-methoxypyridin-3-yl, 2-(2-amino- 2oxoethoxy)phenyl, 3-cyano-4-isopropoxyphenyl or 3-chloropyridin-2-yl. In addition, it is preferred that in the group (vile!) R4tsea H, methyl, trifluoromethyl, trichloromethyl, isopropyl, isobutyl, isopentyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 3,4-dichlorophenyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 4-chloroplr¡ d¡n-3-yl, 2-pyrimidyl or benzyl; R4 uses H or methyl; either R4t and R4u together are vinyl, prop-1-en-2-yl, (1 E)-prop-1-en-1-yl, (1 Z)-prop-1-en-1-yl or cyclopropyl; R4vsea H, S(O)mR1E, OR2Eo N(R3E)(R4E), where if R4ty / o R4ues H or Ci-Cs-alkyl, R4ves S(O)mR1E, OR2Eo N(R3E)(R4E); R1Eis methyl, ethyl, isopropyl, isobutyl, tert-butyl, cyclopropylmethyl, 2,2-dimethylpropyl, 2-methoxy-2-oxoethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl or 2-pyrimidyl; R2Esea H, methyl, ethyl, 2,2,2-trifluoroethyl, isopropyl, cyclopropylmethyl, benzyl, 3-chlorophenyl or 4-chlorophenyl; R3E and R4E together with the nitrogen atom to which they are attached form a 5-membered heterocycle, where the heterocycle group contains one or two N atoms, where the cyclic groups may contain a CO group, and where the C atoms are substituted with trifluoromethyl, methyl or cyclopropyl. In relation to the previous preferences regarding groups R4(iiia), (iiib), (iiic), (iid), (iva), (ivb), (va), (vb), (ve), ( via), (vib), (vic), (vid), (vii) or (viii), which are relevant for the compounds of Formula I, in particular for the Γ compounds, the 1.1 compounds, the l* compounds. 1, compounds I.A, compounds Γ.Α, compounds 1.1.A, compounds Γ.1.Α as defined above, it is further preferred that R1, R2 and R3 correspond to the preferred options provided above. For example, it is preferred relative to the above preferences regarding R4 groups that R1 is H, CHE or C2H5, preferably H or CH3; R2is CH3, CH2CH3, benzyl or halomethyl; R3be H, Br or Cl. or what R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3sea H. In view of the above, the following compounds are particularly preferred as active ingredients according to the present invention. A preferred embodiment relates to compounds of Formula r.A(iiia) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3is H; and wherein at least one of R4a, R4b and R4 is C3-C4-cycloalkenyl, C3-C4-halocycloalkenyl, ORa or SRa, wherein Ra is C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl; and T is O, S or NR1b. Another preferred embodiment refers to compounds of the Formula Γ.Α(ίϋό) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3esH; R4aes as defined above; A is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group; and T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula l*.A(li¡c) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3esH; R4a and R4b are as defined above; E is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group; and T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula l*.A(iiid) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3esH; R4des Ci-C2-haloalkyl or C-C3H5, where the C atoms may be halogenated; G is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group; and T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula l*.A(iva) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; IVIA / a / ZUZ l / U I Ó4U / R2is CH3 or halomethyl; R3esH; R4ees H or CH3; Q is a direct link or a straight-chain or α-branched Ci-Cs-alkylene, C2-C8-alkenylene or C2-C8-alkynylene, where the carbon chains may be substituted or unsubstituted as indicated above; M is O, S, NOCH3O NSCH3; T is O, S or NR1b. Another preferred embodiment refers to compounds of Formula l*.A(ivb) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3o halomethyl; R3esH; R4fes H, Ci-C4-alkyl or Cs-Cs-cycloalkyl; R4ges H, Ci-C4-alkyl or Cs-Cs-cycloalkyl; V esOoS; W is a straight-chain or α-branched Ci-Cs-alkylene, Cs-Cs-cycloalkylene or Cs-Cs-heterocycloalkylene, where W is substituted as indicated above; T is O, SoNR1b. Another preferred embodiment relates to compounds of Formula l*.A(va) as active ingredient, wherein R1 is H or CH3, preferably CH3; R2esCH3; R3 is H, chlorine or bromine, preferably H; R4hes methyl, ethyl, n-butyl, n-pentyl, n-propyl, iso-propyl, allyl, 3,3-dimethylallyl, propargyl, cyclohexyl, tetrahydro-pyranyl, tetrahydro-thiopyranyl, 3-oxetanyl, 5-oxa-[ 3.3.0]bicycloheptanyl, methoxyethyl, methoxypropyl, ethoxyethyl, ethylthioethyl, methylthioethyl, difluoromethyl, trifluoromethyl, 2,2,2-trifluoroethyl, 3,3,3-trifluoropropyl, 3-chloro-2,2,3,3-tetrafluoropropyl, 3-fluoropropyl, 3,3-difluoropropyl, 2,2,2-trifluoroethylthio-ethyl, methylcarbonylmethyl, c-propylcarbonyl-methyl, tert-butylcarbonyl-methyl, methoxycarbonyl-methyl, ethoxycarbonylmethyl, hydroxycarbonyl-methyl, carbamoyl-methyl, N- methylcarbamoyl-methyl, N-cpropylcarbamoyl-methyl, Ν,Ν-dimethylcarbamoyl-methyl, 2-methoxymino-propyl, cyclopropylmethyl, phenyl, 4-methylphenyl, 2-nitrophenyl, 3-methylthiophenyl, 4-chloro-phenyl, 4-fluorophenyl, 4-tert-butyl-phenyl, 4-methoxy-phenyl, 4-nitrophenyl, 4-dimethylamino-phenyl, 2-fluoro-phenyl, 2-methoxy-phenyl, 2-dimethylaminosulfonyl-phenyl, 2-dimethylaminocarbamoyl-phenyl, 3- nitrophenyl, 3-trifluoromethyl-phenyl, 3-chloro-phenyl, 2,5-dichloro-phenyl, 3,5-dichloro-phenyl, 4-chloro-3trifluoromethyl-phenyl, 2,4,5-trichloro-phenyl, 2- pyridyl, 5-(2-chloro)pyridyl, 2-(5-methyl)-pyridyl, 2(6-methyl)-pyridyl, 2-(3-trifluoromethyl)-pyridyl, 2-pyrimidyl, 2-(4-methyl )-pyrimidyl, 2-(5-methyl)pyrimidyl, 2-(4-methoxy)-pyrimidyl, 2-(5-fluoro)-pyrimidyl, 2-(4-trifluoromethyl)-pyrimidyl, 2-(5-trifluoromethyl) -pyrimidyl, 2-(4,6-dimethyl)-pyrimidyl, 2-(4,5-dimethyl)-pyrimidyl, 2-(4,6-dimethoxy)-pyrimidyl, -CH2-2-pyrimidyl -CH2-2-pyrazinyl, -CH2-5-(1-methyl)-imidazol, -CH23-(1-methyl)-pyrazyl, -CH2-4-pyridyl, - CH2-2-pyridyl, -CH2-2-(1-methyl)-imidazolyl, -CH2-3pyridyl, CH2-2-furanyl, -CH2-5-(2-chloro)-pyridyl, benzyl , 3,4-dichloro-benzyl, 2,6-difluorobenzyl, 2-fluoro-6-methoxy-benzyl, 2,6-dichloro-benzyl, 2-chloro-6-trifluoromethyl-benzyl, 2-chloro-6-fluoro-benzyl , -CH2-2-(4,6-dimethoxy¡)-pyrimidyl, 2,6-dimethyl-benzyl, -CH2-I-(3-nitro5-methyl)-pyrazolyl, 2-(1-methyl)- benzimidazolyl, 2-(5-methyl)-oxdiazolyl, 2-[3-methyl-6(trifluoromethyl)-midazo[4.5]-pyridinyl, 3-[4 -ethyl-5-(trifluoromethyl)-]-1,2,4-triazolyl, 3-[4-methyl5-(trifluoromethyl)]-1,2,4-triazol¡l3-[4-methyl- 5-(difluoromethyl)]-1,2,4-triazolyl, 2-(5-phenyl)-1,3,4thiadiazolyl, 2-(1-methyl-5-phenyl)-midazole lo, 2-(4,5-dimethyl)-oxazolí, 2-(1-methyl-5methoxycarbon¡l)-ímidazolí, 2-(1-methyl)-ímídazolí or 1, 2-ethandiyl; m is 0 or 2, preferably 0; T is O, SoNR1b. Another preferred embodiment relates to compounds of Formula 1*.A(vb) as active ingredient, wherein R1 is H, methyl, ethyl or cyclopropyl; R2esCH3; R3 is H, chlorine or bromine, preferably H; R4ies methyl, ethyl, propyl, iso-propyl, cyclopentyl, sec-butyl, ayl, 3-methoxypropyl, 3-cyanopropyl, cyclohexyl, 3,3,3-trifluoro-propyl, 3-fluoro-propyl, 2-methylsulfanylethyl, 2[( 2,2,2-trifluoroethyl)sulfanyl]ethyl, 3,4,4,4-tetrafluoro-3-trifluoromethyl, tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl, tetrahydro-2H-thiopyran-4- yl, phenyl, 3-methylsulfanylphenyl, 4-chlorophenyl, 4-fluorophenyl, 2,5-difluorophenyl, 2,4-difluorophenyl, 3,5-difluorophenyl, 2-chlorophenyl, 3,4-dichlorophenyl, 3-chlorophenyl, 3-trifluoromethyl-phenyl, 3-trifluoromethoxy-phenyl, 4-fluorobenzyl, pyridin-2-yl, pyrimidin-2-ylmethyl, 5-chloropyridin-3-yl, 6-chloropyridin-3-yl, 5fluoropyridin-3-yl, 6-methoxypyridin -3-yl, 5-trifluoromethyl-pyridin-3-yl, pyridin-3-ylmethyl, 6fluoropyridin-3-yl, 6-methylpyridin-3-yl, 6-[6-chloropyridin-3- yloxy]pyridin-3-yl, 6-[6-fluoropyridín3-¡loxy]pyridín-3-yl, 6-{6-[6-fluoropyridín-3-yloxy]pyrid ¡n-3-¡l}oxypyridin-3-yl, 4-methylpyridin-3-yl, 5-methylpyridin-3-yl, pyridin-3-yl, 6-trifluoromethylpyridin-3 -yl, 6-chloro-5-methylpyridin-3-yl, 6cyanopyridin-3-yl, 6-chloro-4-methylpyridin-3-yl, 5-methoxypyridin-3 -yl, 6-bromopyridin-3-yl, 5cyanopyridin-3-yl, quinolin-3-yl, 5,6-dimethoxypyridin-3-yl, 4-chloropyridin-3-yl, 2-chloropyridin3-yl , 5-bromopyridin-3-yl, 5-chloro-2-methoxypyridin-3-yl, 2-fluoro-6-methylpyridin-3-yl, 3cyanophenyl, 3-ethoxyphenyl, 3 -acetamidophenyl, 3-ethylphenyl, 3-methoxyphenyl, 3-propylphenyl, 2fluoro-3-trifluoromethylphenyl, 3-methylphenyl, 3-methylsulfonylphenyl, 3-phenoxyphenyl, 3butylsulfanylphenyl, 4-fluoro-3-trifluoromethylphenyl, 3-methoxycarbonimidoylphenyl, 3 -chloro-4methylphenyl, 3-fluoro-5-trifluoromethylphenyl, 3-chloro-5-trifluoromethylphenyl, 3-chloro-5methoxyphenyl or 3-chloro-4-fluorophenyl or 3-trifluoromethylphenyl; Μλ / a / zuzi / ui T esO, SoNR1b. Another preferred embodiment refers to compounds of Formula l*.A(vc) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4¡ and R4k together with e| nitrogen atom to which they are attached form a 5- or 6-membered heterocycle, where the heterocycle contains the nitrogen atom as a heteroatom; T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula l*.A(via) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R41 is H, methyl, ethyl, iso-propyl, 1-cyane-1-methylethyl or cyclopropyl; T1 is as defined above; T is O, SoNR1b. Another preferred embodiment relates to compounds of Formula l*.A(vib) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4mes methyl or ethyl; T is O, SoNR1b. Another preferred embodiment relates to compounds of Formula l*A(vic) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4nes H, methyl, ethyl, methylsulfonyl or cyclopropylsulfonyl; R4° is H, methyl, ethyl, iso-propyl, iso-butyl, tert-butyl, 2,2,2-trifluoroethyl, 2-hydroxyethyl, 2-methoxyethyl, cyanomethyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, cyclopropyl, 1-cyanocyclopropyl, cyclopentyl, cyclopropylmethyl, methoxy, ethoxy, phenyl, pyridin-3-yl, phenylmethyl or 1-phenyl-2-hydroxyethyl; either R4n and R4° together are (CH2)5, (CH2)4, (CH2)3or (CH2)2O(CH2)2; And thatOoS; T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula r.A(vine) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4p is H, Ci-Ce-alkyl, Cs-Ce-alkenyl or Cs-Ce-alkynyl, which are unsubstituted or substituted as above, or Cs-Ce-cycloalkyl, Ci-Ce-alkylcarbonyl, CiCe-alkoxycarbonyl , aryl-Ci-C4-alkyl or aryl-Ci-C4-alkoxy, which are unsubstituted or substituted as indicated above; R4qes H, Ci-Ce-alkyl, Cs-Ce-alkenyl or Cs-Cs-alkynyl, which are unsubstituted or substituted as indicated above, or Cs-Ce-cycloalkyl, Ci-Ce-alkylcarbonyl, CiCe-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-Ci-C4-alkoxy, which are unsubstituted or substituted as indicated above; and R4res H, Ci-C4-alkyl, Cs-Ce-alkenyl or Cs-Ce-alkynyl, which are unsubstituted or substituted as indicated above, or Cs-Ce-cycloalkyl or C3-C8-cycloalkyl-Ci-C4alkyl, which are unsubstituted or substituted as indicated above, or aryl, hetaryl, arylalkyl or hetarylalkyl, which are unsubstituted or substituted as indicated above; And thatOoS; T is O, S or NR1b. Another preferred embodiment refers to compounds of Formula l*.A(vii) as active ingredient, wherein R1 is H, methyl, ethyl, preferably methyl and ethyl; R2 is CH3; R3 is H, chloro, bromo, preferably H; R4ses 3-[(2,2,2-trifluoroethyl)sulfanyl]phenyl, 2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfanyl]phenyl , 3-(methylsulfanyl)phenyl, pyrimidin-2-yl, 3-[(2,2,2-trifluoroethyl)sulfanyl]phenyl, phenyl, pyridin-3-yl, 3,5-dimethylphenyl , 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2,4-dichlorophenyl, 3,4dichlorophenyl, 1-methyl-1 H-pyrrol-2-yl, 3-furyl, 2,5-dimethyl-3-thien lo, 3[(trifluoromethyl)sulfanyl]phenyl, 3-[(cyclopropylmethyl)sulfanyl]phenyl, 3-(methoxymethyl)phenyl, 3[(tetrahydro-2H-pyran-4 -¡lox¡)methyl]phenyl, 3-(dimethylsulfamo¡l)phenyl, 3-(methylsulfon¡l)phenyl, 4methyl-3-(methylsulfan¡ l)phenyl, 1 -(2-cyanopheny l)-1 H-pyrazol-4-yl, 1 -(4-fluorophenyl)-1 H-pyrazol-4-yl, 1 -phenyl-1 H-pyrazol-4-yl, 1-naphthyl, 5-(methoxycarbonyl)- 1-naphthyl, 4-fluoro-2(methoxycarbonyl)phenyl, 4-fluoro-1-naphthyl, 4-chloro-3-(ethoxycarbonyl)phenyl, 2(methoxycarbonyl)phenyl, pyridine -4-yl, 6-(ethoxycarbonyl)pyridin-2-yl, 3-(ethoxycarbonyl)phenyl, 2-naphthyl, 4-methoxy-3-(methoxycarbonyl)phenyl, 4-chloro-2-(methoxycarbonyl)phenyl , 3-thienyl, 3-(2-ethoxy-2-oxoethoxy)-4-methylphenyl, 3-(2-ethoxy-2-oxoethoxy)phenyl, 3-(2-ethoxy-2-oxoethoxy¡)4,5difluorophenyl, 3-(2-ethoxy-2-oxoethoxy)-4-fluorophenyl, 3-(ethoxycarbonyl)-4-fluorophenyl, (3{[(cyclopropylcarbon¡l)oxy]methyl}phenyl, 3-{[(cyclopropylcarbonyl)oxy]methyl}-4-fluorophenyl, pyridin-2-yl, 3-(difluoromethyl)phenyl, 3-[(trifluoromethyl)sulfinyl]phenyl, 4-fluoro-3(trifluoromethyl)phenyl, 3- chloro-5-(trifluoromethyl)phenyl, 3-(trifluoromethyl)phenyl, 3,5bis(trifluoromethyl)phenyl, 3-fluoro-5-(trifluoromethyl)phenyl, 4-cyano-3-(trifluoromethyl)phenyl, 3(2, 2,2-trifluoroethyl)phenyl, 3-(pentafluoroethyl)phenyl, 3-cyanophenyl, 4-chloro-3-cyanophenyl, 3-cyano-5-fluorophenyl, 3-cyano-5-(trifluoromethyl)phenyl, 5- cyano-2-methoxyphenyl, 3-cyano-4fluorophenyl, 5-cyanopyridin-3-yl, 5-cyano-6-(dimethylamin)pyridin-3-yl, 5-cyano -6-(moroflin-4yl)pyridin-3-yl, 5-cyano-6-ethoxypyridin-3-yl, 5-cyano-6-methoxypyridin-3-yl, 3-chloro-5cyanophenyl, 1-benzofuran- 2-yl, 3-phenyl-1,2-oxazol-5-yl, 3-(ethoxycarbonyl)-1,2-oxazol-5-yl, 1-isopropyl-1 H-1,2,3-triazol-4 -yl, 1 -methyl-1H-1,2,3-triazol-4-yl, 5-cyano-6-methoxypyridin-3yl, 6-methoxypyridin-2-yl, 2,3-dihydro-1-benzofuran -7-yl, 1-benzofuran-7-yl, 2,6-dimethoxypyrid η-3-yl, 2-methoxyphenyl, 1,3-benzodioxol-4-yl, 2,4-dimethoxyphenyl, 2,5-dimethoxyphenyl, 6-(trifluoromethyl )pyridín-2-yl, 5-chloro-2-methoxypyridin-3-yl, 2-methoxypyridin-3-yl, 6-ethoxypyridin-3-yl, 5-chloro-6-methoxypyridin- 3-yl, 2-(methylsulfanyl)pyridin-3-yl, 2-ethoxypyridin-3-yl, 5,6-dimethoxypyridin-3-yl, 2-methoxypyridin-4-yl, 6-methoxy-5(trifluoromethyl )pyridin-3-yl, 6-methoxy-5-nitropyridin-3-yl, 2,6-dimethoxypyridin-4-yl, 2(methylsulfanyl)phenyl, 2-methoxy-6-(trifluoromethyl)-pyridin-4-yl , 3-cyano-5-methoxyphenyl, 5-fluoro2-methoxypyridin-3-yl, 6-isopropoxypyridin-3-yl, 6-methoxypyridin-3-yl, 2-(2-amino-2oxoethoxy)phenyl, 3-cyano-4-isopropoxyphenyl or 3-chloropyridin-2-yl; T is O, S, or NR1b. Another preferred embodiment refers to compounds of Formula r.A(vüi) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2 is CH3; R3 is H; R4tes H, methyl, trifluoromethyl, trichloromethyl, isopropyl, isobutyl, isopentyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 3,4-dichlorophenyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 4-chloropyridin- 3-yl, 2-pyrimidyl or benzyl; R4 is H or methyl; either R4t and R4u together are vinyl, prop-1-en-2-yl, (1E)-prop-1-en-1-yl, (1Z)-prop-1-en-1-yl or cyclopropyl; R4ves H, S(O)mR1E, OR2Eo N(R3E)(R4E), where if R4ty / o R4ues H or Ci-C8-alkyl, R4ves S(O)mR1E, OR2Eo N(R3E)(R4E); R1E is methyl, ethyl, isopropyl, isobutyl, tert-butyl, cyclopropylmethyl, 2,2-dimethylpropyl, 2-methoxy-2-oxoethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl or 2-pyrimidyl; R2Ees H, methyl, ethyl, 2,2,2-trifluoroethyl, isopropyl, cyclopropylmethyl, benzyl, 3-chlorophenyl or 4-chlorophenyl; R3E and R4E together with the nitrogen atom to which they are attached form a 5-membered heterocycle, where the heterocycle group contains one or two N atoms, where the cyclic groups may contain a CO group, and where the C atoms are substituted with trifluoromethyl, methyl or cyclopropyl; T is O, S, or NR1b. Another preferred embodiment refers to compounds of Formula l*.B(iiia) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3is H; and wherein at least one of R4a, R4b and R4 is C3-C4-cycloalkenyl, C3-C4-halocycloalkenyl, ORa or SRa, wherein Ra is C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl; and T is O, SoNR1b. Another preferred embodiment refers to compounds of the Formula r.B(li¡b) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3 is H; R4aes as defined above; A is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group; and T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula r.B(iiic) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3 is H; R4a and R4b are as defined above; E is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group; and T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula l*.B(iiid) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3 is H; R4des Ci-C2-haloalkyl or C-C3H5, where the C atoms may be halogenated; G is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group; and T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula r.B(iva) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3is Η; R4ees H or CH3; Q is a direct link or a straight-chain or α-branched Ci-Cs-alkylene, C2-C8-alkenylene or C2-C8-alkynylene, where the carbon chains may be substituted or unsubstituted as indicated above; M is O, S, NOCH3or NSCH3; T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula l*.B(ivb) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3o halomethyl; R3 is H; R4fes H, Ci-C4-alkyl or Cs-Ce-cycloalkyl; R4ges H, Ci-C4-alkyl or Cs-Cs-cycloalkyl; V esOoS; W is a straight-chain or α-branched Ci-Cs-alkylene, Cs-Cs-cycloalkylene or Cs-Cs-heterocycloalkylene, where W is substituted as indicated above; T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula r.B(va) as active ingredient, wherein R1 is H or CH3, preferably CH3; R2 is CH3; R3 is H, chlorine or bromine, preferably H; R4hes methyl, ethyl, n-butyl, n-pentyl, n-propyl, iso-propyl, allyl, 3,3-dimethylallyl, propargyl, cyclohexyl, tetrahydro-pyranyl, tetrahydro-thiopyranyl, 3-oxetanyl, 5-oxa-[ 3.3.0]bicycloheptanyl, methoxyethyl, methoxypropyl, ethoxyethyl, ethylthioethyl, methylthioethyl, difluoromethyl, trifluoromethyl, 2,2,2-trifluoroethyl, 3,3,3-trifluoropropyl, 3-chloro-2,2,3,3-tetrafluoropropyl, 3-fluoropropyl, 3,3-difluoropropyl, 2,2,2-trifluoroethylthio-ethyl, methylcarbonylmethyl, c-propylcarbonyl-methyl, tert-butylcarbonyl-methyl, methoxycarbonyl-methyl, ethoxycarbonylmethyl, hydroxycarbonyl-methyl, carbamoyl-methyl, N- methylcarbamoyl-methyl, N-cpropylcarbamoyl-methyl, Ν,Ν-dimethylcarbamoyl-methyl, 2-methoxymino-propyl, cyclopropylmethyl, phenyl, 4-methylphenyl, 2-nitrophenyl, 3-methylthiophenyl, 4-chloro-phenyl, 4-fluorophenyl, 4-tert-butyl-phenyl, 4-methoxy-phenyl, 4-nitrophenyl, 4-dimethylamino-phenyl, 2-fluoro-phenyl, 2-methoxy-phenyl, 2-dimethylaminosulfonyl-phenyl, 2-dimethylaminocarbamoyl-phenyl, 3- nitrophenyl, 3-trifluoromethyl-phenyl, 3-chloro-phenyl, 2,5-dichloro-phenyl, 3,5-dichloro-phenyl, 4-chloro-3trifluoromethyl-phenyl, 2,4,5-trichloro-phenyl, 2- pyridyl, 5-(2-chloro)pyridyl, 2-(5-methyl)-pyridyl, 2(6-methyl)-pyridyl, 2-(3-trifluoromethyl)-pyridyl, 2-pyrimidyl, 2-(4-methyl )-pyrimidyl, 2-(5-methyl)pyrimidyl, 2-(4-methoxy)-pyrimidyl, 2-(5-fluoro)-pyrimidyl, 2-(4-trifluoromethyl)-pyrimidyl, 2-(5 IVIA / a / ZUZ l / U I Ó4U / trifluoromethyl)-pyrimidyl, 2-(4,6-dimethyl)-pyrimidyl, 2-(4,5-dimethyl)-pyrimidyl, 2-(4,6-dimethoxy)-pyrimidyl, - CH2-2-pyrimidyl, -CH2-2-pyrazinyl, -CH2-5-(1-methyl)-imidazolyl, -CH23-(1 -methyl)-pyrazolyl, -CH2-4-pyridyl, -CH2-2 -pyridyl, -CH2-2-(1-methyl)-imidazol¡l, -CH2-3pyridyl, CH2-2-furanyl, -CH2-5-(2-chloro)-pyridyl, benzyl, 3,4- dichloro-benzyl, 2,6-difluorobenzyl, 2-fluoro-6-methoxy-benzyl, 2,6-dichloro-benzyl, 2-chloro-6-trifluoromethyl-benzyl, 2-chloro-6-fluoro-benzyl, -CH2-2-(4,6-dimethoxy)-pyrimidyl, 2,6-dimethyl I-benzyl, -CH2-I -(3-nitro5-methyl)-pyrazolyl, 2-(1-methyl) -benzimidazolyl, 2-(5-methyl)-oxdiazolyl, 2-[3-methyl-6(trifluoromethyl)-imidazo[4.5]-pyridínyl, 3-[4-ethyl-5-(trifluoromethyl)-]-1 ,2,4-triazolyl, 3-[4-methyl5-(trifluoromethyl)]-1,2,4-triazolyl, 3-[4-methyl-5-(difluoromethyl)]-1,2,4-triazolyl , 2-(5-phenyl)1,3,4-thiadiazolyl, 2-(1-methyl-5-phenyl)-midazolyl, 2-(4,5-dlmethyl)-oxazolyl, 2 -(1-methyl-5methoxycarbonylj-imidazolyl, 2-(1-methyl)-midazolyl or 1,2-ethandyl; m is 0 or 2, preferably 0; T is O, S or NR1b. Another preferred embodiment relates to compounds of Formula l*.B(vb) as active ingredient, wherein R1 is H, methyl, ethyl or cyclopropyl; R2esCH3; R3 is H, chlorine or bromine, preferably H; R4ies methyl, ethyl, propyl, iso-propyl, cyclopentyl, sec-butyl, allyl, 3-methoxypropyl, 3-cyanopropyl, cyclohexyl, 3,3,3-trifluoro-propyl, 3-fluoro-propyl, 2-methylsulfanylethyl, 2[( 2,2,2-trifluoroethyl)sulfanyl]ethyl, 3,4,4,4-tetrafluoro-3-trifluoromethyl, tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl, tetrahydro-2H-thiopyran-4-yl, phenyl, 3-methylsulfanylphenyl, 4-chlorophenyl, 4-fluorophenyl, 2,5-difluorophenyl, 2,4-difluorophenyl, 3,5-difluorophenyl, 2-chlorophenyl, 3,4-dichlorophenyl, 3-chlorophenyl, 3-trifluoromethyl-phenyl, 3- trifluoromethoxy-phenyl, 4fluorobenzyl, pyridin-2-yl, pyrimidin-2-ylmethyl, 5-chloropyridin-3-yl, 6-chloropyridin-3-yl, 5fluoropyridin-3-yl, 6-methoxypyridin ¡n-3-yl, 5-trifluoromethyl-pyridin-3-yl, pyridin-3-ylmethyl, 6fluoropyridin-3-yl, 6-methylpyridin-3-yl, 6-[6-chloropyridin-3-yloxy]pyridin -3-yl, 6-[6-fluoropyridin3-yloxy]pyridin-3-yl, 6-{6-[6-fluoropyridin-3-¡loxy]pyridin-3-¡l}oxypyridin-3-yl, 4- methylpyridin-3-yl, 5-methylpyridin-3-yl, pyridin-3-yl, 6-trifluoromethylpyridin-3-yl, 6-chloro-5- methylpyridin-3-yl, 6-cyanopyridin-3-yl, 6-chloro-4-methylpyridin-3-yl, 5-methoxypyridin-3-yl, 6-bromopyridin-3-yl, 5-cyanopyridin-3-yl, quinolin- 3-yl, 5,6-dimethoxypyridin-3-yl, 4-chloropyridin-3-yl, 2-chloropyridin3-yl, 5-bromopyridin-3-yl, 5-chloro-2-methoxypyridin-3-yl 3-methylsulfonylphenyl -phenoxyphenyl, 3-butylsulfanylphenyl, 4-fluoro-3-trifluoromethylphenyl, 3-methoxycarbonimidoylphenyl, 3-chloro-4methylphenyl, 3-fluoro-5-trifluoromethylphenyl, 3-chloro-5-trifluoromethylphenyl, 3-chloro-5methoxyphenyl or 3-chloro-4 -fluorophenyl or 3-trifluoromethylphenyl; T is O, SoNR1b. iviA / a / ¿uz ι / u 1 Another preferred embodiment refers to compounds of Formula l*.B(vc) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4j and R4k together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocycle, where the heterocycle contains the nitrogen atom as a heteroatom; T is O, S or NR1b. Another preferred embodiment refers to compounds of Formula l*.B(via) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R41 is H, methyl, ethyl, iso-propyl, 1-cyane-1-methylethyl or cyclopropyl; T1 is as defined above; T esO, SoNR1b. Another preferred embodiment relates to compounds of Formula l*.B(vib) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4mes methyl or ethyl; T is O, S or NR1b. Another preferred embodiment relates to compounds of the Formula r.B(vic) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4nes H, methyl, ethyl, methylsulfonyl or cyclopropylsulfonyl; R4° is H, methyl, ethyl, iso-propyl, iso-butyl, tert-butyl, 2,2,2-trifluoroethyl, 2-hydroxyethyl, 2-methoxyethyl, cyanomethyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, cyclopropyl, 1-cyanocyclopropyl, cyclopentyl, cyclopropylmethyl, methoxy, ethoxy, phenyl, pyridin-3-yl, phenylmethyl or 1-phenyl-2-hydroxyethyl; either R4 and R4o together are (Ch2)5i(CH2)4, (CH2)3o (CH2)2O(CH2)2; And thatOoS; T is O, SoNR1b. Another preferred embodiment refers to compounds of Formula l*.B(vid) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4p is H, Oí-Ce-alkyl, C3-Ce-alkenyl or C3-Ce-alkynyl, which are unsubstituted or substituted as indicated above, or Cs-Ce-cycloalkyl, Ci-Ce-alkylcarbonyl, CiCe-alkoxycarbonyl , aryl-Ci-C4-alkyl or aryl-Ci-C4-alkoxy, which are unsubstituted or substituted as indicated above; R4p is H, Ci-Ce-alkyl, C3-Ce-alkenyl or C3-Ce-alkynyl, which are unsubstituted or substituted as above, or Cs-Ce-cycloalkyl, Ci-Ce-alkylcarbonyl, CiCe-alkoxycarbonyl , aryl-Ci-C4-alkyl or aryl-Ci-C4-alkoxy, which are unsubstituted or substituted as indicated above; and R4res H, Ci-C4-alkyl, Cs-Ce-alkenyl or Cs-Ce-alkynyl, which are unsubstituted or substituted as indicated above, or Cs-Ce-cycloalkyl or C3-C8-cycloalkyl-Ci- C4alkyl, which are unsubstituted or substituted as indicated above, or aryl, hetaryl, arylalkyl or hetarylalkyl, which are unsubstituted or substituted as indicated above; And thatOoS; T is O, S or NR1b. Another preferred embodiment refers to compounds of Formula l*.B(v¡) as active ingredient, wherein R1 is H, methyl, ethyl, preferably methyl and ethyl; R2esCH3; R3 is H, chloro, bromo, preferably H; R4ses 3-[(2,2,2-trifluoroethyl)sulfan¡l]phenyl, 2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfan¡l]phenyl , 3-(methylsulfanyl)phenyl, pinmidin-2-yl, 3-[(2,2,2-trifluoroethyl)sulfanyl]phenyl, phenyl, pyridin-3-yl, 3,5-dimethylphenyl , 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2,4-dichlorophenyl, 3,4dichlorophenyl, 1-methyl-1 H-pyrrol-2-yl, 3-furyl, P,5-dimethyl-3-thienyl, 3[(trifluoromethyl)sulfanyl]phenyl, 3-[(cyclopropylmethyl)sulfan¡l]phenyl, 3-(methoxymethyl)phenyl, 3[(tetrahydro-2H-pyran-4-¡lox¡)methyl]phenyl , 3-(dimethylsulfamoyl)phenyl, 3-(methylsulfonyl)phenyl, 4methyl-3-(methylsulfanyl)phenyl, 1 -(2-cyanophenyl)-1H-pyrazol-4-yl, 1 - (4-fluorophenyl)-1H-pyrazol-4yl, 1-phenyl-1H-pyrazol-4-yl, 1-naphthyl, 5-(methoxycarbonyl)-1-naphthyl, 4-fluoro-2(methoxycarbonyl)phenyl, 4-fluoro-1-naphthyl, 4-chloro-3-(ethoxycarbonyl)phenyl, 2(methoxycarbonyl)phenyl, pyridin-4-yl, 6-(ethoxycarbonyl)pyridin-2-yl, 3-(ethoxycarbonyl)phenyl , 2naphthyl, 4-methoxy-3-(methoxycarbonyl)phenyl, 4-chloro-2-(methoxycarbonyl)phenyl, 3-thienyl, 3-(2ethoxy-2-oxoethoxy)-4-methylphenyl, 3-(2- ethoxy-2-oxoethoxy)phenyl, 3-(2-ethoxy-2-oxoethoxy¡)4,5difluorophenyl, 3-(2-ethoxy-2-oxoethoxy)-4-fluorophenyl, 3-(ethoxycarbonyl)-4-fluorophenyl, (3{[(cyclopropylcarbonyl)oxy]methyl}phenyl, 3-{[(cyclopropylcarbonyl)oxy]methyl}-4-fluorophenyl, pyridin-2-yl, 3-(difluoromethyl)phenyl, 3-[(trifluoromethyl)sulfinyl] phenyl, 4-fluoro-3 Μλ / a / zuzi / ui ow / (trifluoromethyl)phenyl, 3-chloro-5-(trifluoromethyl)phenyl, 3-(trifluoromethyl)phenyl, 3,5bis(trifluoromethyl)phenyl, 3-fluoro-5-(trifluoromethyl )phenyl, 4-cyano-3-(trifluoromethyl)phenyl, 3(2,2,2-trifluoroethyl)phenyl, 3-(pentafluoroethyl)phenyl, 3-cyanophenyl, 4-chloro-3-cyanophenyl, 3cyano -5-fluorophenyl, 3-cyano-5-(trifluoromethyl)phenyl, 5-cyano-2-methoxyphenyl, 3-cyano-4fluorophenyl, 5-cyanopyridin-3-yl, 5-cyano-6- (dimethylamin)pyridin-3-yl, 5-cyano-6-(moroflin-4yl)pyridin-3-yl, 5-cyano-6-ethoxypyridin- 3-yl, 5-cyano-6-methoxypyridin-3-yl, 3-chloro-5cyanophenyl, 1-benzofuran-2-yl, 3-phenyl-1,2-oxazol-5-yl, 3-( ethoxycarbonyl)-1,2-oxazol-5-yl, 1-isopropyl-1H-1,2,3-triazol-4-yl, 1-methyl-1H-1,2,3-triazol-4-yl, 5-cyano-6-methoxypyridin-3yl, 6-methoxypyridin-2-yl, 2,3-dihydro-1-benzofuran-7-yl, 1-benzofuran-7-yl , 2,6dimethoxypyridi η-3-yl, 2-methoxyphenyl, 1,3-benzodioxol-4-yl, 2,4-dimethoxyphenyl, 2,5dimethoxyphenyl, 6-(trifluoromethyl)pyridin-2-¡ lo, 5-chloro-2-methoxypyrid¡n-3-ílo, 2-methoxypyríd¡n-3yl, 6-ethoxypyridí η-3-yl, 5-chloro-6-methoxypyríd¡ n-3-yl, 2-(methylsulfanyl)pyridin-3-yl, 2-ethoxypyridin-3-yl, 5,6-dimethoxypyridin-3-yl, 2-methoxypyridin-4 -yl, 6-methoxy-5(trifluoromethyl)pyridin-3-yl, 6-methoxy-5-nitropyridin-3-yl, 2,6-dimethoxypyridin-4-yl, 2(methylsulfanyl)phenyl, 2 -methoxy-6-(trifluoromethyl)-pyridin-4-yl, 3-cyano-5-methoxyphenyl, 5-fluoro2-methoxypyridin-3-yl, 6-isopropoxypyridin-3-yl, 6-methoxypyridin-3- yl, 2-(2-amino-2oxoethoxy)phenyl, 3-cyano-4-isopropoxyphenyl or 3-chloropyridin-2-yl; T is O, S or NR1b. Another preferred embodiment refers to compounds of the Formula Γ.Β(νίϋ) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4tes H, methyl, trifluoromethyl, trichloromethyl, isopropyl, isobutyl, isopentyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 3,4-dichlorophenyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 4-chlorophenyl d¡n-3-yl, 2-pyrimidyl or benzyl; R4ues H or methyl; either R4t and R4u together are vini lo, prop-1 -en-2-yl, (1 E)-prop-1 -en-1 -yl, (1 Z)-prop-1 -en-1 -yl or cyclopropyl; R4ves H, S(O)mR1E, OR2Eo N(R3E)(R4E), where if R4ty / o R4ues H or Ci-C8-alkyl, R4ves S(O)mR1E, OR2Eo N(R3E)(R4E); R1E is methyl, ethyl, isopropyl, isobutyl, tert-butyl, cyclopropylmethyl, 2,2-dimethylpropyl, 2-methoxy-2-oxoethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl or 2-pyrimidyl; R2Ees H, methyl, ethyl, 2,2,2-trifluoroethyl, isopropyl, cyclopropylmethyl, benzyl, 3-chlorophenyl or 4-chlorophenyl; R3E and R4E together with the nitrogen atom to which they are attached form a 5-membered heterocycle, where the heterocycle group contains one or two N atoms, where the cyclic groups may contain a CO group, and where the C atoms are substituted with trifluoromethyl, methyl or cyclopropyl; MA / a / 4ÍU¿l / Ul ÓW / T esO, SoNR1b. More preferred embodiments refer to compounds of Formula Γ.1 .A(liia) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3is H; and wherein at least one of R4a, R4b, and R4° is C3-C4-cycloalkenyl, Cs-Ci-halocycloalkenyl, ORa or SRa, where Ra is C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl. Additional more preferred embodiments relate to compounds of Formula l*.1.A(iiib) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CHa; R2is CH3 or halomethyl; R3esH; R4aes as defined above; A is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group. Additional more preferred embodiments relate to compounds of Formula l*.1.A(iiic) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3esH; R4a and R4b as defined above; E is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group. Additional more preferred embodiments relate to compounds of the Formula Γ.1 .A(ii¡d) as active ingredient, where R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3esH; R4des Ci-C2-haloalkyl or C-C3H5, where the C atoms may be halogenated; G is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group. Additional more preferred embodiments relate to compounds of the Formula Γ.1 .A(iva) as active ingredient, where R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3esH; R4ees H or CH3; Q is a direct bond or a straight or α-branched chain Ci-Cs-alkylene, C2-C8-alkenylene or C2-C8-alkynylene, where the carbon chains may be substituted or unsubstituted as indicated above; M is O, S, NOCH3or NSCH3. Additional more preferred embodiments relate to compounds of Formula l*.1.A(ivb) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3esH; R4fes H, Ci-Cvalkyl or Cs-Cs-cycloalkyl; R49 is H, Ci-C4-alkyl or Cs-Ce-cycloalkyl; V esOoS; W is a straight or branched chain Ci-Ce-alkylene, Cs-Cs-cycloalkylene or C3-Cs-heterocycloalkylene, where W is substituted as indicated above. Additional more preferred embodiments relate to compounds of Formula l*.1.A(va) as active ingredient, wherein R1 is H or CH3, preferably CH3; R2esCH3; R3 is H, chlorine or bromine, preferably H; R4hes methyl, ethyl, n-butyl, n-pentyl, n-propyl, iso-propyl, allyl, 3,3-dimethylallyl, propargyl, cyclohexyl, tetrahydro-pyranyl, tetrahydro-thiopyranyl, 3-oxetanyl, 5-oxa-[ 3.3.0]bicycloheptanyl, methoxyethyl, methoxypropyl, ethoxyethyl, ethylthioethyl, methylthioethyl, difluoromethyl, trifluoromethyl, 2,2,2-trifluoroethyl, 3,3,3-trifluoropropyl, 3-chloro-2,2,3,3-tetrafluoropropyl, 3-fluoropropyl, 3,3-difluoropropyl, 2,2,2-trifluoroethylthio-ethyl, methylcarbonylmethyl, c-propylcarbonyl-methyl, tert-butylcarbonyl-methyl, methoxycarbonyl-methyl, ethoxycarbonylmethyl, hydroxycarbonyl-methyl, carbamoyl-methyl, N- methylcarbamoyl-methyl, N-cpropylcarbamoyl-methyl, Ν,Ν-dimethylcarbamoyl-methyl, 2-methoxymino-propyl, cyclopropylmethyl, phenyl, 4-methylphenyl, 2-nitrophenyl, 3-methylthiophenyl, 4-chloro-phenyl, 4-fluorophenyl, 4-tert-butyl-phenyl, 4-methoxy-phenyl, 4-nitrophenyl, 4-dimethylamino-phenyl, 2-fluoro-phenyl, 2-methoxy-phenyl, 2-dimethylaminosulfonyl-phenyl, 2-dimethylaminocarbamoyl-phenyl, 3- nitrophenyl, 3-trifluoromethyl-phenyl, 3-chloro-phenyl, 2,5-dichloro-phenyl, 3,5-dichloro-phenyl, 4-chloro-3trifluoromethyl-phenyl, 2,4,5-trichloro-phenyl, 2-pyridyl, 5-(2-chloro)pyridyl, 2-(5-methyl)-pyridyl, 2(6-methyl)-pyridyl, 2-(3-trifluoromethyl)-pyridyl, 2-pyrimidyl, 2- (4-methyl)-pyrimidyl, 2-(5-methyl)pyrimidyl, 2-(4-methoxy)-pyrimidyl, 2-(5-fluoro)-pyrimidyl, 2-(4-trifluoromethyl)-pyrimidyl, 2 -(5trifluoromethyl)-pyrimidyl, 2-(4,6-dimethyl)-pyrimidyl, 2-(4,5-dimethyl)-pyrimidyl, 2-(4,6-dimethoxy)-pyrimidyl, -CH2-2-pyrimidyl, -CH2-2-pyrazinyl, -CH2-5-(1-methyl)-imidazolyl, -CH23-(1-methyl)-pyrazolyl, -CH2-4-pyridyl, -CH2-2-pyridyl, -CH2-2- (1-methyl)-imidazolyl, -CH2-3pyridyl, CH2-2-furanyl, -CH2-5-(2-chloro)-pyridyl, benzyl, 3,4-dichloro-benzyl, 2,6-difluorobenzyl, 2- fluoro-6-methoxy-benzyl, 2,6-dichloro-benzyl, 2-chloro-6-trifluoromethyl-benzyl, 2-chloro-6-fluoro-benzyl, -CH2-2-(4,6-dimethoxy)-pyr imid¡l, 2,6-d i methyl I-benzyl, -CH2-I -(3-nitro5-methyl)-pyrazolyl, 2-(1-methyl)-benzimidazolyl, 2-(5-methyl)-oxdiazolyl, 2-[3-methyl-6 iviA / a / zuz ι / u 1 (trifluoromethyl)-imidazo[4.5]-pyridinyl, 3-[4-ethyl-5-(trifluoromethyl)-]-1,2,4 -triazolyl, 3-[4-methyl5-(trif fluoromethyl)]-1,2,4-triazolyl, 3-[4-methyl-5-(difluoromethyl)]-1,2,4-triazolyl, 2-(5 -phenyl)1,3,4-thiadiazolyl, 2-(1-methyl-5-phenyl)-imidazolyl, 2-(4,5-dimethyl)-oxazolyl, 2-(1-methyl-5-methoxycarbonyl)- imidazolyl, 2-(1-methyl)-imidazolyl or 1,2-ethanediyl; m is 0 or 2, preferably 0. Further more preferred embodiments refer to compounds of Formula 1*.1 .A(vb) as active ingredient, wherein R1 is H, methyl, ethyl or cyclopropyl; R2esCH3; R3 is H, chlorine or bromine, preferably H; R4 is methyl, ethyl, propyl, iso-propyl, cyclopentyl, sec-butyl, ayl, 3-methoxypropyl, 3-cyanopropyl, cyclohexyl, 3,3,3-trifluoro-propyl, 3-fluoro-propyl, 2-methylsulfanylethyl, 2[( 2,2,2-trifluoroethyl)sulfan¡l]ethyl, 3,4,4,4-tetrafluoro-3-thfluoromethyl, tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl, tetrahydro-2H-thiopyran- 4-yl, phenyl, 3-methylsulfanylphenyl, 4-chlorophenyl, 4-fluorophenyl, 2,5-difluorophenyl, 2,4-difluorophenyl, 3,5-difluorophenyl, 2-chlorophenyl, 3,4-dichlorophenyl, 3-chlorophenyl, 3-trifluoromethyl- phenyl, 3-trifluoromethoxy-phenyl, 4-fluorobenzyl, pyridin-2-yl, pyrimidin-2-ylmethyl, 5-chloropyridin-3-yl, 6-chloropyridin-3-yl, 5fluoropyridin-3-yl, 6-methoxypyridin -3-yl, 5-trifluoromethyl-pyridin-3-yl, pyridin-3-ylmethyl, 6fluoropyridin-3-yl, 6-methylpyridin-3-yl, 6-[6-chloropyridin-3- yloxy]pyr¡din-3-yl, 6-[6-fluoropyridin3-¡loxy]pyr¡d¡n-3-yl, 6-{6-[6-fluorop¡r¡d¡n-3 -¡lox¡]pyrádin-3-¡l}oxy¡pyridín-3-¡lo, 4-methylpyridín-3-¡lo, 5-methylpyridín-3- yl, pyridin-3-yl, 6-trifluoromethylpyridin-3-yl, 6-chloro-5-methylpyridin-3-yl, 6cyanopyridin-3-yl, 6-chloro-4-methylpyridin-3 -yl, 5-methoxypyridin-3-yl, 6-bromopyridin-3-yl, 5cyanopyridin-3-yl, quinolin-3-yl, 5,6-dimethoxypyridin-3-yl, 4-chloropyridin-3-yl Ilo, 2-chloropyridin3-yl, 5-bromopyridin-3-yl, 5-chloro-2-methoxypyridin-3-yl, 2-fluoro-6-methylpyridin-3-yl, 3cyanophenyl, 3-ethoxyphenyl, 3-acetamidophenyl, 3-ethylphenyl, 3-methoxyphenyl, 3-propylphenyl, 2fluoro-3-trifluoromethylphenyl, 3-methylphenyl, 3-methylsulfonylphenyl, 3-phenoxyphenyl, 3-butylsulfanylphenyl, 4-fluoro-3-trifluoromethylphenyl, 3-methoxycarbonoimidoylphenyl, 3-chloro-4-methylphenyl, 3-fluoro-5-trifluoromethylphenyl, 3-chloro-5-trifluoromethylphenyl, 3-chloro-5-methoxyphenyl or 3-chloro-4-fluorophenyl or 3-trifluoromethylphenyl. Additional more preferred embodiments relate to compounds of Formula l*.1.A(vc) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4¡ and R4k together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocycle, wherein the heterocycle contains the nitrogen atom as a heteroatom. Additional more preferred embodiments refer to compounds of Formula Γ.1 .A(via) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R41 is H, methyl, ethyl, iso-propyl, 1-cyano-1-methylethyl or cyclopropyl; T1 is as defined above; Further more preferred embodiments refer to compounds of Formula 1*.1 .A(vib) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2 is CH3; R3is H; R4mes methyl or ethyl. Further more preferred embodiments refer to compounds of Formula 1*.1 .A(vic) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4 is H, methyl, ethyl, methylsulfonyl, or cyclopropylsulfonyl; R4° is H, methyl, ethyl, iso-propyl, iso-butyl, tert-butyl, 2,2,2-trifluoroethyl, 2-hydroxyethyl, 2-methoxyethyl, cyanomethyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, cyclopropyl, 1-cyanocyclopropyl, cyclopentyl, cyclopropylmethyl, methoxy, ethoxy, phenyl, pyridin-3-yl, phenylmethyl or 1-phenyl-2-hydroxyethyl; either R4n and R40 together are (CH2)5, (ΟΗ2)4, (CH2)3 or (CH2)2O(CH2)2; And thatOoS; Further more preferred embodiments refer to compounds of Formula F.1 .A(vine) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4pes H, Ci-Ce-alkyl, Cs-Ce-alkenyl or Cs-Ce-alkynyl, which are unsubstituted or substituted as above, or Cs-Ce-cycloalkyl, Ci-Ce-alkylcarbonyl, CiCe-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-Ci-Ci-alkoxy, which are unsubstituted or substituted as indicated above; R4pes H, Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Ce-alkynyl, which are unsubstituted or substituted as indicated above, or C3-C6-cycloalkyl, Ci-Cs-alkylcarbonyl, CiCs-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-Ci-C4-alkoxy, which are unsubstituted or substituted as indicated above; R4res H, Ci-C4-alkyl, C3-C6-alkenyl or C3-C6-alkynyl, which are unsubstituted or substituted as above, or C3-Cs-cycloalkyl or C3-C8-cycloalkyl-Ci-C464 alkyl , which are unsubstituted or substituted as indicated above, or aryl, hetaryl, arylalkyl or hetarylalkyl, which are unsubstituted or substituted as indicated above; And it's O or S. Additional more preferred embodiments relate to compounds of Formula l*.1.A(v¡) as active ingredient, wherein R1 is H, methyl, ethyl, preferably methyl and ethyl; R2esCH3; R3 is H, chlorine, bromine, preferably H; R4ses 3-[(2,2,2-trifluoroethyl)sulfanyl]phenyl, 2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfanyl]phenyl, 3-(methylsulfanyl)phenyl, pyrimidin-2-yl, 3-[(2,2,2-trifluoroethyl)sulfinyl]phenyl, phenyl, pyridin-3-yl, 3,5-dimethylphenyl, 2-chlorophenyl , 3-chlorophenyl, 4-chlorophenyl, 2,4-dichlorophenyl, 3,4dichlorophenyl, 1 -methyl-1 H-pyrrol-2-llo, 3-furyl, 2,5-dimethyl-3-thienyl, 3[(trifluoromethyl )sulfanyl]phenyl, 3-[(cyclopropylmethyl)sulfanyl]phenyl, 3-(methoxymethyl)phenyl, 3[(tetrahydro-2H-pyran-4-yloxy)methyl]phenyl, 3-(dimethylsulfamoyl)phenyl, 3-(methylsulfonyl)phenyl, 4methyl-3-(methyl Isu Ifani l)phenyl, 1 -(2-cyanophenyl)-1 H-pyrazole -4-yl , 1 -(4-f luorofen ¡I)-1 H-pyrazol-4yl, 1 -phenyl-1 H-pyrazol-4-yl, 1-naphthyl, 5-(methoxycarbonyl)-1-naphthyl, 4-fluoro- 2(methoxycarbonyl)phenyl, 4-fluoro-1-naphthyl, 4-chloro-3-(ethoxycarbonyl)phenyl, 2(methoxycarbonyl)phenyl, pyridin-4-yl, 6-(ethoxycarbonyl)pyridin-2-yl , 3-(ethoxycarbonyl)phenyl, 2naphthyl, 4-methoxy-3-(methoxycarbonyl)phenyl, 4-chloro-2-(methoxycarbonyl)phenyl, 3-thienyl, 3-(2ethoxy-2-oxoethoxy)-4- methylphenyl, 3-(2-ethoxy-2-oxoethoxy)phenyl, 3-(2-ethoxy-2-oxoethoxy)4,5difluorophenyl, 3-(2-ethoxy-2-oxoethoxy)-4-fluorophenyl, 3-(ethoxycarbonyl )-4-fluorophenyl, (3{[(cyclopropylcarbonyl)oxy]methyl}phenyl, 3-{[(cyclopropylcarbonyl)oxy]methyl}-4-fluorophenyl, pyridin-2-yl, 3-(difluoromethyl)phen lo, 3-[(trifluoromethyl)sulfányl]phenyl, 4-fluoro-3(trifluoromethyl)phenyl, 3-chloro-5-(trifluoromethyl)phenyl, 3-(trifluoromethyl)phenyl, 3,5bis(trifluoromethyl)phenyl, 3-fluoro-5-(trifluoromethyl)phenyl, 4-cyano-3-(trifluoromethyl)phenyl, 3(2,2,2-trifluoroethyl)phenyl, 3-(pentafluoroethyl) )phenyl, 3-cyanophenyl, 4-chloro-3-cyanophenyl, 3-cyano-5-fluorophenyl, 3-cyano-5-(trifluoromethyl)phenyl, 5-cyano-2-methoxyphenyl, 3-cyano-4fluorophenyl, 5-cyanopyri d¡n-3-¡lo, 5-cyano-6-(dimet¡lamin)pyr¡d¡n-3-¡lo, 5-cyano-6-(moroflin-4yl)pyridin- 3-yl, 5-cyano-6-ethoxypyridin-3-yl, 5-cyano-6-methoxypyridin-3-yl, 3-chloro-5cyanophenyl, 1-benzofuran-2-yl, 3-phenyl -1,2-oxazol-5-yl, 3-(ethoxycarbonyl)-1,2-oxazol-5-yl, 1 -isopropyl-1 H-1,2,3-triazol-4-yl, 1 -methyl- 1 H-1,2,3-triazol-4-yl, 5-cyano-6-methoxypyridin-3yl, 6-methoxypyridin-2-yl, 2,3-dihydro-1-benzofuran-7-yl, 1- benzofuran-7-yl, 2,6dimethoxypyridin-3-yl, 2-methoxyphenyl, 1,3-benzodioxol-4-yl, 2,4-dimethoxyphenyl, 2,5dimethoxyphenyl, 6-(trifluoromethyl)pyridin-2 -llo, 5-chloro-2-methoxypyridin-3-yl, 2-methoxypyridin-3-yl, 6-ethoxypyridin-3-yl, 5-chloro-6-methoxypyridin-3-yl, 2-(methylsulfanyl)p¡ ridin-3-yl, 2ethoxypyridin-3-yl, 5,6-dimethoxypyridin-3-yl, 2-methoxypyridin-4-yl, 6-methoxy-5(trifluoromethyl)pyridin-3-yl, 6-methoxy-5- nitropyridin-3-yl, 2,6-dimethoxypyridin-4-yl, 265 (methylsulfanyl)phenyl, 2-methoxy-6-(trifluoromethyl)-pyridin-4-yl, 3-cyano-5-methoxyphenyl, 5 -fluoro2-methoxypyridin-3-yl, 6-isopropoxypyridin-3-yl, 6-methoxypyridin-3-yl, 2-(2-amino-2oxoethoxy)phenyl, 3-cyano-4-isopropoxyphenyl or 3- chloropyridin-2-yl. Additional more preferred embodiments relate to compounds of Formula Γ.1.A(viii) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4tes H, methyl, trifluoromethyl, trichloromethyl, isopropyl, sobutyl, isopentyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 3,4-dichlorophenyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 4-chloropyrid n-3-yl, 2-pyrimidyl or benzyl; R4ues H or methyl; either R4t and R4u together are vinyl, prop-1-en-2-yl, (1E)-prop-1-en-1-yl, (1Z)-prop-1-en-1-yl or cyclopropyl; R4ves H, S(O)mR1E, OR2Eo N(R3E)(R4E), where if R4ty / o R4ues H or Ci-C8-alkyl, R4ves S(O)mR1E, OR2Eo N(R3E)(R4E); R1E is methyl, ethyl, isopropyl, isobutyl, tert-butyl, cyclopropylmethyl, 2,2-dimethylpropyl, 2-methoxy-2-oxoethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl or 2-pyrimidyl; R2Ees H, methyl, ethyl, 2,2,2-thfluoroethyl, isopropyl, cyclopropylmethyl, benzyl, 3-chlorophenyl or 4-chlorophenyl; R3E and R4E together with the nitrogen atom to which they are attached form a 5-membered heterocycle, where the heterocycle group contains one or two N atoms, where the cyclic groups may contain a CO group, and where the C atoms are substituted with trifluoromethyl, methyl or cyclopropyl. Additional more preferred embodiments relate to compounds of Formula Γ.1.B(iiia) as active ingredient R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3o halomethyl; R3is H; and wherein at least one of R4a, R4b and R4 is C3-C4-cycloalkenyl, C3-C4-halocycloalkenyl, ORa or SRa, wherein Ra is C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl. Additional more preferred embodiments relate to compounds of Formula Γ.1.B(iiib) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3o halomethyl; R3esH; R4aes as defined above; A is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group. Additional more preferred embodiments relate to compounds of Formula l*.1.B(iiic) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3 or halomethyl; R3esH; R4a and R4b as defined above; E is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group. Additional more preferred embodiments relate to compounds of Formula l*.1.B(iiid) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3o halomethyl; R3esH; R4des Ci-C2-haloalkyl or C-C3H5, where the C atoms may be halogenated; G is a C3-C4-cycloalkenyl or C3-C4-halocycloalkenyl group. Additional more preferred embodiments relate to compounds of Formula l*.1.B(iva) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3o halomethyl; R3esH; R4ees H or CH3; Q is a direct bond or a straight-chain or α-branched Ci-Cs-alkylene, C2-C8-alkenylene or C2-C8-alkylene, where the carbon chains may be substituted or unsubstituted as indicated previously; M is O, S, NOCH3or NSCH3. Additional more preferred embodiments relate to compounds of Formula Γ.1.B(ivb) as active ingredient, wherein R1 is H, CH3 or C2H5, preferably H or CH3; R2is CH3o halomethyl; R3esH; R4fes H, Ci-C4-alkyl or Cs-Ce-cycloalkyl; R49 is H, Ci-C4-alkyl or Cs-Ce-cycloalkyl; V esOoS; W is a straight-chain or α-branched Ci-Cs-alkylene, Cs-Cs-cycloalkylene or Cs-Cs-heterocycloalkylene, where W is substituted as indicated above. Additional more preferred embodiments relate to compounds of Formula l*.1.B(va) as active ingredient, wherein R1 is H or CH3, preferably CH3; R2esCH3; R3 is H, chlorine or bromine, preferably H; R4hes methyl, ethyl, n-butyl, n-pentyl, n-propyl, iso-propyl, allyl, 3,3-dimethylallyl, propargyl, cyclohexyl, tetrahydro-pyranyl, tetrahydro-thiopyranyl, 3-oxetanyl, 5-oxa-[ 3.3.0]bicycloheptanyl, methoxyethyl, methoxypropyl, ethoxyethyl, ethylthioethyl, methylthioethyl, difluoromethyl, trifluoromethyl, 2,2,2-trifluoroethyl, 3,3,3-trifluoropropyl, 3-chloro-2,2,3,3-tetrafluoropropyl, 3-fluoropropyl, 3,3-difluoropropyl, 2,2,2-trifluoroethylthio-ethyl, methylcarbonylmethyl, c-propylcarbonyl-methyl, tert-butylcarbonyl-methyl, methoxycarbonyl-methyl, ethoxycarbonylmethyl, hydroxycarbonyl-methyl, carbamoyl-methyl, N- methylcarbamoyl-methyl, N-cpropylcarbamoyl-methyl, Ν,Ν-dimethylcarbamoyl-methyl, 2-methoxymino-propyl, cyclopropylmethyl, phenyl, 4-methylphenyl, 2-nitrophenyl, 3-methylthiophenyl, 4-chloro-phenyl, 4-fluorophenyl, 4-tert-butyl-phenyl, 4-methoxy-phenyl, 4-nitrophenyl, 4-dimethylamino-phenyl, 2-fluoro-phenyl, 2-methoxy-phenyl, 2-dimethylaminosulfonyl-phenyl, 2-dimethylaminocarbamoyl-phenyl, 3- nitrophenyl, 3-trifluoromethyl-phenyl, 3-chloro-phenyl, 2,5-dichloro-phenyl, 3,5-dichloro-phenyl, 4-chloro-3trifluoromethyl-phenyl, 2,4,5-trichloro-phenyl, 2- pyridyl, 5-(2-chloro)pyridyl, 2-(5-methyl)-pyridyl, 2(6-methyl)-pyridyl, 2-(3-trifluoromethyl)-pyridyl, 2-pyrimidyl, 2- (4-methyl)-pyrimidyl, 2-(5-methyl)pyrimidyl, 2-(4-methoxy)-pyrimidyl, 2-(5-fluoro)-pyrimidyl, 2-(4-trifluoromethyl)-pyrimidyl, 2 -(5trifluoromethyl)-pyrimidyl, 2-(4,6-dimethyl)-pyrimidyl, 2-(4,5-dimethyl)-pyrimidyl, 2-(4,6-dimethoxy)-pyrimidyl, -CH2-2-pyrimidyl, -CH2-2-pyrazinyl, -CH2-5-(1-methyl)-imidazolyl, -CH23-(1-methyl)-pyrazolyl, -CH2-4-pyridyl, -CH2-2-pyridyl, -CH2-2- (1-methyl)-imidazolyl, -CH2-3pyridyl, CH2-2-furanyl, -CH2-5-(2-chloro)-pyridyl, benzyl, 3,4-dichloro-benzyl, 2,6-difluorobenzyl, 2- fluoro-6-methoxy-benzyl, 2,6-dichloro-benzyl, 2-chloro-6-trifluoromethyl-benzyl, 2-chloro-6-fluoro-benzyl, -CH2-2-(4,6-dimethoxy)-pyrimidyl, 2 ,6-dimethyl-benzyl, -CH2-I-(3-nitro5-methyl)-pyrazolyl, 2-(1-methyl)-benzimidazolyl, 2-(5-methyl)-oxdiazolyl, 2-[3-methyl -6(trifluoromethyl)-imidazo[4.5]-pyridinyl, 3-[4-ethyl-5-(trifluoromethyl)-]-1,2,4-triazolyl, 3-[4-methyl5-(trifluoromethyl )]-1,2,4-triazolyl, 3-[4-methyl-5-(difluoromethyl)]-1,2,4-triazolyl, 2-(5-phenyl)1,3,4-thiadiazolyl, 2-(1-methyl-5-phenyl)-midazolyl, 2-(4,5-dimethyl)-oxazolyl, 2-(1-methyl-5methoxycarbonyl)-midazolyl, 2- (1-methyl)-imidazolyl or 1,2-ethanediyl; m is 0 or 2, preferably 0. Additional more preferred embodiments relate to compounds of Formula Γ.1.B(vb) as active ingredient, wherein R1 is H, methyl, ethyl or cyclopropyl; R2esCH3; R3 is H, chlorine or bromine, preferably H; R4ies methyl, ethyl, propyl, iso-propyl, cyclopentyl, sec-butyl, ayl, 3-methoxypropyl, 3-cyanopropyl, cyclohexyl, 3,3,3-trifluoro-propyl, 3-fluoro-propyl, 2-methylsulfanylethyl, 2[( 2,2,2-trifluoroethyl)sulfanyl]ethyl, 3,4,4,4-tetrafluoro-3-trifluoromethyl, tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl, tetrahydro-2H-thiopyran-4-yl , phenyl, 3-methylsulfanilphenyl, 4-chlorophenyl, 4-fluorophenyl, 2,5-difluorophenyl, 2,4-difluorophenyl, 3,5-difluorophenyl, 2chlorophenyl, 3,4-dichlorophenyl, 3-chlorophenyl, 3-trifluoromethyl-phenyl, 3 -trifluoromethoxy-phenyl, 4-fluorobenzyl, pyridin-2-yl, pyrimidin-2-ylmethyl, 5-chloropyridin-3-yl, 6-chloropyridin-3-yl, 5fluoropyridin-3-yl, 6-methoxypyridin-3-yl, 5-trifluoromethyl-pyridin-3-yl, pyridin-3-ylmethyl, 6fluoropyridin-3-yl, 6-methylpyridin-3-yl, 6-[6-chloropyridin-3-yloxy]pyridin- 3-yl, 6-[6-fluoropyridin-3-yloxy]pyridin-3-yl, 6-{6-[6-fluoropyridin-3-yloxy]pyridin-3-yl}oxypyridin-3 -yl, 4-methylpyridin-3-yl, 5-methylpyridin-3-yl, pyridin-3-yl, 6-trifluoromethylpyridin-3-yl, 6-chloro-5-methylpyridin-3-yl, 6cyanopyridin-3-yl yl, 6-chloro-4-methylpyridin-3-yl, 5-methoxypyridin-3-yl, 6-bromopyridin-3-yl, 5cyanopyridin-3-yl, quinolin -3-yl, 5,6-dimethoxypyridin-3-yl, 4-chloropyridin-3-yl, 2-chloropyridin3-yl, 5-bromopyridin-3-yl, 5-chloro-2-methoxypyridin-3-yl, 2 -fluoro-6-methylpyridin-3-yl, 3cyanophenyl, 3-ethoxyphenyl, 3-acetamidophenyl, 3-ethylphenyl, 3-methoxyphenyl, 3-propylphenyl, 2fluoro-3-trifluoromethylphenyl, 3-methylphenyl, 3-methylsulfon ylphenyl, 3- phenoxyphenyl, 3-butylsulfanylphenyl, 4-fluoro-3-trifluoromethylphenyl, 3-methoxycarbonimidoylphenyl, 3-chloro-4methylphenyl, 3-fluoro-5-trifluoromethylphenyl, 3-chloro-5-trifluoromethylphenyl, 3-chloro- 5methoxyphenyl or 3-chloro-4-fluorophenyl or 3-trifluoromethylphenyl. Additional more preferred embodiments relate to compounds of Formula l*.1.B(vc) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; r4¡ and R«k together with e| The nitrogen atom to which they are attached form a 5- or 6-membered heterocycle, where the heterocycle contains the nitrogen atom as a heteroatom. Additional more preferred embodiments relate to compounds of Formula l*.1.B(via) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R41 is H, methyl, ethyl, iso-propyl, 1-cyano-1-methylethyl or cyclopropyl; T1 is as defined above; Additional more preferred embodiments relate to compounds of Formula Γ.1.B(vib) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4mes methyl or ethyl. Additional more preferred embodiments relate to compounds of Formula l*.1.B(vic) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; IVIA / a / ZUZ l / U I Ó4U / R4 is H, methyl, ethyl, methylsulfonyl, or cyclopropylsulfonyl; R4° is H, methyl, ethyl, iso-propyl, iso-butyl, tert-butyl, 2,2,2-trifluoroethyl, 2-hydroxyethyl, 2-methoxyethyl, cyanomethyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, cyclopropyl, 1-cyanocyclopropyl, cyclopentyl, cyclopropylmethyl, methoxy, ethoxy, phenyl, pyridin-3-yl, phenylmethyl or 1-phenyl-2-hydroxyethyl; either R4n and R40 together are (CH2)5, (CH2)4, (CH2)3or (CH2)2O(CH2)2; And it's O or S. Additional more preferred embodiments relate to compounds of Formula Γ.1.B(vine) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4pes H, Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Ce-alkynyl, which are unsubstituted or substituted as indicated above, or Cs-Cs-cycloalkyl, Ci-Cs-alkylcarbonyl, CiCs-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-Ci-C4-alkoxy, which are unsubstituted or substituted as indicated above; R4qes H, Ci-Ce-alkyl, C3-Cs-alkenyl or C3-Cs-alkynyl, which are unsubstituted or substituted as indicated above, or Cs-Cs-cycloalkyl, Ci-Cs-alkylcarbonyl, CiCs-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-Ci-C4-alkoxy, which are unsubstituted or substituted as indicated above; R4res H, Ci-C4-alkyl, C3-Cs-alkenyl or Cs-Ce-alkynyl, which are unsubstituted or substituted as indicated above, or Cs-Cs-cycloalkyl or C3-C8-cycloalkyl-Ci-C4alkyl, which are unsubstituted or substituted as indicated above, or aryl, hetaryl, arylalkyl or hetarylalkyl, which are unsubstituted or substituted as indicated above; And it's O or S. Additional more preferred embodiments relate to compounds of Formula l*.1.B(vii) as active ingredient, wherein R1 is H, methyl, ethyl, preferably methyl and ethyl; R2esCH3; R3 is H, chlorine, bromine, preferably H; R4ses 3-[(2,2,2-trifluoroethyl)sulfanyl]phenyl, 2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfanyl]phenyl, 3-(methylsulfanyl)phenyl, pyrimidin-2-yl, 3-[(2,2,2-trifluoroethyl)sulfinyl]phenyl, phenyl, pyridin-3-yl, 3,5-dimethylphenyl, 2-chlorophenyl, 3-chlorophenyl , 4-chlorophenyl, 2,4-dichlorophenyl, 3,4dichlorophenyl, 1-methyl-1H-pyrrol-2-yl, 3-furyl, 2,5-dimethyl-3-thienyl, 3[(trifluoromethyl)sulfanyl]phenyl, 3-[(cyclopropylmethyl)sulfanyl]phenyl, 3-(methoxymethyl)phenyl, 3[(tetrahydro-2H-pyran-4-yloxy)methyl]phenyl, 3-(dimethylsulfamoyl)phenyl, 3-(methylsulfonyl)phenyl, 4methyl- 3-(methylsulfanyl)phenyl, 1 -(2-cyanophenyl)-1 H-pyrazol-4-yl, 1 -(4-fluorophenyl)-1 H-pyrazol-4-yl, 1-phenyl-1H-pyrazol-4- yl, 1-naphthyl, 5-(methoxycarbonyl)-1-naphthyl, 4-fluoro-2(methoxycarbonyl)phenyl, 4-fluoro-1-naphthyl, 4-chloro-3-(ethoxycarbonyl)phenyl, 2(methoxycarbonyl) )phenyl, pyridin-4-yl, 6-(ethoxycarbonyl)pyridin-2-yl, 3-(ethoxycarbonyl)phenyl, 2-naphthyl, 4-methoxy-3-(methoxycarbonyl)phen lo, 4-chloro-2-(methoxycarbonyl)phenyl, 3-thienyl, 3-(2ethoxy-2-oxoethoxy)-4-methylphenyl, 3-(2-ethoxy-2-oxoethoxy)phenyl, 3-(2- ethoxy-2-oxoethoxy¡)4,5difluorophenyl, 3-(2-ethoxy-2-oxoethoxy)-4-fluorophenyl, 3-(ethoxycarbonyl)-4-fluorophenyl, (3{[(cyclopropylcarbonyl)oxy]methyl} phenyl, 3-{[(cyclopropylcarbonyl)oxy]methyl}-4-fluorophenyl, pyridin-2-yl, 3-(difluoromethyl)phenyl, 3-[(trifluoromethyl)sulfinyl]phenyl, 4-fluoro-3(tnfluoromethyl)phenyl , 3-chloro-5-(trifluoromethyl)phenyl, 3-(trifluoromethyl)phenyl, 3,5bis(trifluoromethyl)phenyl, 3-fluoro-5-(trifluoromethyl)phenyl, 4-cyano-3- (trifluoromethyl)phenyl, 3(2,2,2-trifluoroethyl)phenyl, 3-(pentafluoroethyl)phenyl, 3-cyanophenyl, 4-chloro-3-cyanophenyl, 3-cyano-5-fluorophenyl, 3- cyano-5-(trifluoromethyl)phenyl, 5-cyano-2-methoxyphenyl, 3-cyano-4fluorophenyl, 5-cyanopyridin-3-yl, 5-cyano-6-(dimethylamin)pyridin-3- io, 5-cyano-6-(moroflin-4yl)pyridin-3-yl, 5-cyano-6-ethoxypyridin-3-yl, 5-cyano-6-methoxypyridin-3-yl, 3-chloro- 5cyanophenyl, 1-benzofuran-2-yl, 3-phenyl-1,2-oxazol-5-yl, 3-(ethoxycarbonyl)-1,2-oxazol-5-yl, 1 -isopropyl-1 H-1,2 ,3-triazol-4-yl, 1 -methyl-1H-1,2,3-triazol-4-yl, 5-cyano-6-methoxypyridin-3yl, 6-methoxypyridin-2-yl, 2,3-dihydro -1-benzofuran-7-yl, 1-benzofuran-7-yl, 2,6-dimethoxypyridin-3-yl, 2-methoxyphenyl, 1,3-benzodioxol-4-yl, 2,4-dimethoxyphenyl, 2,5-dimethoxyphenyl , 6-(trifluoromethyl)pyridin-2-yl, 5-chloro-2-methoxypyridin-3-yl, 2-methoxypyridin-3-yl, 6-ethoxypyridin-3-yl, 5-chloro-6-methoxypyridin-3- Ilo, 2-(methylsulfanyl)pyridin-3-yl, 2-ethoxypyridin-3-yl, 5,6-dimethoxypyridin-3-yl, 2-methoxypyridin-4-yl, 6-methoxy-5(trifluoromethyl)pyridin- 3-yl, 6-methoxy-5-nitropyridin-3-yl, 2,6-dimethoxypyridin-4-yl, 2(methylsulfanyl)phenyl, 2-methoxy-6-(trifluoromethyl)-pyridin-4-yl, 3- cyano-5-methoxyphenyl, 5-fluoro2-methoxypyridin-3-yl, 6-isopropoxypyridin-3-yl, 6-methoxypyridin-3-yl, 2 -(2-amino-2oxoethoxy)phenyl, 3-cyano-4-isopropoxyphenyl or 3-chloropyridin-2-yl. Additional more preferred embodiments relate to compounds of Formula l*.1.B(viii) as active ingredient, wherein R1 is methyl, ethyl or cyclopropyl; R2esCH3; R3esH; R4tes H, methyl, trifluoromethyl, trichloromethyl, isopropyl, isobutyl, isopentyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 3,4-dichlorophenyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 4-chloropyridin- 3-yl, 2-pyrimidyl or benzyl; R4ues H or methyl; either R4t and R4u together are vinyl, prop-1-en-2-yl, (1E)-prop-1-en-1-yl, (1Z)-prop-1-en-1-yl or cyclopropyl; R4ves H, S(O)mR1E, OR2Eo N(R3E)(R4E), where if R4ty / o R4ues H or Ci-C8-alkyl, R4ves S(O)mR1E, OR2Eo N(R3E)(R4E); R1E is methyl, ethyl, isopropyl, isobutyl, tert-butyl, cyclopropylmethyl, 2,2-dimethylpropyl, 2-methoxy-2-oxoethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl or 2-pyrimidyl; R2Ees H, methyl, ethyl, 2,2,2-trifluoroethyl, isopropyl, cyclopropylmethyl, benzyl, 3-chlorophenyl or 4-chlorophenyl; R3E and R4E together with the nitrogen atom to which they are attached form a 5-membered heterocycle, where the heterocycle group contains one or two N atoms, where the cyclic groups may contain a CO group, and where the C atoms are substituted with trifluoromethyl, methyl or cyclopropyl. Additional even more preferred embodiments refer to the compounds of the Formula Γ.1 .A(vic) as active ingredient, l*.1 .A(vi¡) or Γ.1 .A(v¡¡) , where R1 is H, methyl or ethyl; R2 is CH3; R3 is H; R4n, R4° is methyl; R4ses phenyl; R4t and R4u together are cyclopropyl; R4ves H; and And so. In particular, preference is given to the compounds of Formula I as disclosed in PCT / EP2019 / 050537, pages 60 to 83, in Tables 1 to 46, which collectively and as individual embodiments of the active ingredient in the agrochemical composition are incorporated by reference herein. The agrochemical composition can be prepared in a known manner, such as that described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; o Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005. The agrochemical composition is usually prepared by contacting the hydrophobically modified fumed silica with the active ingredient, preferably in the presence of water. In one embodiment, the resulting mixture is then subjected to grinding or crushing to produce the suspension of the active ingredient. In another embodiment, the active ingredient is contacted with water and ground or crushed to produce an aqueous suspension of the active ingredient, whereupon said aqueous suspension is contacted with the hydrophobically modified fumed silica. Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetting agents, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, antifreeze agents, antifoam agents, colorants, sticking agents and binders. Suitable liquid carriers and solvents are water and organic solvents, such as medium to high boiling mineral oil fractions, eg kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, eg toluene, paraffin, tetrahydronaphthalene, alkylated naphthalenes; alcohols, eg ethanol, propanol, butanol, benzyl alcohol, cyclohexanol; glycols; DMSO; ketones, for example, cyclohexanone; esters, for example, lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, for example, N-methylpyrrolidone, dimethylamides of fatty acids; and mixtures of these. Suitable solid carriers or fillers are mineral earths, for example silicates, silica gels, talc, kaolin, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulphate, magnesium sulphate, magnesium oxide; polysaccharides, eg cellulose, starch; fertilizers, for example, ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of plant origin, for example, cereal flour, bark flour, wood flour, nutshell flour and mixtures of these. Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes and mixtures thereof. Such surfactants can be used as an emulsifier, dispersant, solubilizer, wetting agent, penetration enhancer, protective colloid or adjuvant. Examples of surfactants are listed in McCutcheon's, VoL1: Emulsifiers & Detergent, McCutcheon's Directories, Glen Rock, USA, 2008 (International ed. or North American ed.). Suitable anionic surfactants are alkali metal, alkaline earth metal or ammonium salts of sulfonates, sulfates, phosphates, carboxylates and mixtures thereof. Examples of sulfonates are alkylaryl sulfonates, diphenyl sulfonates, alpha-olefin sulfonates, lignin sulfonates, fatty acid and oil sulfonates, ethoxylated alkylphenol sulfonates, alkoxylated arylphenol sulfonates, condensed naphthalene sulfonates, dodecylbenzene and tridecylbenzene sulfonates, naphthalene sulfonates. and alkylnaphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols or of esters of fatty acids. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alkylphenol or alcohol ethoxylates. Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters that have been alkoxylated with from 1 to 50 equivalents. Ethylene oxide and / or propylene oxide can be used for alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, glucose sucrose esters or alkylpolyglucosides. Examples of polymeric surfactants are homopolymers or copolymers of vinylpyrrolidone, vinyl alcohols or vinyl acetate. Suitable cationic surfactants are quaternary surfactants, for example, quaternary ammonium compounds with one or two hydrophobic groups, or salts of long chain primary amines. Suitable amphoteric surfactants are alkylbetaines and imidazolines. Suitable block polymers are block polymers of type A-B or A-B-A comprising blocks of polyethylene oxide and polypropylene oxide, or of type A-B-C comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacid comb polymers or polyacrylic acid. Examples of polybases are polyvinylamines or polyethyleneamines. Suitable adjuvants are compounds that have little or no pesticidal activity at all, and that improve the biological performance of compound I on the target. Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Additional examples are listed in Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5. Suitable thickeners are polysaccharides (for example, xanthan gum, carboxymethyl cellulose), inorganic clays (organically modified or unmodified), polycarboxylates and silicates. Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones. Suitable antifreeze agents are ethylene glycol, propylene glycol, urea and glycerin. Suitable antifoam agents are silicones, long chain alcohols and fatty acid salts. Suitable dyes (e.g. in red, blue or green) are low water solubility pigments and water soluble dyes. Examples are inorganic dyes (for example, iron oxide, titanium oxide, iron hexacyanoferrate) and organic dyes (for example, alizarincyanine, azocyanine and phthalocyanine dyes). Suitable tackifiers or binders are polyvinylpyrrolidones, polyvinyl acetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes and cellulose ethers. The agrochemical composition may optionally comprise additional auxiliaries, such as 0.1-1% by weight of bactericides, 5-15% by weight of antifreeze agents, 0.1-1% by weight of antifoaming agents and 0.1-1% by weight of colorants. Seed treatment solutions (LS), suspoemulsions (SE), fluid concentrates (FS) are generally used for the treatment of plant propagation materials, particularly seeds. The compositions in question provide, after a two- to ten-fold dilution, active substance concentrations of 0.01 to 60% by weight, preferably 0.1 to 40% by weight, in ready-to-use preparations. The application can be carried out before sowing or during it. Methods for applying the agrochemical composition to the plant propagation material, especially seeds, include coating, coating, pelletizing, spraying, soaking and in-furrow application methods of the propagation material. Preferably, the agrochemical composition is applied to the plant propagation material by a method that does not induce germination, for example, by coating, pelletizing, coating and spraying seeds. When used for plant protection, the amounts of active ingredient applied vary, depending on the type of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha. ha, and in particular from 0.1 to 0.75 kg per ha. In the treatment of plant propagation materials such as seeds, for example by spraying, coating or soaking seeds, amounts of active ingredient of 0.1 to 1000 g, preferably 1 to 1000 g, more preferably are required. from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilograms of plant propagation material (preferably seeds). When used in the protection of stored materials or products, the amount of active ingredient applied depends on the type of application area and the desired effect. The quantities usually applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material. Various types of additional oils, humectants, adjuvants, fertilizers or micronutrients and pesticides (e.g. herbicides, insecticides, fungicides, growth regulators, protectants) may be added to the agrochemical composition, as premixes or, if applicable, only immediately before use (tank mix). These agents can be mixed with the compositions according to the invention in a weight ratio of 1:100 to 100:1, preferably 1:10 to 10:1. Generally, the user applies the composition according to the invention with a pre-dosing device, a backpack sprayer, a spray tank, a spray plane or an irrigation system. Generally, the agrochemical composition is composed of water, buffer and / or additional auxiliaries in the desired application concentration and, as a result, the ready-to-use spray liquor or agrochemical composition according to the invention is obtained. Generally, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of useful agricultural area. According to one embodiment, the user himself can mix the individual components of the composition according to the invention, such as parts of a kit or parts of a binary or ternary mixture, in a spray tank and auxiliaries can be added. additional, if appropriate. Application methods The agrochemical composition is suitable for use in protecting crops, plants, plant propagation materials, such as seeds, or soil or water, in which the plants grow, from attack or infestation by animal pests. Therefore, the present invention also relates to a plant protection method, comprising contacting crops, plants, plant propagation materials, such as seeds, or soil or water, in which the plants grow, to protect these from attack or infestation by animal pests, with a pesticide-effective amount of the agrochemical composition. The agrochemical composition is suitable for use in combating or controlling animal pests. Therefore, the present invention also relates to a method of combating or controlling animal pests, which comprises contacting the animal pests, their habitat, breeding area or food supply, or the crops, plants, propagation materials of plants, such as seeds, or soil, or the area, material or environment in which animal pests are growing or can grow, with a pesticide effective amount of the agrochemical composition of the present invention. The agrochemical composition is effective through contact and ingestion. Furthermore, the agrochemical composition can be applied at all stages of development, such as egg, larva, pupa and adult. The application can be carried out both before and after infestation by pests of crops, plants, plant propagation materials such as seeds, soil or area, material or environment. Suitable application methods include, but are not limited to, soil treatment, seed treatment, in-furrow application, and foliar application. Soil treatment methods include soil soaking, drip irrigation (drip application to soil), soaking roots, tubers or bulbs, or soil injection. Seed treatment techniques include seed coating, seed coating, seed dusting, seed soaking, and seed pelleting. In-furrow applications generally include the steps of forming a furrow in cultivated land, sowing seeds in the furrow, applying the agrochemical composition in the furrow, and closing the furrow. Foliar application refers to the application of the agrochemical composition to the foliage of plants, for example, by spray equipment. In the case of foliar applications, it may be advantageous to modify pest behavior with the use of pheromones in combination with the agrochemical composition. Pheromones suitable for specific crops and pests are known to those in the mid-level trade and are publicly available in pheromone and semiochemical databases, such as http: / / www.pherobase.com. As used herein, the term "contact" includes both direct contact (applying the agrochemical composition directly to the animal or plant pest, usually on the foliage, stem or roots of the plant) and indirect contact (applying the agrochemical composition at the locus, that is, the habitat, reproduction zone, plant, seed, soil, area, material or environment where a pest is growing or can grow, of the animal or plant pest). The term animal pest includes arthropods, gastropods and nematodes. Preferred animal pests according to the invention are arthropods, preferably insects and arachnids, in particular insects. Insects, which are of particular importance to crops, are generally called insect pests that attack crops. The term crop refers to both growing crops and harvested crops. The term plant includes cereals, for example, durum and other wheat, rye, barley, triticale, oats, rice, or zea mays (forage zea and sweet zea mays / forage and sweet corn); beet, for example sugar beet or fodder beet; fruits, such as pome fruits, stone fruits or berries, for example, apples, pears, plums, peaches, nectarines, almonds, cherries, papayas, strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as beans, lentils, peas, alfalfa or soybeans; oilseed plants, such as canola (rapeseed), turnip, mustard, olives, sunflowers, coconut, cocoa beans, castor plants, palm oil, peanuts or soybeans; cucurbits, such as pumpkins, pumpkins, cucumbers or melons; fiber plants, such as cotton, linseed, hemp or jute; citrus fruits, such as oranges, lemons, grapefruits or tangerines; vegetables, such as eggplant, spinach, lettuce (for example, iceberg lettuce), radicchio, cabbage, asparagus, collard greens, carrots, onions, garlic, leeks, tomatoes, potatoes, cucurbits or bell peppers; lauraceae plants, such as avocados, cinnamon or camphor; energy plants and raw materials, such as corn, soybeans, rapeseed, sugar cane or palm oil; tobacco; nuts, for example, English walnuts; pistachios; coffee; tea; bananas; vines (table grapes and juice grape vines); hop; sweet herb (also called Stevia); natural rubber plants or ornamental and forestry plants, such as flowers (e.g. carnations, petunias, geraniums / pelargoniums, pansies and house joys), shrubs, planifolias (e.g. poplars) or evergreens, e.g. conifers; eucalyptus; grass; grama; grass, such as grass for animal feed or ornamental uses. Preferred plants include potatoes, sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, canola, legumes, sunflowers, coffee or sugar cane; fruit; vines; decorative plants; or vegetables, such as cucumbers, tomatoes, beans or squash. The term cultivated plants should be understood to include plants that have been modified by mutagenesis or genetic engineering to provide a new trait to a plant or to modify a trait already present. In the case of soil treatment, furrow application or application at the place of residence or nest of the pest, the amount of active ingredient varies from 0.0001 to 500 g per 100 m2, preferably from 0.001 to 20 g per 100 m2. For use in treating crop plants, for example by foliar application, the application rate of the active ingredients of the invention may be in the range of 0.0001 g to 4000 g per hectare, for example, 1 g to 2 kg per hectare or from 1 g to 750 g per hectare, desirably from 1 g to 100 g per hectare, more desirably from 10 g to 50 g per hectare, for example, from 10 to 20 g per hectare, from 20 to 30 g per hectare, 30 to 40 g per hectare or 40 to 50 g per hectare. The following clauses represent embodiments of the present invention: Clause 1: An aqueous agrochemical composition comprising a) suspended particles of an active ingredient; and b) hydrophobically modified fumed silica; wherein the active ingredient has a water solubility of at least 1 g / L at 25°C. Clause 2: The agrochemical composition according to clause 1, containing the active ingredient in a concentration of at least 10% by weight based on the total weight of the agrochemical composition. Clause 3: The agrochemical composition according to clause 1 or 2, containing the silica in a concentration of 0.01 to 10% by weight based on the total weight of the agrochemical composition. Clause 4: The agrochemical composition according to any of clauses 1 to 3, where the water solubility of the active ingredient is at least 10 g / L at 25°C. Clause 5: The agrochemical composition according to any of clauses 1 to 4, wherein the water solubility of the active ingredient is up to 100 g / L at 25°C. Clause 6: The agrochemical composition according to any of clauses 1 to 5, wherein the suspended particles of the active ingredient have an average diameter of 0.5 pm to 20 pm. Clause 7: The agrochemical composition according to any of clauses 1 to 6, wherein the active ingredient is a compound of Formula I where RP1, RP2 and RP3 are independently of each other H, CN, halogen, Ci-C4-alkyl, Ci-C3-haloalkyl, Ci-C4-alkoxy, Ci-C3-haloalkoxy, Ci-C4-alkylthio, Ci-C3-haloalkylthio, Ci-C4-alkylsulfinyl, CiCs-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C3-haloalkylsulfonyl, Cs-Ce-cycloalkyl, C3Ce-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl or Ci-C4-alkox¡Ci-C4-alkyl; Z1esNoCH; Z2esNoCH; Z3es N or CR4; T is S, O or NR1b, where R1bes H, Ci-Cio-alkyl, Ci-C4-haloalkyl, C3-Cio-cycloalkyl, C3-Cio-cycloalkylmethyl, C3Cio-halocycloalkyl, C2-Cio-alkenyl, C2-Cio-haloalkenyl, C2-Cio-alkynyl, C1 -C10alkoxy-Ci-C4-alkyl, ORa, 3- to 10-membered heterocyclyl, 3- to 10-membered heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl , wherein the cyclic moieties are unsubstituted or substituted with one or more similar or different substituents; R1is H, CN, Ci-Cio-alkyl, Ci-Cio-haloalkyl, C3-Cio-cycloalkyl, Cs-Cw-halocycloalkyl, Ci-C4-alkoxy-Ci-C4-alkyl, C2-Cio-alkenyl, C2-Cw -haloalkenyl, C2-Cio-alkynyl, C3Cio-haloalkynyl, Ci-Cs-alkylene-CN, ORa, Ci-Cs-alkylene-OR3, C(Y)Rb, Ci-Cs-alkyleneC(Y)Rb, C(Y )ORC, Ci-C5-alkylene-C(Y)ORc, S(O)2Rd, NReRf, Ci-C5-alkylene-NReRf, C(Y)NR9Rh, Ci-C5-alkylene-C(Y)NR9Rh, S (O)mNReRf, C(Y)NR'NReRf, Ci-C5-alkyleneS(O)2Rd, Ci-C5-alkylene-S(O)mNReRf, Ci-C5-alkylene-C(Y)NR'NReRf, aryl , 3- to 10-membered heterocyclyl, hetaryl, aryl-Ci-Cs-alkyl, C3-Cio-cycloalkyl-Ci-C5-alkyl, 3- to 10-membered heterocyclylCi-Cs-alkyl or hetaryl-Ci-Cs-alkyl, in where the cyclic moieties are unsubstituted or substituted with one or more equal or different Ryy / or Rxísubstituents; R2is H, CN, Ci-Cw-alkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, L1-C3-Cio-cycloalkyl, L1(3- to 6-membered heterocyclyl), L1-aryl or L1-heteroaryl, which heterocyclyl groups contain one or more equal or different O, N, S(O)m or NR3A heteroatoms, which cyclic groups may contain one or more CO groups, and wherein the groups are unsubstituted or substituted with one or more Rxíequal substituents or different; where L1 is a direct bond, Ci-Cs-alkylene, C2-C8-alkenylene, C2-C8-alkynylene or C3-Cecycloalkylene, wherein the C atoms are unsubstituted or substituted with one or more equal or different substituents; R3 is H, halogen, CN, Ci-Cio-alkyl, Ci-Cio-haloalkyl, Ci-Cw-alkoxy or Ci-Cio-haloalkoxy; R4 is (i) H, CN, NO2, halogen, Ci-Cio-alkyl, C2-Cio-alkenyl or C2-Cio-alkynyl, wherein the C atoms are unsubstituted or substituted with one or more equal Rxísubstituents or different; or ORa, SRd, C(Y)Rb, C(Y)ORC, S(O)Rd, S(O)2Rd, NReRf, C(Y)NR9Rh, S(O)mNReRf, C(Y)NR'NReRf, Ci-C5-alkylene-ORa, Ci-C5-alkylene-CN, Ci-C5-alkylene-C(Y)Rb, C1-C5-alkylene-C(Y)ORc, Ci-C5-alkylene-NReRf, Ci-C5- alkylene-C(Y)NR9Rh, Ci-Cs-alkyleneS(O)mRd, Ci-C5-alkylene-S(O)mNR®Rf, Ci-C5-alkylene-NR'NReRf; or 3- to 10-membered heterocyclyl, hetaryl, Cs-Cio-cycloalkyl, Cs-Cio-cycloalkenyl, aryl, 3- to 10-membered heterocyclyl-Ci-Cs-alkyl, hetaryl-Ci-Cs-alkyl, C3-Cio-cycloalkyl -CiCs-alkyl, Cs-Cw-cycloalkenyl-Ci-Cs-alkyl or aryl-Ci-Cs-alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more Rygual or different substituents; or R4 is (ii) L2-C3-Cio-cycloalkenyl, L2-C3-Cio-cycloalkenyloxy or L2-C3-Cio-cycloalkenylthio, wherein the cycloalkenyl rings are unsubstituted or substituted with one or more Ryequal or different substituents; where L2 is Ci-Cs-alkylene, Cp-Cs-alkenylene, C2-C8-alkynylene or Cs-Ce-cycloalkylene, wherein the C atoms are unsubstituted or substituted with one or more equal or different Rx substituents; or R4es (iii) any of the following groups R4aR4aR4a£ Z_r4c I— / — β—E5R4b / - χ Wr-kx§R4br- x H-S(O)m-R4d...... K(ma), — ​​(inb),K(me),5(md); where R4a, R4b and R4c are independently of each other H, halogen, CN, NO2, Ci-Cio-alkyl, C2-C10alkenyl or C2-Cio-alkynyl, wherein the C atoms are unsubstituted or substituted with one or more substituents Rx¡ same or different; Ci-Cio-haloalkyl, Ci-Cio-alkoxy or Ci-C4-alkoxy-Ci-Cio-alkyl, wherein the C atoms are unsubstituted or substituted with one or more identical or different R substituents; ORa, SRa, C(Y)Rb, C(Y)ORC, C(Y)NRsRh, C(Y)NR'NReRf, S(O)mRd, S(O)mNReRf, C1-C5alkylene-ORa, Ci- Cs-alkylene-CN, Ci-C5-alkylene-C(Y)Rb, Ci-C5-alkylene-C(Y)ORc, C1-C5alkylene-NReRf, Ci-C5-alkylene-C(Y)NRsRh, Ci- C5-alkylene-S(O)mRd, Ci-Cs-alkyleneS(O)mNReRfo Ci-C5-alkylene-NR¡NReRf; 3- to 10-membered heterocyclyl, Cs-Cw-cycloalkyl, Cs-Cio-cycloalkenyl, hetaryl, aryl, 3- to 10-membered heterocyclyl-Ci-Cs-alkyl, Cs-Cio-cycloalkyl-Ci-Cs-alkyl, C3- C10cycloalkenyl-Ci-C5-alkyl, hetaryl-Ci-C5-alkyl or aryl-Ci-Cs-alkyl, wherein the cyclic moieties are unsubstituted or are substituted by one or more of the same or different Ry substituents; A is a 3 to 12-membered non-aromatic carbocycle or heterocycle, which heterocycle contains one or more of the same or different N, O or S heteroatoms, where S may be oxidized, and whose carbocycles or heterocycles are unsubstituted or substituted by one or more equal or different R! and / or R1 substituents; D is a direct bond, Ci-Ce-alkylene, C2-C6-alkenylene or C2-C6-alkynylene, the carbon chains of which are unsubstituted or substituted with one or more of the same or different R substituents; E is a 3 to 12-membered non-aromatic carbocycle or heterocycle, which heterocycle contains one or more of the same or different N, O or S heteroatoms, wherein S may be oxidized, and whose carbocycles or heterocycles are unsubstituted or substituted with one or more identical or different Rny / or R1 substituents; R4des Ci-C4-haloalkyl or Cs-Cs-cycloalkyl, which may be halogenated; G is Ci-Ce-alkylene, Cs-Cs-alkenylene, Ca-Cs-alkynylene, Cs-Ce-cycloalkylene or Cs-Cecycloalkenylene, wherein the C atoms are unsubstituted or are substituted by one or more of the same Rp substituents or different; or R4es (iv) any of the following groups M l-W-V R4f R4e(iva), R4g(ivb); where R4ees is H, C1 -Ce-alkyl, C2-C8-alken¡l, C2-C8-alkynyl, Cs-Ce-cycloalkyl, Cs-Cecycloalkenyl or a 3- to 6-membered heterocycle, which heterocycle contains one or more N heteroatoms, The same or different O or S, wherein S may be oxidized, whose groups are unsubstituted or are substituted by one or more of the same or different Rry / or R1 substituents; Q is a direct bond, Ci-Cs-alkylene, C2-C8-alkenylene or C2-C8-alkynylene, whose carbon chains are unsubstituted or substituted with one or more of the same or different R substituents; Q and R4 together form a 3- to 6-membered carbocyclic ring or a 4- to 6-membered heterocycle with a direct bond to imidazole, which heterocycle contains one or more of the same or different N, O, or S heteroatoms, where S may be oxidized , and whose rings are unsubstituted or substituted with one or more identical or different Rry / or R1¡ substituents; M is O, S, NRM, NORMo NSRM; where RM is a group mentioned for R4eo where R and Q together form a 4- to 6-membered unsaturated non-aromatic N-containing heterocycle, which heterocycle may contain an additional O or S heteroatom, where S may be oxidized, and which ring is unsubstituted or substituted by one or more substituents Same or different; R4ges H, Ci-Ce-alkyl, Ci-Ce-alkyl-X, Cs-Ce-cycloalkyl or Cs-Ce-cycloalkyl-X; and R4fes Ci-Ce-alkyl, Ci-Ce-alkyl-X, Cs-Ce-cycloalkyl or Cs-Ce-cycloalkyl-X, wherein the Ci-Ce-alkyl or Cs-Ce-cycloalkyl groups are unsubstituted or substituted with one or more identical or different R' substituents; where X is O, S, NHo NR';o R4g and R4f together with the carbon atom to which they are attached form a saturated or unsaturated carbocycle or heterocycle of 3 to 8 members, whose heterocycle contains one or more N, O or S heteroatoms, the same or different, where S may be oxidized, and wherein the carbocycles or heterocycles are unsubstituted or substituted with one or more identical or different R* and / or R1 substituents; W is Ci-Cs-alkylene, Cs-Cs-cycloalkylene, Cs-Cs-heterocycloalkylene, C2-C8-alkenylene, Cs-Cs-cycloalkenylene, Cs-Cs-heterocycloalkenylene or C2-C8-alkynylene, where W is unsubstituted or is substituted with one or more identical or different Rly / or R1¡ substituents; V is O, S or NR1a, where R1aes H, Ci-Cio-alkyl, Ci-C4-haloalkyl, Cs-Cio-cycloalkyl, Cs-Cio-cycloalkylmethyl, CsCio-halocycloalkyl, C2-Cio-alkenyl, C2-Cio-haloalkenyl, C2-Cio-alkynyl , C1-C10alkoxy-Ci-C4-alkyl, ORa, 3- to 10-membered heterocyclyl, 3- to 10-membered heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4 -alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different Raa substituents; or where R1a and R4g together with the carbon atom to which R4g is attached and the nitrogen atom to which R1a is attached, as well as the nitrogen atom between said carbon atom and said nitrogen atom, form a 4 to 8 membered heterocycle, which contains the two nitrogen atoms as heteroatoms and may further contain one or more identical or different N, O or S heteroatoms, where S may be oxidized, and where the heterocycle is unsubstituted or substituted with one or more substituents R * and / or R1! same or different; or R4es (v) any of the groups (va) S(O)m-R4h, (vb) O-R4io (ve) NR4iR4k; where R4h, R4'are independently of each other CN; Ci-Cs-alkyl, C2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA1 substituents; Cs-Cs-cycloalkyl, Cs-Cs-cycloalkenyl or 3- to 8-membered heterocyclyl, the heterocyclyl group of which contains one or more O, N, S(O)m or NR3A heteroatoms, the same or different of which cyclic groups may contain one or more equal or different C(GA)R2 groups, and whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; Cs-Cs-cycloalkyl-Ci-Ci-alkyl, C5-C8-cycloalkenyl-Ci-C4-alkyl or 3- to 8-membered heterocyclyl-Ci-C4alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(0 )m or NR3Aequal or different, whose cyclic groups may contain one or more C(GA)R2Aequal or different groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more RA4 equal or different substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more identical or different RA5 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; where GAes O, N-CN or N-OR2A; R2Ais H; Ci-Cs-alkyl, Cs-Cs-alkenyl or C2-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, Cs-Cs-cycloalkenyl or 3- to 8-membered heterocyclyl, whose heterocyclyl group contains one or more equal or different O or S(O)heteroatoms, and whose cyclic groups are unsubstituted or substituted with one or more identical or different RA4 substituents; Cs-Cs-cycloalkyl-Ci-Ci-alkyl, C5-C8-cycloalkenyl-Ci-C4-alkyl or 3- to 8-membered heterocyclyl-Ci-C4alkyl, the heterocyclyl group of which contains one or more O or S(O)m heteroatoms same or different, and wherein the C atoms of these groups are unsubstituted or substituted with one or more RA4 equal or different substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more equal or different RA6 substituents; R3Aes H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Ce-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; or CONR2AR4Aor COR2A; R4Ais H; Ci-Ce-alkyl, Cs-Ce-alkenyl or Cs-Ce-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; and where R4jes H; Ci-Ce-alkyl, Cs-Cs-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; or C(O)R2B, C(O)NR3BR4B, C(O)OR5B, SO2R6B; R4kesH; NR3aBR4aB; Ci-Cs-alkyl, C2-Cs-alkenyl, C2-C8-alkynyl or Ci-C4-alkoxy, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, Cs-Cs-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more O heteroatoms, N, S(O)m or NR4aBíequal or different, whose cyclic groups may contain one or more CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more RA4íequal or different substituents ; aryl, aryl-Ci-C4-alkyl, hetaryl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more equal or different RA6 substituents; either R4¡ and R4k together with the nitrogen atom to which they are attached form a 3 to 7-membered heterocycle, which heterocycle contains the nitrogen atom as a heteroatom and may also contain one or more heteroatoms O, N, S(O)mo N equal or different, and whose rings are unsubstituted or substituted with one or more RA8 equal or different substituents; where R2B, R3B, R4B are independently of each other H; Ci-Ce-alkyl, C2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more identical or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RA substituents; R3aBes H; Ci-Ce-alkyl, whose aliphatic groups are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; R4aBes H; Ci-C4-alkyl, the aliphatic groups of which are unsubstituted or substituted with one or more substituents selected from the same or different halogen or Ci-C4-alkoxy; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; either C(O)R2B, C(O)OR5BoSO2R6B R5Bes Ci-Cs-alkyl, C2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more substituents selected from the same or different halogen or Ci-C4-alkoxy; either Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; R6Bes Ci-Cs-alkyl, C2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Ce-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more identical or different RA4 substituents; or aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; or R4es (vi) any of the groups (via) C(T1)R41, (vib) C(O)OR4m, (vic) C(Y)NR4nR4° or (vid) C(Y)NR4PNR4ciR4r; where R41 is H; Ci-Ce-alkyl, C2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl or 3- to 8-membered heterocyclyl, whose heterocyclyl group contains one or more equal or different O or S(O) heteroatoms, and whose cyclic groups are unsubstituted or substituted with one or more RA4 equal or different substituents different; C3-C8-cycloalkyl-Ci-C4-alkyl or heterocyclyl-Ci-C4-alkyl of 3 to 8 members, the heterocyclyl group of which contains one or more identical or different O or S(0)m heteroatoms and where the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more equal or different RAS substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; and where T1is O, N-OR1C, N-NR2CR3Co # # , where # are the bonds to the carbon atom of the C(T1) portion of the C(T1)R41 group; and where LA and LB are independently of each other O or S(O)m; and A1 is C2-C4-alkylene, wherein the C atoms are unsubstituted or substituted with one or more equal or different R4 substituents; and where R1Ces H; Ci-Ce-alkyl, Cs-Cs-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more equal or different RA4 substituents; C3-C8-cycloalkyl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA4 substituents; aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; R2Ces H; Ci-Ce-alkyl, C2-Cs-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, Ci-Ce-alkylcarbonyl, Ci-Ce-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-CiC4-alkoxy, the groups of which are unsubstituted or substituted with one or more identical or different RA4 substituents; R3Ces H; Ci-Ce-alkyl, Cs-Cs-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; C3-Cs-cycloalkyl, Cs-Cs-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl groups of which contain one or more heteroatoms O, N, S(O)mo NR3A¡equal or different, whose cyclic groups may contain one or more CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more substituents RA4¡equal or different; aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; R4Ces halogen; Ci-Ca-alkyl, C2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; aryl, wherein these groups are unsubstituted or substituted with one or more equal or different RA6 substituents; or two R4C attached to the same carbon atom form a C2-C4-alkylene chain, the chain of which is unsubstituted or substituted with one or more equal or different RA4 substituents; or two R4C attached to the same carbon atom form a Ci-C4-alkenylene chain with the double bond of the chain attached to said carbon atom, which chain is unsubstituted or substituted with one or more equal RA4 substituents or different; R4month H; Ci-Ce-alkyl, C2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, whose cyclic groups are unsubstituted or substituted with one or more identical or different RA4 substituents; C3-C8-cycloalkyl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more equal or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more equal or different RA6 substituents; R4nes H; Ci-C8-alkyl, C2-C8-alkenyl or C2-G8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, Ci-C4-alkylsulfonyl, Cs-Ce-cycloalkylsulfonyl, Ci-C4-alkylcarbonyl or Ci-C4-alkoxycarbonyl, the groups of which are unsubstituted or substituted with one or more equal RA4 substituents or different; or phenyl-Ci-C2-alkoxycarbonyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA6 substituents; R4° is H; Ci-Cs-alkyl, C2-C8-alkenyl, C2-Cs-alkynyl, Ci-C4-alkoxy, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA2 substituents; Cs-Cs-cycloalkyl or 3- to 8-membered heterocyclyl, whose heterocyclyl group contains one or more heteroatoms O, N, S(O)m or NR3Aequal or different, whose cyclic groups may contain one or more CO groups, and whose cyclic groups do not are substituted or are substituted with one or more identical or different RA4 substituents; C3-C8-cycloalkyl-Ci-C4-alkyl or heterocyclyl-Ci-C4-alkyl of 3 to 8 members, whose heterocyclyl group contains one or more heteroatoms O, N, S(O)mo NR4Aequal or different, whose cyclic groups can contain one or more CO groups, and wherein the C atoms of these groups are unsubstituted or substituted with one or more equal or different RA4 substituents; aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more identical or different RA7 substituents; or aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA7 substituents; either R4n and R4o together withθ| The nitrogen atom to which they are attached form a 3- to 8-membered heterocycle, which heterocycle contains one or more N, O, or S heteroatoms, the same or different, where S may be oxidized, and where the heterocycle is unsubstituted or is substituted with one or more identical or different RA4 substituents; R4pes H; Ci-Ce-alkyl, C2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, Ci-Ce-alkylcarbonyl, Ci-Cs-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-CiC4-alkoxy, the groups of which are unsubstituted or substituted with one or more identical or different RA4 substituents ; R4qes H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Ce-cycloalkyl, Ci-Cs-alkylcarbonyl, Ci-Cs-alkoxycarbonyl, aryl-Ci-C4-alkyl or aryl-CiC4-alkoxy, the groups of which are unsubstituted or substituted with one or more RA4 substituents equal to or different; R4res H; Ci-Cs-alkyl, C2-C8-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA3 substituents; Cs-Cs-cycloalkyl, Cs-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR3A¡equal or different, whose cyclic groups may contain one or more CO groups equal or different, and where the C atoms of these groups are unsubstituted or are substituted with one or more substituents RA4 equal or different ; aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; or R4 is (vii) R4sen where R4 is aryl or hetaryl, the cyclic groups of which are unsubstituted or substituted with one or more equal or different R1D substituents; where R1Des CN, NO2, halogen, NR2DR3D; Ci-C4-alkyl, Ci-C4-alkoxy-Ci-C4-alkyl, C1-C4halogenalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkyl-S(O)m-, Ci-C4 -haloalkylS(O)m-, carboxy; or aryl or hetaryl, the groups of which are unsubstituted or substituted with one or more RA6 same or different substituents; or two adjacent R1Da groups together with the neighboring atoms to which they are attached form a fused 3- to 8-membered heterocycle, which heterocycle contains one or more of the same or different N, O or S heteroatoms, wherein S may be oxidized, and whose heterocycle is unsubstituted or is substituted with one or more equal or different RA6 substituents; R2Des H; Ci-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl or Cs-Ce-cycloalkyl, the groups of which are unsubstituted or substituted with one or more equal or different RA3 or RA4 substituents; R3Des H; Ci-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl or Cs-Ce-cycloalkyl, the groups of which are unsubstituted or substituted with one or more identical or different RA3 or RA4 substituents; either R2Dy rsd together with e| The nitrogen atom to which they are attached form a 3- to 8-membered heterocycle, which heterocycle contains one or more N, O, or S heteroatoms, the same or different, where S may be oxidized, and whose heterocycle is unsubstituted or substituted with one or more equal or different RA substituents; or R4es (viii) CR4tR4uR4ven where R4tes H; CN; Ci-Cs-alkyl, Cs-Cs-alkenyl or C2-C8-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, Cs-Cs-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)mo NR1Equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; Cs-Cs-cycloalkenyl or 3- to 8-membered heterocyclyl, whose heterocyclyl group contains one or more O, N, S(O)mo NR1 Same or different heteroatoms, whose cyclic groups may contain one or more same or different CO groups, and in where the C atoms of these groups are unsubstituted or substituted with one or more equal or different RA4 substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RAS substituents; R4ues H; Ci-C4-alkyl, whose aliphatic groups are unsubstituted or substituted with one or more equal or different RA3 substituents; either R4t and R4u together with the carbon atom to which they are attached form a carbocyclic or heterocyclic ring of 3 to 8 members, whose heterocyclic ring contains one or more heteroatoms O, N, S(O)mo NR1F¡equal or different, whose cyclic groups can contain one or more equal or different CO groups, and wherein the carbocyclic or heterocyclic ring is unsubstituted or substituted with one or more equal or different RA3 substituents; either R4t and R4u together are Cz-Ce-alkenyl, whose aliphatic groups are unsubstituted or substituted with one or more identical or different RA3 substituents; R4ves H; S(O)mR1E, OR2Eo N(R3E)(R4E), where if R4ty / o R4ues H or Ci-Ce-alkyl, whose aliphatic groups are unsubstituted or substituted with one or more equal or different RA3 substituents, R4ves S (O)mR1E, OR2E or N(R3E)(R4E); R1E is Ci-Cs-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA9 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1F¡equal or different, whose cyclic groups may contain one or more same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more plus the same or different RA4 substituents; Cs-Cs-cycloalkenyl, Cs-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1Equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more identical or different RA6 substituents; R2Ees H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more equal or different RA9 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)mo NR1Equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; Cs-Cs-cycloalkenyl, C5-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1 Same or different, whose cyclic groups may contain one or more same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more RA4 same or different substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, the groups of which are unsubstituted or substituted with one or more equal or different RA6 substituents; R3Ees H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted by one or more of the same or different RA3 substituents; Cs-Cs-cycloalkyl, Cs-Cs-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)mo NR1 Same or different, whose cyclic groups may contain one or more same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more RA4 same or different substituents; Cs-Cs-cycloalkenyl, Cs-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1 Same or different, whose cyclic groups may contain one or more same or different CO groups, and where the C atoms of these groups are unsubstituted or substituted with one or more RA4 substituents! same or different; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, whose groups are unsubstituted or are substituted by one or more of the same or different RA6 substituents; R4Ees H; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted by one or more of the same or different RA3 substituents; or C(O)N(R5E)(R6E), C(O)R7E, C(O)OR8E, or SO2R9E; either R3E and R4Jtogether with the nitrogen atom to which they are attached form a 3- to 9-membered heterocycle, whose heterocyclyl group contains one or more of the same or different O, N, S(0)m or NR1F heteroatoms, whose cyclic groups may contain one or more plus the same or different CO groups, and wherein the C atoms of these groups are unsubstituted or are substituted by one or more of the same or different RA8 substituents; either R5E and R6E are independently of each other H; Ci-Cs-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, whose aliphatic groups are unsubstituted or substituted by one or more of the same or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or plus heteroatoms O, N, S(O)m or NR1F the same or different, whose cyclic groups may contain one or more of the same or different CO groups, and where the O atoms of these groups are unsubstituted or are substituted by one or more substituents RA4 same or different; 3 to 8-membered Cs-Cs-cycloalkenyl or heterocyclyl, the heterocyclyl group of which contains one or more of the same or different O, N, S(O)m or NR1F heteroatoms, the cyclic groups of which may contain one or more of the same or different CO groups, and in where the C atoms of these groups are unsubstituted or substituted with one or more identical or different RA4 substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, whose groups are unsubstituted or are substituted by one or more of the same or different RA6 substituents; either R5E and R6 Together with the nitrogen atom to which they are attached form a 3- to 8-membered heterocyclic ring, which heterocyclic ring contains one or more of the same or different O or S(O)m heteroatoms, and which heterocycle is unsubstituted or substituted with one or more identical or different RA1° substituents; R7Ees H; Ci-Ce-alkyl, Ca-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted by one or more of the same or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or plus heteroatoms O, N, S(O)m or NR1F the same or different, whose cyclic groups may contain one or more of the same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted by one or more substituents RA4 same or different; Cs-Cs-cycloalkenyl, Cs-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or heterocyclyl-Ci-C4-3- to 8-membered alkyl, the heterocyclyl group of which contains one or more O, N, heteroatoms S(O)m or NR1R1, the same or different, whose cyclic groups may contain one or more of the same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted by one or more of the same or different RA4 substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, whose groups are unsubstituted or are substituted by one or more of the same or different RA6 substituents; R8Ees H; Ci-Ce-alkyl, C3-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or are substituted by one or more of the same or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)mo NR1Equal or different, whose cyclic groups may contain one or more equal or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more equal or different RA4 substituents; Cs-Cs-cycloalkenyl, C5-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)m or NR1 Same or different, whose cyclic groups may contain one or more same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more RA4 same or different substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, whose groups are unsubstituted or are substituted by one or more of the same or different RA6 substituents; R9E is Ci-Cs-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted with one or more identical or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more heteroatoms O, N, S(O)mo NR1 Same or different, whose cyclic groups may contain one or more same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more RA4 same or different substituents; Cs-Cs-cycloalkenyl, Cs-C8-cycloalkenyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, the heterocyclyl group of which contains one or more O heteroatoms, N, S(O)m or NR1 Same or different, whose cyclic groups may contain one or more same or different CO groups, and where the C atoms of these groups are unsubstituted or are substituted with one or more substituents RA4 same or different; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, whose groups are unsubstituted or are substituted by one or more of the same or different RA6 substituents; R1FesH; Ci-Ce-alkyl, Cs-Cs-alkenyl or Cs-Cs-alkynyl, the aliphatic groups of which are unsubstituted or substituted by one or more of the same or different RA3 substituents; Cs-Cs-cycloalkyl, C3-C8-cycloalkyl-Ci-C4-alkyl, 3- to 8-membered heterocyclyl or 3- to 8-membered heterocyclyl-Ci-C4-alkyl, where the C atoms of these groups are unsubstituted or are substituted with one or more identical or different RA4 substituents; or aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, whose groups are unsubstituted or are substituted by one or more of the same or different RA6 substituents; and where Ra, Rb, Rc are independently of each other H, Ci-C4-alkyl, Ci-C4-haloalkyl, Ca-Ce-cycloalkyl, Cs-Cs-cycloalkylmethyl, Cs-Ce-halocycloalkyl, Cs-Ce-cycloalkenyl, Ca-Cecycloalkenylmethyl, Cs-Cs-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, 3-6 membered heterocyclyl, 3-6 membered heterocyclyl-Ci-C4alkyl members, aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the cyclic moieties are unsubstituted or are substituted with one or more equal or different R substituents, Rdes H, Ci-C4-alkoxy, Ci-C4-alkyl, Ci-C4-haloalkyl, Ca-Ce-cycloalkyl, Ca-Cecycloalkylmethyl, Ca-Ce-halocycloalkyl, Ca-Ce-cycloalkenyl, Ca-Ce-cycloalkenylmethyl, Ca-Ce-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4alkoxy-Ci-C4-alkyl, 3- to 6-membered heterocyclyl, 3-membered heterocyclyl-Ci-C4-alkyl 6-membered, aryl, hetaryl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4-alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different Raa substituents; Re, Rf are independently of each other H, Ci-C4-alkyl, Ci-C4-haloalkyl, Ca-Ce-cycloalkyl, Ca-Ce-cycloalkylmethyl, Ca-Ce-halocycloalkyl, Ca-Ce-cycloalkenyl, Ca-Cecycloalkenylmethyl, Ca- Ce-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, C1C4-alkylsulfonyl, Ci- C4-haloalkylsulfonyl, 3- to 6-membered heterocyclyl, 3- to 6-membered heterocyclylCi-C4-alkyl, 3- to 6-membered heterocylcarbonyl, 3- to 6-membered heterocyclyl-CiC4-alkylcarbonyl, heterocyclyl-Ci-C4-alkyl- 3- to 6-membered sulfonyl, aryl, arylcarbonyl, aryl-Ci-C4-alkylcarbonyl, arylsulfonyl, hetaryl, hetaryl-CiC4-alkylcarbonyl, hetarylcarbonyl, hetarylsulfonyl, aryl-Ci-C4-alkyl or hetaryl-Ci-C4alkyl , wherein the cyclic portions are unsubstituted or are substituted with one or more of the same or different Raai substituents; either King Rf together with the nitrogen atom to which they are attached form a saturated or unsaturated 5- or 6-membered heterocycle, which may contain an additional O, S, or N heteroatom, where S may be oxidized, and where the heterocycles are unsubstituted. or are substituted with one or more of the same or different Raai substituents; R9, Rhson independently of each other H, Ci-C4-alkyl, Ci-C4-haloalkyl, L-Ca-Ce-cycloalkyl, L-Ca-Ce-halocycloalkyl, L-Ca-Ce-cycloalkenyl, L-Ca-Ce- halocycloalkenyl, C2-C4alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, 3- to 6-membered heterocyclyl, 3- to 6-membered heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4alkyl or hetaryl-Ci-C4-alkyl, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different Raa substituents; R' is H, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, L-Ca-Ce-cycloalkyl, L-Ca-CB-halocycloalkyl, L-Cs-Ce-cycloalkenyl, L-Cs-Ce-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, aryl or aryl 1-Ci-C4-alkyl, wherein the aryl rings are unsubstituted or substituted by one or more of the same or different Raa substituents; Ri bonded to C is halogen, OH, CN, NO2, Ci-Cio-alkyl, Ci-Cio-haloalkyl, Ci-Cio-alkoxy, C1Cio-haloalkoxy, S(O)mRk, Cs-Ce-cycloalkyl or heterocycle of 3 to 6 members, whose heterocycle contains one or more heteroatoms N, O or S equal or different, where S can be oxidized, whose Ri groups are unsubstituted or are substituted with one or more substituents Rmy / or R1 equal or different , and wherein two R¡ groups connected to the same ring atoms or to adjacent ring atoms can together form a 3- to 6-membered carbocycle or heterocycle, which heterocycle contains one or more N, O or S heteroatoms, the same or different, where S may be oxidized, whose cycles are unsubstituted or substituted with one or more Rmy / or R1 substituents of the same or different nature; Rkes H, Ci-C4-alkyl, Ci-C4-haloalkyl or Cs-Ce-cycloalkyl, the cycle of which is unsubstituted or substituted with one or more equal or different R1 substituents; R1 attached to N is Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkylcarbonyl, C1-C4haloalkylcarbonyl or Ci-C4-alkoxycarbonyl; R attached to C is halogen, OH, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, or S(O)mRk; Rnunited to C is halogen, CN, NO2, Ci-C2-alkyl, Ci-C4-haloalkyl, C2-C6-alkenyl, C2-C6alkynyl, Cs-Ce-cycloalkyl, Cs-Ce-cycloalkenyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C1-C4alkylidene, =0, =S, =NR1°, =NOR1°, =NSR1° or S(O)mR1°, or two Rnadjacent groups form together with the atoms to which they are attached a 3- to 8-membered carbocycle or heterocycle, whose heterocycle contains one or more identical or different N, O or S heteroatoms, where S may be oxidized, whose Rncyclic portions are unsubstituted or substituted with one or more halogen substituents, R ° and / or R1¡equal or different; R1° is H, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, or Ci-C4-alkoxy; R° attached to C is Ci-C4-alkyl, Ci-C4-haloalkyl, Ca-Ce-cycloalkyl, Ci-C4-alkoxy, C1-C4alkylcarbonyl, Ci-C4-haloalkylcarbonyl or Ci-C4-alkoxycarbonyl; Rp is halogen, CN, NO2, Ci-C2-alkyl, Ci-Cs-haloalkyl, Cs-Ce-cycloalkyl, Ci-C4-alkoxy or Ci-Cz-haloalkoxy, or two Rp groups can together form a carbocycle or heterocycle of 3 to 6 members, whose heterocycle contains one or more identical or different N, O or S heteroatoms, where S may be oxidized, whose carbocycle or heterocycle is unsubstituted or substituted with one or more equal or different Rp substituents; Rp is halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, Ci-C4-alkoxy or Ci-C4-haloalkoxy; IVIA / a / ZUZ l / U I Ó4U / Rrund to C is halogen, CN, NO2, Ci-C2-alkyl, Ci-C2-haloalkyl, Ci-C4-alkoxy, C1-C2haloalkoxy or S(O)mRk; or two Rr groups together form a 3- to 6-membered carbocycle or heterocycle, which heterocycle contains one or more of the same or different N, O or S heteroatoms, wherein S may be oxidized, and whose carbocycles or heterocycles are unsubstituted or substituted with Rs; Halogen Rses, CN, NO2, Ci-C2-alkyl, Ci-C2-haloalkyl, Cs-Ce-cycloalkyl, Ci-C4-alkoxy¡ or Ci-C2-haloalkoxy¡; R' attached to C is halogen, NO2, CN, Ci-Ce-alkyl, Ci-Ce-alkoxy, Ci-Ce-haloalkyl, Ci-Cehaloalkoxy, Cs-Ce-cycloalkyl, Cs-Ce-cycloalkoxy, Cs-Ce- halocycloalkyl, Cs-Cehalocycloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, S(O)mRw, =O, =S, =NRV, =NORVor =NSRV; or two R' attached to the same carbon atom or to adjacent carbon atoms together with the carbon atoms to which they are attached form a saturated or unsaturated 3- to 6-membered carbocycle or heterocycle, which heterocycle contains one or more N, O heteroatoms or Same or different, where S may be oxidized, where N is unsubstituted or substituted with one or more Same or different substituents; Rves Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl or Cs-Ce-halocycloalkyl; Rwes H, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Ce-cycloalkyl, Cs-Ce-halocycloalkyl, C1-C4alkoxy or Ci-C4-haloalkoxy; Halogen Rxes, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy¡, S(O)mRd, S(O)mNReRf, NReRf, C(O) NRaRh, Ci-Ci0-alkylcarbonyl, C1-C4haloalkylcarbonyl, Ci-C4-alkoxycarbonyl, Ci-C4-haloalkoxycarbonyl, Cs-Ce-cycloalkyl, 5- to 7-membered heterocyclyl, 5- or 6-membered hetaryl, aryl, Cs-Ce- cycloalkoxy, 3- to 6-membered heterocyclyloxy or phenoxy, wherein the cyclic moieties are unsubstituted or substituted with one or more equal or different substituents; Ryes halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, S(O)mRd, S(O)mNReRf, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, C1-C4alkoxycarbonyl, Ci-C4-haloalkoxycarbonyl, Cs-Ce-cycloalkyl, Cs-Ce-halocycloalkyl, C2C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl or Ci-C4-alkoxy- Ci-C4-alkyl; Raaes halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy or Ci-C4-haloalkoxy; RA1is CN, halogen, Ci-C4-alkoxy, C1 -C4-alkyl-S(O)m-, C(O)R2A, C(O)NR2AR3Aor C(GA)R2A; RA2 is CN, halogen, OH, Ci-C4-alkoxy, Ci-C4-alkoxycarbonyl or Ci-C4-alkyl-S(O)m-; RA3 is CN, halogen, Ci-C4-alkoxy or C1 -C4-alkyl-S(O)m-; RA4 is CN, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl or Ci-C4-alkoxy; RA5es CN, NO2, halogen, oxime ether, acylamido, Ci-C4-alkyl, Ci-C4-haloalkyl, C1-C4alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkyl-S(O)m-, Ci- C4-haloalkyl-S(O)m-; or aryl, aryloxy, hetaryl or hetaryloxy, the aromatic groups of which are unsubstituted or substituted with one or more identical or different RZ1 substituents; where RZ1es CN, NO2, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkyl-S(O)m-, Ci-C4-haloalkyl -S(O)m-, hetaryloxy or aryloxy; RA6is CN, NO2, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkyl-S(O)m- or Ci-C4-haloalkyl -S(0)m-; RA7is CN, NO2, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, OH, Ci-C4-alkoxy, C1-C4haloalkoxy, Ci-C4-alkyl-S(O)m- or Ci-C4-haloalkyl- S(O)m-; RA8es H, CN, NO2, Ci-C4-alkyl, Cs-Ce-cycloalkyl, Ci-Cs-haloalkyl, Ci-C4-alkoxy, C1-C4haloalkoxy, Cs-Ce-halogencycloalkyl, Ci-C4-alkoxy-Ci-C4 -alkyl, cyano-Ci-C4-alkyl, C3C6-cycloalkyl-Ci-C4-alkyl, C2-C6-alkenyl, Cs-Cs-alkynyl, Ci-C4-alkyl-S(O)m-, C1- C4alkylcarbonyl, Ci-Cs-haloalkylcarbonyl, Ci-Ce-alkoxycarbonyl, Ci-Cealkylaminocarbonyl, di-(Ci-C6)-alkylaminocarbonyl, Ci-Ce-alkylcarbonylamino, aryl or hetaryl, wherein the aryl or hetaryl groups do not are substituted or are substituted with one or more identical or different RZ2 substituents; where RZ2is CN, NO2, halogen, Ci-Cs-alkyl, Cs-Ce-alkenyl, Ca-Ce-alkynyl, Ci-C4-alkoxy, C1-C4haloalkyl, Ci-Ce-haloalkoxy or Ci-C4-alkylthio; RA9 is CN, halogen, Ci-C4-alkoxy, C1 -C4-alkyl-S(O)m-, C(O)OR2A, C(O)NR2AR3Aor C(GA)R2A; RA1° is Ci-C2-alkyl, Ci-C2-haloalkyl, Ci-C2-alkoxy; And thatOoS; m is 0, 1 or 2; and the salts, stereoisomers, tautomers and N-oxides thereof. Clause 8: The agrochemical composition according to clause 7, where RP1, RP2, RP3 are H and T is O. Clause 9: The agrochemical composition according to any of clauses 7 or 8, wherein R1 is H, Ci-C2-alkyl, Cs-Cs-cycloalkyl or Ci-C2-alkoxy-Ci-C2-alkyl; R2 is Ci-Ce-alkyl or Ci-Cs-haloalkyl; and R3 is H, Ci-C2-alkyl or Ci-C2-haloalkyl. Clause 10: The agrochemical composition according to any of clauses 7 to 9, wherein the active ingredient is a compound of Formula (la) Clause 11: The agrochemical composition according to any of clauses 7 to 10, wherein the active ingredient is a compound of Formula (Ib) Clause 12: The agrochemical composition according to any of clauses 7 to 11, where Z1 and Z3 are N and Z2 is CH. Clause 13: The agrochemical composition according to any of clauses 7 to 12, where Z1 is CH, Z2 is N and Z3 is CR4. Clause 14: The agrochemical composition according to any of clauses 1 to 13, containing a second active ingredient. Clause 15: The use of hydrophobically modified fumed silica as defined in any of clauses 1 to 14 to stabilize an aqueous agrochemical composition comprising suspended particles of an active ingredient. Advantages: The agrochemical composition is characterized by very high storage stability, low particle growth, reduced sedimentation, reduced gelation, an advantageous rheological profile and high biological efficiency. The term stability as used herein generally refers to the physical stability of the agrochemical formulation. Consequently, the term stabilizer generally refers to physical stabilization (e.g., increased storage stability). The following examples illustrate the invention. EXAMPLES The following ingredients were used to prepare the agrochemical compositions of the examples. Insecticide A: 1 -[(1 RS)-1,2-dimethylpropyl]- / V-ethyl-5-methyl- / V-pyridazin-4-I-1 / 7-pyrazole-4-carboxamide. Dispersant: lignosulfonate, about 9% by weight organic sulfur content Antifoam: dimethylsiloxane emulsion on silica particles, 20% by weight foam remover content Biocide A: glycol-based benzisothiazolinone solution Biocide B: aqueous composition of benzisothiazolinones and 5-chloro-2-methylisothiazolin-3-one Silica particles A: hydrophilic fumed silica particles, BET surface area 200 m2 / g, average particle diameter 12 nm. Silica particles B: hydrophilic fumed silica particles, BET surface 300 m2 / g. Silica C particles: hydrophilic fumed silica particles, BET surface 50 m2 / g. Silica D particles: hydrophobic fumed silica particles, BET surface 220-280 m2 / g, surface modified with octamethylcyclotetrasiloxane, carbon content 1.5-3% by weight. Silica E particles: hydrophobic fumed silica particles, BET surface 125-175 m2 / g, surface modified with octylsilyl groups, carbon content 4.5-6.5% by weight. Silica F particles: surface treated fumed silica particles, hydrophobic and hydrophilic properties, BET surface 190 m2 / g, produced by surface modification of silica B particles with hexadecylsilane, carbon content 0.9-1.8% by weight. Silica G particles: hydrophobic fumed silica particles, surface modified with dimethyldichlorosilane, water solubility below 0.1 g / L, BET surface 90-130 m2 / g, 0.6 to 1.2 wt% carbon content Silica H particles: hydrophobic fumed silica particles, BET surface 150-190 m2 / g, surface modified with dimethyldichlorosilane, carbon content 0.8-1.4% by weight. Wetting agent: ethoxylated castor oil, 40 ethylene oxide units polymerized per molecule on average, saponification value 58-66 (according to ISO 3657) Example 1: Suspension concentrates SC-1 to SC-8 and control SC-C1 containing the ingredients were prepared according to Table A. The suspension concentrates differed in the type of silica particle used, as provided in Table B, where SC-C1 was produced without silica particles. The suspension concentrates were prepared by adding in a first stage insecticide A, 50% of the total amount of the wetting agent, dispersing agent, antifoam, biocide A, biocide B, acetic acid and, in the case of SC-1 to SC- 8, silica particles to water. The resulting base grind was homogenized in a second stage until uniform and then ground in a ball mill until an average particle size of 2-3 micrometers was achieved. The resulting composition was mixed in a third step with xanthan gum, which had been hydrated as a 3% by weight dilution in water, and the remaining wetting agent until it became homogeneous. The suspension concentrates were then placed in a cycling chamber at 20°C / 40°C for a day or a month (24 hours at 20°C and then 24 hours at 40°C), after which the concentrates in suspension were analyzed by visual inspection and by evaluating rheological properties. The results of these analyzes were summarized in Table B. Component Concentration [% by weight] Insecticide A 20.85 Wetting agent 8.00 Dispersant 2.00 Antifoam 0.40 Biocide A 0.20 Biocide B 0.10 Xanthan gum 0.13 Acetic acid 0.09 Silica particles 1.00 Water up to 100 Table A: Ingredients of suspension concentrates SC-1 to SC-8 Concentrate in Concentrate Silica particles Stability analysis after incubation in the cycle chamber One day of incubation One month of incubation SC-C1 Equilibrated with water Gelified Gelified SC-1 Silica particles A Gelified Gelified SC-2 Silica particles B Gelified Gelified SC-3 Silica particles C Gelified Gelified SC-4 Silica particles D Fluid Fluid SC-5 Silica particles E Fluid Fluid SC-6 Silica particles F Fluid Slightly fluid SC-7 Silica particles G Fluid Fluid SC- 8 Silica particles H Fluid Fluid Table B: Silica particles contained in suspension concentrates SC-1 to SC-C8 and results of stability analyzes after incubation in the cycling chamber. SC-C1 did not contain silica particles, but was equilibrated with water. Example 2: Suspension concentrates SC-9 to SC-13 and SC-C2 containing the ingredients were prepared according to Table C. The suspension concentrates differed in the concentration of silica particles G, as provided in Table D . The suspension concentrates were prepared by adding in a first step insecticide A, 50% of the total amount of the wetting agent, dispersing agent, antifoam, biocide A, biocide B, acetic acid and the assigned amount of silica particles G to water. . The resulting base grind was homogenized in a second stage until uniform and then ground in a ball mill until an average particle size of 2-3 micrometers was achieved. The resulting composition was mixed in a third step with xanthan gum, which had been hydrated as a 3% by weight dilution in water, and the remaining wetting agent until it became homogeneous. The suspension concentrates were then placed in a 20°C / 40°C cycling chamber for two weeks (24 hours at 20°C and then 24 hours at 40°C), after which the suspension concentrates were analyzed by visual inspection and by evaluation of rheological properties. The results of these analyzes were summarized in Table D. Component Concentration [% by weight] Insecticide A 31.82 Wetting agent 8.00 Dispersant 3.00 Antifoam 0.40 Biocide A 0.20 Biocide B 0.10 Xanthan gum 0.06 Acetic acid 0.15 Silica particles G see Table D Water up to 100 Table C: Ingredients of suspension concentrates SC-9 to SC-14 Concentrate in Concentrate Concentration of silica G particles in % by weight Stability analysis after incubation in the cycle chamber SC-C2 0.0 Gelified SC-9 0.5 Fluid SC-10 1.0 Fluid SC-11 1.5 Fluid SC-12 2.0 Slightly fluid SC-13 3.0 Slightly fluid Table D: Silica particles contained in suspension concentrates SC-9 to SC-13 and results of stability analyzes after incubation in the cycling chamber. SC-C2 did not contain silica particles.

Claims

1) An aqueous agrochemical composition comprising a) suspended particles of dimpropyridaz; and b) hydrophobically modified fumed silica. 2) The agrochemical composition according to claim 1, containing dimpropyridaz in a concentration of at least 10% by weight based on the total weight of the agrochemical composition. 3) The agrochemical composition according to claim 1 or 2, containing silica in a concentration of 0.01 to 10% by weight depending on the total weight of the agrochemical composition. 4) The agrochemical composition according to any of claims 1 to 3, containing silica in a concentration of at least 0.1% by weight based on the total weight of the agrochemical composition. 5) The agrochemical composition according to any of claims 1 to 4, having a weight ratio of dimpropyridaz to silica of 500:1 to 5:

1. 6) The agrochemical composition according to any of claims 1 to 5, wherein the silica has a BET surface area of ​​10 to 500 m2 / g according to DIN ISO 9277:2014-01. 7) The agrochemical composition according to any of claims 1 to 6, wherein the silica has a carbon content of at least 0.5% by weight based on the total weight of the hydrophobically modified silica. 8) The agrochemical composition according to any of claims 1 to 7, wherein the suspended particles of the active ingredient have a mean diameter of 0.5 pm to 20 pm. 9) The agrochemical composition according to any of claims 1 to 8, wherein the hydrophobic fumed silica has at least one covalently bonded hydrocarbon chain containing from 1 to 20 carbon atoms. 10) The agrochemical composition according to any of claims 1 to 9, containing a second active ingredient selected from insecticides, fungicides and herbicides. 11) The use of hydrophobically modified fumed silica as defined in any of claims 1 to 9 to stabilize an aqueous agrochemical composition comprising suspended particles of dimpropyridaz as defined in any of claims 1 to 10. 12) A method for stabilizing an aqueous agrochemical composition comprising suspended particles of dimpropyridaz as defined in any of claims 1 to 10, comprising the step of contacting hydrophobically modified fumed silica as defined in any of claims 1 to 9 with dimpropyridaz particles as defined in any of claims 1 to 10 and water. 13) A method for treating, controlling, preventing or protecting animals against parasite infestation or infection by administering or applying orally, topically or parenterally to the animals the agrochemical composition 101 as defined in any of claims 1 to 10. 14) A method for preparing the agrochemical composition according to any of claims 1 to 10, comprising the step of contacting the hydrophobically modified fumed silica as defined in any of claims 1 to 9 with dimpropyridaz as defined in any of claims 1 to 10 in the presence of water. 15) The plant propagation material containing the agrochemical composition as defined in any of claims 1 to 10.